ID,Description,GeneRatio,BgRatio,pvalue,p.adjust,qvalue,geneID,Count
R-HSA-6791226,Major pathway of rRNA processing in the nucleolus and cytosol,11/54,184/10899,1.1987362637935783e-9,1.8936711379528322e-7,1.5921630885138015e-7,RPL37/RPL6/RPL12/RPS6/RPL30/DDX21/EXOSC7/RPL4/RPP30/RPS24/RPP38,11
R-HSA-72689,Formation of a pool of free 40S subunits,9/54,101/10899,1.3215465442825845e-9,1.8936711379528322e-7,1.5921630885138015e-7,RPL37/RPL6/RPL12/RPS6/EIF3H/RPL30/EIF3A/RPL4/RPS24,9
R-HSA-8868773,rRNA processing in the nucleus and cytosol,11/54,194/10899,2.1017574109812718e-9,1.8936711379528322e-7,1.5921630885138015e-7,RPL37/RPL6/RPL12/RPS6/RPL30/DDX21/EXOSC7/RPL4/RPP30/RPS24/RPP38,11
R-HSA-156827,L13a-mediated translational silencing of Ceruloplasmin expression,9/54,111/10899,3.0802547515729876e-9,1.8936711379528322e-7,1.5921630885138015e-7,RPL37/RPL6/RPL12/RPS6/EIF3H/RPL30/EIF3A/RPL4/RPS24,9
R-HSA-72706,GTP hydrolysis and joining of the 60S ribosomal subunit,9/54,112/10899,3.3368902711379468e-9,1.8936711379528322e-7,1.5921630885138015e-7,RPL37/RPL6/RPL12/RPS6/EIF3H/RPL30/EIF3A/RPL4/RPS24,9
R-HSA-72312,rRNA processing,11/54,204/10899,3.572964411231759e-9,1.8936711379528322e-7,1.5921630885138015e-7,RPL37/RPL6/RPL12/RPS6/RPL30/DDX21/EXOSC7/RPL4/RPP30/RPS24/RPP38,11
R-HSA-72613,Eukaryotic Translation Initiation,9/54,119/10899,5.722161990199317e-9,2.2745593911042285e-7,1.9124067704087194e-7,RPL37/RPL6/RPL12/RPS6/EIF3H/RPL30/EIF3A/RPL4/RPS24,9
R-HSA-72737,Cap-dependent Translation Initiation,9/54,119/10899,5.722161990199317e-9,2.2745593911042285e-7,1.9124067704087194e-7,RPL37/RPL6/RPL12/RPS6/EIF3H/RPL30/EIF3A/RPL4/RPS24,9
R-HSA-156842,Eukaryotic Translation Elongation,8/54,93/10899,1.5618541970039163e-8,5.518551496080504e-7,4.6398943396373664e-7,RPL37/RPL6/RPL12/EEF1G/RPS6/RPL30/RPL4/RPS24,8
R-HSA-72766,Translation,11/54,291/10899,1.4030417810925422e-7,4.461672863874284e-6,3.7512906568158502e-6,RPL37/RPL6/RPL12/EEF1G/RPS6/EIF3H/RPL30/EIF3A/RPL4/MRPS16/RPS24,11
R-HSA-156902,Peptide chain elongation,7/54,89/10899,2.4728184869619137e-7,6.552968990449072e-6,5.509613120073037e-6,RPL37/RPL6/RPL12/RPS6/RPL30/RPL4/RPS24,7
R-HSA-192823,Viral mRNA Translation,7/54,89/10899,2.4728184869619137e-7,6.552968990449072e-6,5.509613120073037e-6,RPL37/RPL6/RPL12/RPS6/RPL30/RPL4/RPS24,7
R-HSA-2408557,Selenocysteine synthesis,7/54,93/10899,3.3488070491285376e-7,7.606576011591965e-6,6.395466093824426e-6,RPL37/RPL6/RPL12/RPS6/RPL30/RPL4/RPS24,7
R-HSA-72764,Eukaryotic Translation Termination,7/54,93/10899,3.3488070491285376e-7,7.606576011591965e-6,6.395466093824426e-6,RPL37/RPL6/RPL12/RPS6/RPL30/RPL4/RPS24,7
R-HSA-975956,Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),7/54,95/10899,3.8765775436682474e-7,8.218344392576684e-6,6.909829446257788e-6,RPL37/RPL6/RPL12/RPS6/RPL30/RPL4/RPS24,7
R-HSA-9633012,Response of EIF2AK4 (GCN2) to amino acid deficiency,7/54,101/10899,5.898306611098557e-7,1.1722884389558383e-5,9.85638078433575e-6,RPL37/RPL6/RPL12/RPS6/RPL30/RPL4/RPS24,7
R-HSA-1799339,SRP-dependent cotranslational protein targeting to membrane,7/54,112/10899,1.1916439547996524e-6,2.2290751625075854e-5,1.8741644861864505e-5,RPL37/RPL6/RPL12/RPS6/RPL30/RPL4/RPS24,7
R-HSA-927802,Nonsense-Mediated Decay (NMD),7/54,115/10899,1.4248722370986352e-6,2.3847861652492945e-5,2.0050833696568052e-5,RPL37/RPL6/RPL12/RPS6/RPL30/RPL4/RPS24,7
R-HSA-975957,Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC),7/54,115/10899,1.4248722370986352e-6,2.3847861652492945e-5,2.0050833696568052e-5,RPL37/RPL6/RPL12/RPS6/RPL30/RPL4/RPS24,7
R-HSA-2408522,Selenoamino acid metabolism,7/54,118/10899,1.695200476738156e-6,2.695368758013668e-5,2.266215374165746e-5,RPL37/RPL6/RPL12/RPS6/RPL30/RPL4/RPS24,7
R-HSA-168273,Influenza Viral RNA Transcription and Replication,7/54,135/10899,4.1732577561418534e-6,6.319504602157664e-5,5.31332065192998e-5,RPL37/RPL6/RPL12/RPS6/RPL30/RPL4/RPS24,7
R-HSA-168255,Influenza Infection,7/54,156/10899,1.083434339450047e-5,1.497965738891804e-4,1.2594614289259128e-4,RPL37/RPL6/RPL12/RPS6/RPL30/RPL4/RPS24,7
R-HSA-9711097,Cellular response to starvation,7/54,156/10899,1.083434339450047e-5,1.497965738891804e-4,1.2594614289259128e-4,RPL37/RPL6/RPL12/RPS6/RPL30/RPL4/RPS24,7
R-HSA-9010553,Regulation of expression of SLITs and ROBOs,7/54,171/10899,1.9699851819469567e-5,2.6102303660797174e-4,2.1946326149759963e-4,RPL37/RPL6/RPL12/RPS6/RPL30/RPL4/RPS24,7
R-HSA-376176,Signaling by ROBO receptors,7/54,218/10899,9.268357136458564e-5,0.0011789350277575294,9.912264053307264e-4,RPL37/RPL6/RPL12/RPS6/RPL30/RPL4/RPS24,7
R-HSA-72695,"Formation of the ternary complex, and subsequently, the 43S complex",4/54,51/10899,1.1317790145629636e-4,0.0013842527947347015,0.0011638537234777038,RPS6/EIF3H/EIF3A/RPS24,4
R-HSA-72649,Translation initiation complex formation,4/54,58/10899,1.8728431936928874e-4,0.002127014769979779,0.0017883540270601257,RPS6/EIF3H/EIF3A/RPS24,4
R-HSA-72702,Ribosomal scanning and start codon recognition,4/54,58/10899,1.8728431936928874e-4,0.002127014769979779,0.0017883540270601257,RPS6/EIF3H/EIF3A/RPS24,4
R-HSA-72662,"Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S",4/54,59/10899,2.0017064620397914e-4,0.0021949746721677712,0.0018454934350566501,RPS6/EIF3H/EIF3A/RPS24,4
R-HSA-170834,Signaling by TGF-beta Receptor Complex,4/54,93/10899,0.0011340301342692813,0.012020719423254382,0.010106794880856052,SMAD2/UCHL5/MYC/UBE2D1,4
R-HSA-2173793,Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer,3/54,51/10899,0.0020239271325874887,0.020761575102026496,0.017455941992435386,SMAD2/MYC/UBE2D1,3
R-HSA-71291,Metabolism of amino acids and derivatives,7/54,374/10899,0.00233566844397195,0.02321070516197125,0.01951512449897616,RPL37/RPL6/RPL12/RPS6/RPL30/RPL4/RPS24,7
R-HSA-9700206,Signaling by ALK in cancer,3/54,55/10899,0.002514390622561107,0.023516947587483295,0.019772607372461958,EEF1G/RPS6/KIF5B,3
R-HSA-9725370,Signaling by ALK fusions and activated point mutants,3/54,55/10899,0.002514390622561107,0.023516947587483295,0.019772607372461958,EEF1G/RPS6/KIF5B,3
R-HSA-9006936,Signaling by TGFB family members,4/54,122/10899,0.0030692347231921326,0.02788618977071709,0.02344618405085118,SMAD2/UCHL5/MYC/UBE2D1,4
R-HSA-5688426,Deubiquitination,6/54,298/10899,0.0034059986983866423,0.030086321835748674,0.025296013724859866,SMAD2/VDAC2/UCHL5/IDE/MYC/UBE2D1,6
R-HSA-9725371,Nuclear events stimulated by ALK signaling in cancer,2/54,19/10899,0.0039036408689124957,0.033550210711193885,0.028208386364260995,RPS6/KIF5B,2
R-HSA-141405,Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components,2/54,21/10899,0.004763668802769829,0.038842222545661685,0.03265781041574998,BUB3/UBE2D1,2
R-HSA-141430,Inactivation of APC/C via direct inhibition of the APC/C complex,2/54,21/10899,0.004763668802769829,0.038842222545661685,0.03265781041574998,BUB3/UBE2D1,2
R-HSA-8949215,Mitochondrial calcium ion transport,2/54,23/10899,0.005702866070082153,0.04533778525715312,0.03811915741581229,YME1L1/VDAC2,2
R-HSA-179409,APC-Cdc20 mediated degradation of Nek2A,2/54,26/10899,0.007256632072305288,0.05494307140459718,0.04619510141267027,BUB3/UBE2D1,2
R-HSA-2173788,Downregulation of TGF-beta receptor signaling,2/54,26/10899,0.007256632072305288,0.05494307140459718,0.04619510141267027,SMAD2/UCHL5,2
R-HSA-380994,ATF4 activates genes in response to endoplasmic reticulum  stress,2/54,27/10899,0.00781243040873759,0.05777564813903613,0.04857667867366825,NFYA/EXOSC7,2
R-HSA-2173795,Downregulation of SMAD2/3:SMAD4 transcriptional activity,2/54,30/10899,0.00959076019163004,0.06931503956678074,0.05827878202569451,SMAD2/UBE2D1,2
R-HSA-381042,PERK regulates gene expression,2/54,32/10899,0.010866865587932036,0.07679251682138638,0.0645657043119237,NFYA/EXOSC7,2
R-HSA-2173796,SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription,2/54,36/10899,0.01362970737836946,0.09221802013449976,0.07753517747157543,SMAD2/MYC,2
R-HSA-9735869,SARS-CoV-1 modulates host translation machinery,2/54,36/10899,0.01362970737836946,0.09221802013449976,0.07753517747157543,RPS6/RPS24,2
R-HSA-446203,Asparagine N-linked glycosylation,5/54,304/10899,0.01693757829194458,0.11221145618413285,0.09434528259109483,ARF1/NUS1/SEC24C/DERL1/PPP6C,5
R-HSA-5663202,Diseases of signal transduction by growth factor receptors and second messengers,6/54,433/10899,0.01959157413501218,0.1271453178557933,0.10690139270232211,EEF1G/RPS6/SMAD2/CTBP2/KIF5B/MYC,6
R-HSA-2173789,TGF-beta receptor signaling activates SMADs,2/54,46/10899,0.021698416558679646,0.13800192931320254,0.11602942749272907,SMAD2/UCHL5,2
R-HSA-2132295,MHC class II antigen presentation,3/54,123/10899,0.022915957546534516,0.14230779865115176,0.11964972147432158,ARF1/SEC24C/KIF5B,3
R-HSA-5689880,Ub-specific processing proteases,4/54,220/10899,0.02327045764106884,0.14230779865115176,0.11964972147432158,SMAD2/VDAC2/IDE/MYC,4
R-HSA-9754678,SARS-CoV-2 modulates host translation machinery,2/54,50/10899,0.025361437820962437,0.15216862692577462,0.12794052048707966,RPS6/RPS24,2
R-HSA-1655829,Regulation of cholesterol biosynthesis by SREBP (SREBF),2/54,55/10899,0.030266534285547205,0.17823625745933355,0.14985769412337216,NFYA/SEC24C,2
R-HSA-6784531,tRNA processing in the nucleus,2/54,57/10899,0.03232599473205588,0.18690302408715945,0.1571445485539176,RPP30/RPP38,2
R-HSA-8866654,E3 ubiquitin ligases ubiquitinate target proteins,2/54,59/10899,0.03443925372771975,0.19556576223955144,0.16442801591806047,DERL1/UBE2D1,2
R-HSA-5678895,Defective CFTR causes cystic fibrosis,2/54,61/10899,0.03660508920093356,0.20421786606836617,0.1717025421428832,ERLIN1/DERL1,2
R-HSA-9033241,Peroxisomal protein import,2/54,63/10899,0.03882229719318275,0.21285328461089853,0.17896303969271182,IDE/UBE2D1,2
R-HSA-199977,ER to Golgi Anterograde Transport,3/54,154/10899,0.040639337591199455,0.2177753656451668,0.18310143288272882,ARF1/SEC24C/PPP6C,3
R-HSA-9614085,FOXO-mediated transcription,2/54,65/10899,0.04108969163116355,0.2177753656451668,0.18310143288272882,NFYA/SMAD2,2
R-HSA-204005,COPII-mediated vesicle transport,2/54,68/10899,0.04458233174367964,0.22866421765306655,0.19225657492181036,SEC24C/PPP6C,2
R-HSA-5693571,Nonhomologous End-Joining (NHEJ),2/54,68/10899,0.04458233174367964,0.22866421765306655,0.19225657492181036,DCLRE1C/NHEJ1,2
R-HSA-381183,ATF6 (ATF6-alpha) activates chaperone genes,1/54,10/10899,0.048475217343111776,0.24086123617358662,0.20251159876892091,NFYA,1
R-HSA-390450,Folding of actin by CCT/TriC,1/54,10/10899,0.048475217343111776,0.24086123617358662,0.20251159876892091,CCT8,1
R-HSA-174184,Cdc20:Phospho-APC/C mediated degradation of Cyclin A,2/54,73/10899,0.050638025813494913,0.24706775113119328,0.2077299198521122,BUB3/UBE2D1,2
R-HSA-179419,APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint,2/54,74/10899,0.051883102303876556,0.24706775113119328,0.2077299198521122,BUB3/UBE2D1,2
R-HSA-5625970,RHO GTPases activate KTN1,1/54,11/10899,0.05319395535977789,0.24706775113119328,0.2077299198521122,KIF5B,1
R-HSA-176409,APC/C:Cdc20 mediated degradation of mitotic proteins,2/54,76/10899,0.054406099205524416,0.24706775113119328,0.2077299198521122,BUB3/UBE2D1,2
R-HSA-176814,Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins,2/54,77/10899,0.05568375082092508,0.24706775113119328,0.2077299198521122,BUB3/UBE2D1,2
R-HSA-5619084,ABC transporter disorders,2/54,78/10899,0.05697199371324927,0.24706775113119328,0.2077299198521122,ERLIN1/DERL1,2
R-HSA-381033,ATF6 (ATF6-alpha) activates chaperones,1/54,12/10899,0.05788972376633261,0.24706775113119328,0.2077299198521122,NFYA,1
R-HSA-4641265,Repression of WNT target genes,1/54,12/10899,0.05788972376633261,0.24706775113119328,0.2077299198521122,CTBP2,1
R-HSA-71384,Ethanol oxidation,1/54,12/10899,0.05788972376633261,0.24706775113119328,0.2077299198521122,ALDH1B1,1
R-HSA-9755088,Ribavirin ADME,1/54,12/10899,0.05788972376633261,0.24706775113119328,0.2077299198521122,NT5C2,1
R-HSA-8852135,Protein ubiquitination,2/54,79/10899,0.05827069602150785,0.24706775113119328,0.2077299198521122,DERL1/UBE2D1,2
R-HSA-9694516,SARS-CoV-2 Infection,4/54,298/10899,0.05966266406332729,0.24964114700181683,0.2098935827158606,RPS6/SEC24C/SRPK1/RPS24,4
R-HSA-176408,Regulation of APC/C activators between G1/S and early anaphase,2/54,81/10899,0.0608989564512393,0.25150478118823505,0.21146049130027048,BUB3/UBE2D1,2
R-HSA-171007,p38MAPK events,1/54,13/10899,0.06256263227341607,0.25506303926854246,0.21445220779281626,RALB,1
R-HSA-948021,Transport to the Golgi and subsequent modification,3/54,185/10899,0.06359621551347153,0.25599489282637905,0.2152356927437944,ARF1/SEC24C/PPP6C,3
R-HSA-3656237,Defective EXT2 causes exostoses 2,1/54,14/10899,0.067212790077682,0.26258870419313335,0.2207796453659579,EXT1,1
R-HSA-3656253,"Defective EXT1 causes exostoses 1, TRPS2 and CHDS",1/54,14/10899,0.067212790077682,0.26258870419313335,0.2207796453659579,EXT1,1
R-HSA-174143,APC/C-mediated degradation of cell cycle proteins,2/54,88/10899,0.07040842497606764,0.26258870419313335,0.2207796453659579,BUB3/UBE2D1,2
R-HSA-453276,Regulation of mitotic cell cycle,2/54,88/10899,0.07040842497606764,0.26258870419313335,0.2207796453659579,BUB3/UBE2D1,2
R-HSA-1502540,Signaling by Activin,1/54,15/10899,0.07184030586415913,0.26258870419313335,0.2207796453659579,SMAD2,1
R-HSA-5609975,Diseases associated with glycosylation precursor biosynthesis,1/54,15/10899,0.07184030586415913,0.26258870419313335,0.2207796453659579,NUS1,1
R-HSA-6785631,ERBB2 Regulates Cell Motility,1/54,15/10899,0.07184030586415913,0.26258870419313335,0.2207796453659579,DIAPH1,1
R-HSA-9694631,Maturation of nucleoprotein,1/54,15/10899,0.07184030586415913,0.26258870419313335,0.2207796453659579,SRPK1,1
R-HSA-429958,mRNA decay by 3' to 5' exoribonuclease,1/54,16/10899,0.0764452878086036,0.26292708426926786,0.22106414897184395,EXOSC7,1
R-HSA-8949664,Processing of SMDT1,1/54,16/10899,0.0764452878086036,0.26292708426926786,0.22106414897184395,YME1L1,1
R-HSA-9614657,FOXO-mediated transcription of cell death genes,1/54,16/10899,0.0764452878086036,0.26292708426926786,0.22106414897184395,NFYA,1
R-HSA-9705683,SARS-CoV-2-host interactions,3/54,202/10899,0.07825775623388591,0.26292708426926786,0.22106414897184395,RPS6/SEC24C/RPS24,3
R-HSA-381119,Unfolded Protein Response (UPR),2/54,94/10899,0.07891971058164428,0.26292708426926786,0.22106414897184395,NFYA/EXOSC7,2
R-HSA-9692914,SARS-CoV-1-host interactions,2/54,95/10899,0.0803686297534728,0.26292708426926786,0.22106414897184395,RPS6/RPS24,2
R-HSA-450385,Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA,1/54,17/10899,0.08102784357983728,0.26292708426926786,0.22106414897184395,EXOSC7,1
R-HSA-450513,"Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA",1/54,17/10899,0.08102784357983728,0.26292708426926786,0.22106414897184395,EXOSC7,1
R-HSA-450604,KSRP (KHSRP) binds and destabilizes mRNA,1/54,17/10899,0.08102784357983728,0.26292708426926786,0.22106414897184395,EXOSC7,1
R-HSA-9617828,FOXO-mediated transcription of cell cycle genes,1/54,17/10899,0.08102784357983728,0.26292708426926786,0.22106414897184395,SMAD2,1
R-HSA-9754189,Germ layer formation at gastrulation,1/54,17/10899,0.08102784357983728,0.26292708426926786,0.22106414897184395,SMAD2,1
R-HSA-1660514,Synthesis of PIPs at the Golgi membrane,1/54,18/10899,0.08558808034207654,0.27154940900510227,0.228313637495187,ARF1,1
R-HSA-74259,Purine catabolism,1/54,18/10899,0.08558808034207654,0.27154940900510227,0.228313637495187,NT5C2,1
R-HSA-6811434,COPI-dependent Golgi-to-ER retrograde traffic,2/54,99/10899,0.08624682487268971,0.27154940900510227,0.228313637495187,ARF1/KIF5B,2
R-HSA-1362277,Transcription of E2F targets under negative control by DREAM complex,1/54,19/10899,0.09012610475725258,0.27611158999969626,0.2321494334985861,MYC,1
R-HSA-9758941,Gastrulation,1/54,19/10899,0.09012610475725258,0.27611158999969626,0.2321494334985861,SMAD2,1
R-HSA-382556,ABC-family proteins mediated transport,2/54,103/10899,0.09225163709013652,0.27611158999969626,0.2321494334985861,ERLIN1/DERL1,2
R-HSA-167044,Signalling to RAS,1/54,20/10899,0.09464202298731728,0.27611158999969626,0.2321494334985861,RALB,1
R-HSA-168927,"TICAM1, RIP1-mediated IKK complex recruitment",1/54,20/10899,0.09464202298731728,0.27611158999969626,0.2321494334985861,UBE2D1,1
R-HSA-176407,Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase,1/54,20/10899,0.09464202298731728,0.27611158999969626,0.2321494334985861,UBE2D1,1
R-HSA-176412,Phosphorylation of the APC/C,1/54,20/10899,0.09464202298731728,0.27611158999969626,0.2321494334985861,UBE2D1,1
R-HSA-9687136,Aberrant regulation of mitotic exit in cancer due to RB1 defects,1/54,20/10899,0.09464202298731728,0.27611158999969626,0.2321494334985861,UBE2D1,1
R-HSA-72306,tRNA processing,2/54,107/10899,0.09837603144983305,0.2840110733468589,0.23879117057299623,RPP30/RPP38,2
R-HSA-164938,Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters,1/54,21/10899,0.09913594069654508,0.2840110733468589,0.23879117057299623,ARF1,1
R-HSA-1181150,Signaling by NODAL,1/54,22/10899,0.10360796305381526,0.2941726093849398,0.24733479901944624,SMAD2,1
R-HSA-69618,Mitotic Spindle Checkpoint,2/54,113/10899,0.10777198710388042,0.29880439935388103,0.251229120939708,BUB3/UBE2D1,2
R-HSA-171319,Telomere Extension By Telomerase,1/54,23/10899,0.10805819473489409,0.29880439935388103,0.251229120939708,PPP6C,1
R-HSA-5620922,BBSome-mediated cargo-targeting to cilium,1/54,23/10899,0.10805819473489409,0.29880439935388103,0.251229120939708,CCT8,1
R-HSA-166208,mTORC1-mediated signalling,1/54,24/10899,0.11248673992469838,0.30314223132249224,0.25487628850020866,RPS6,1
R-HSA-174048,APC/C:Cdc20 mediated degradation of Cyclin B,1/54,24/10899,0.11248673992469838,0.30314223132249224,0.25487628850020866,UBE2D1,1
R-HSA-452723,Transcriptional regulation of pluripotent stem cells,1/54,24/10899,0.11248673992469838,0.30314223132249224,0.25487628850020866,SMAD2,1
R-HSA-389960,Formation of tubulin folding intermediates by CCT/TriC,1/54,25/10899,0.1168937023195552,0.3072082424596575,0.2582949142163291,CCT8,1
R-HSA-937041,IKK complex recruitment mediated by RIP1,1/54,25/10899,0.1168937023195552,0.3072082424596575,0.2582949142163291,UBE2D1,1
R-HSA-9705462,Inactivation of CSF3 (G-CSF) signaling,1/54,25/10899,0.1168937023195552,0.3072082424596575,0.2582949142163291,UBE2D1,1
R-HSA-3238698,WNT ligand biogenesis and trafficking,1/54,26/10899,0.12127918512944513,0.30972532219780524,0.260411227534732,VPS26A,1
R-HSA-6803529,FGFR2 alternative splicing,1/54,26/10899,0.12127918512944513,0.30972532219780524,0.260411227534732,TIAL1,1
R-HSA-1630316,Glycosaminoglycan metabolism,2/54,124/10899,0.12558434415806963,0.30972532219780524,0.260411227534732,B3GNT2/EXT1,2
R-HSA-9007101,Rab regulation of trafficking,2/54,124/10899,0.12558434415806963,0.30972532219780524,0.260411227534732,GDI2/GGA2,2
R-HSA-1538133,G0 and Early G1,1/54,27/10899,0.12564329108024175,0.30972532219780524,0.260411227534732,MYC,1
R-HSA-201556,Signaling by ALK,1/54,27/10899,0.12564329108024175,0.30972532219780524,0.260411227534732,MYC,1
R-HSA-264876,Insulin processing,1/54,27/10899,0.12564329108024175,0.30972532219780524,0.260411227534732,KIF5B,1
R-HSA-77387,Insulin receptor recycling,1/54,27/10899,0.12564329108024175,0.30972532219780524,0.260411227534732,IDE,1
R-HSA-164952,The role of Nef in HIV-1 replication and disease pathogenesis,1/54,28/10899,0.1299861224159362,0.31079388667870467,0.26130965645942067,ARF1,1
R-HSA-201451,Signaling by BMP,1/54,28/10899,0.1299861224159362,0.31079388667870467,0.26130965645942067,UBE2D1,1
R-HSA-2022854,Keratan sulfate biosynthesis,1/54,28/10899,0.1299861224159362,0.31079388667870467,0.26130965645942067,B3GNT2,1
R-HSA-389957,Prefoldin mediated transfer of substrate  to CCT/TriC,1/54,28/10899,0.1299861224159362,0.31079388667870467,0.26130965645942067,CCT8,1
R-HSA-9615017,"FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes",1/54,29/10899,0.1343077809008536,0.31636943945534407,0.26599747640402976,SMAD2,1
R-HSA-983170,"Antigen Presentation: Folding, assembly and peptide loading of class I MHC",1/54,29/10899,0.1343077809008536,0.31636943945534407,0.26599747640402976,SEC24C,1
R-HSA-8866652,Synthesis of active ubiquitin: roles of E1 and E2 enzymes,1/54,30/10899,0.13860836782186148,0.321733291732496,0.2705073025490036,UBE2D1,1
R-HSA-9674555,Signaling by CSF3 (G-CSF),1/54,30/10899,0.13860836782186148,0.321733291732496,0.2705073025490036,UBE2D1,1
R-HSA-8856688,Golgi-to-ER retrograde transport,2/54,133/10899,0.14064841658812524,0.324102873007419,0.2724996019327522,ARF1/KIF5B,2
R-HSA-2022928,HS-GAG biosynthesis,1/54,31/10899,0.14288798399056313,0.32689481229495737,0.27484701199245015,EXT1,1
R-HSA-389958,Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding,1/54,32/10899,0.14714672974548693,0.33244263796623585,0.2795115195081891,CCT8,1
R-HSA-9679506,SARS-CoV Infections,4/54,413/10899,0.14740381117370835,0.33244263796623585,0.2795115195081891,RPS6/SEC24C/SRPK1/RPS24,4
R-HSA-5694530,Cargo concentration in the ER,1/54,33/10899,0.15138470495426037,0.33652979863729876,0.282947927354763,SEC24C,1
R-HSA-5663220,RHO GTPases Activate Formins,2/54,140/10899,0.1526251979179738,0.33652979863729876,0.282947927354763,DIAPH1/BUB3,2
R-HSA-9678108,SARS-CoV-1 Infection,2/54,141/10899,0.15435285621329642,0.33652979863729876,0.282947927354763,RPS6/RPS24,2
R-HSA-1638074,Keratan sulfate/keratin metabolism,1/54,34/10899,0.15560200901577992,0.33652979863729876,0.282947927354763,B3GNT2,1
R-HSA-187687,Signalling to ERKs,1/54,34/10899,0.15560200901577992,0.33652979863729876,0.282947927354763,RALB,1
R-HSA-4791275,Signaling by WNT in cancer,1/54,34/10899,0.15560200901577992,0.33652979863729876,0.282947927354763,CTBP2,1
R-HSA-3781865,Diseases of glycosylation,2/54,143/10899,0.15781988347628623,0.33652979863729876,0.282947927354763,NUS1/EXT1,2
R-HSA-432720,Lysosome Vesicle Biogenesis,1/54,35/10899,0.15979874086236512,0.33652979863729876,0.282947927354763,ARF1,1
R-HSA-532668,N-glycan trimming in the ER and Calnexin/Calreticulin cycle,1/54,35/10899,0.15979874086236512,0.33652979863729876,0.282947927354763,DERL1,1
R-HSA-936440,Negative regulators of DDX58/IFIH1 signaling,1/54,35/10899,0.15979874086236512,0.33652979863729876,0.282947927354763,UBE2D1,1
R-HSA-8956319,Nucleotide catabolism,1/54,36/10899,0.16397499896190793,0.34081078215612237,0.2865472978075309,NT5C2,1
R-HSA-9687139,Aberrant regulation of mitotic cell cycle due to RB1 defects,1/54,36/10899,0.16397499896190793,0.34081078215612237,0.2865472978075309,UBE2D1,1
R-HSA-2514859,"Inactivation, recovery and regulation of the phototransduction cascade",1/54,37/10899,0.1681308813200093,0.34453297096421664,0.28967684417382006,METAP1,1
R-HSA-2514856,The phototransduction cascade,1/54,38/10899,0.17226648548210832,0.34453297096421664,0.28967684417382006,METAP1,1
R-HSA-6814122,Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding,1/54,38/10899,0.17226648548210832,0.34453297096421664,0.28967684417382006,CCT8,1
R-HSA-8864260,Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors,1/54,38/10899,0.17226648548210832,0.34453297096421664,0.28967684417382006,MYC,1
R-HSA-8950505,Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation,1/54,38/10899,0.17226648548210832,0.34453297096421664,0.28967684417382006,ARF1,1
R-HSA-9675126,Diseases of mitotic cell cycle,1/54,38/10899,0.17226648548210832,0.34453297096421664,0.28967684417382006,UBE2D1,1
R-HSA-390471,Association of TriC/CCT with target proteins during biosynthesis,1/54,39/10899,0.17638190853559943,0.34558968740527174,0.2905653114893712,CCT8,1
R-HSA-5689896,Ovarian tumor domain proteases,1/54,39/10899,0.17638190853559943,0.34558968740527174,0.2905653114893712,UBE2D1,1
R-HSA-8853884,Transcriptional Regulation by VENTX,1/54,39/10899,0.17638190853559943,0.34558968740527174,0.2905653114893712,UBE2D1,1
R-HSA-8957322,Metabolism of steroids,2/54,154/10899,0.17714188379578394,0.34558968740527174,0.2905653114893712,NFYA/SEC24C,2
R-HSA-6783310,Fanconi Anemia Pathway,1/54,40/10899,0.18047724711194169,0.3499497840341308,0.29423119875759435,DCLRE1A,1
R-HSA-165159,MTOR signalling,1/54,41/10899,0.18455259738875862,0.3535405178893087,0.2972502202710507,RPS6,1
R-HSA-3560782,Diseases associated with glycosaminoglycan metabolism,1/54,41/10899,0.18455259738875862,0.3535405178893087,0.2972502202710507,EXT1,1
R-HSA-2426168,Activation of gene expression by SREBF (SREBP),1/54,42/10899,0.18860805509192724,0.357008104281148,0.30016570171271634,NFYA,1
R-HSA-9035034,RHOF GTPase cycle,1/54,42/10899,0.18860805509192724,0.357008104281148,0.30016570171271634,DIAPH1,1
R-HSA-69242,S Phase,2/54,163/10899,0.19322115880169147,0.3614372264643405,0.3038896243692238,MYC/UBE2D1,2
R-HSA-9609507,Protein localization,2/54,163/10899,0.19322115880169147,0.3614372264643405,0.3038896243692238,IDE/UBE2D1,2
R-HSA-6811438,Intra-Golgi traffic,1/54,44/10899,0.19665967343457247,0.36571798919411724,0.3074888091867123,ARF1,1
R-HSA-5693532,DNA Double-Strand Break Repair,2/54,168/10899,0.20223898388793163,0.3739069585835015,0.3143739406825865,DCLRE1C/NHEJ1,2
R-HSA-8854214,TBC/RABGAPs,1/54,46/10899,0.2046328589907963,0.37614594889637704,0.3162564416407805,GGA2,1
R-HSA-9020591,Interleukin-12 signaling,1/54,47/10899,0.2085902740478769,0.3812167077426716,0.32051984033975034,ARF1,1
R-HSA-2122947,NOTCH1 Intracellular Domain Regulates Transcription,1/54,48/10899,0.21252836151575516,0.3861943940686294,0.3247049854135447,MYC,1
R-HSA-5619115,Disorders of transmembrane transporters,2/54,176/10899,0.2167689924143603,0.3914543114381933,0.3291274250423738,ERLIN1/DERL1,2
R-HSA-195258,RHO GTPase Effectors,3/54,327/10899,0.22005468900557454,0.3914543114381933,0.3291274250423738,DIAPH1/KIF5B/BUB3,3
R-HSA-1227986,Signaling by ERBB2,1/54,50/10899,0.22034692373407738,0.3914543114381933,0.3291274250423738,DIAPH1,1
R-HSA-1483249,Inositol phosphate metabolism,1/54,50/10899,0.22034692373407738,0.3914543114381933,0.3291274250423738,MINPP1,1
R-HSA-180786,Extension of Telomeres,1/54,51/10899,0.22422758242320617,0.39394680226839535,0.33122306446928973,PPP6C,1
R-HSA-5620920,Cargo trafficking to the periciliary membrane,1/54,51/10899,0.22422758242320617,0.39394680226839535,0.33122306446928973,CCT8,1
R-HSA-195721,Signaling by WNT,3/54,332/10899,0.22658846808672917,0.39590732336032897,0.3328714337422164,CTBP2/VPS26A/MYC,3
R-HSA-73894,DNA Repair,3/54,336/10899,0.23184404306293482,0.39887754669454706,0.3353687416763157,DCLRE1C/DCLRE1A/NHEJ1,3
R-HSA-1660499,Synthesis of PIPs at the plasma membrane,1/54,53/10899,0.23193211156991256,0.39887754669454706,0.3353687416763157,ARF1,1
R-HSA-9013405,RHOD GTPase cycle,1/54,54/10899,0.23575616338396588,0.39887754669454706,0.3353687416763157,DIAPH1,1
R-HSA-1638091,Heparan sulfate/heparin (HS-GAG) metabolism,1/54,55/10899,0.23956152688578847,0.39887754669454706,0.3353687416763157,EXT1,1
R-HSA-3371497,HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand,1/54,55/10899,0.23956152688578847,0.39887754669454706,0.3353687416763157,DNAJA1,1
R-HSA-429914,Deadenylation-dependent mRNA decay,1/54,55/10899,0.23956152688578847,0.39887754669454706,0.3353687416763157,EXOSC7,1
R-HSA-2151201,Transcriptional activation of mitochondrial biogenesis,1/54,56/10899,0.24334829169104177,0.39887754669454706,0.3353687416763157,TFAM,1
R-HSA-432722,Golgi Associated Vesicle Biogenesis,1/54,56/10899,0.24334829169104177,0.39887754669454706,0.3353687416763157,ARF1,1
R-HSA-2467813,Separation of Sister Chromatids,2/54,191/10899,0.24425351741010623,0.39887754669454706,0.3353687416763157,BUB3/UBE2D1,2
R-HSA-447115,Interleukin-12 family signaling,1/54,57/10899,0.24711654699388086,0.39887754669454706,0.3353687416763157,ARF1,1
R-HSA-936837,Ion transport by P-type ATPases,1/54,57/10899,0.24711654699388086,0.39887754669454706,0.3353687416763157,CUTC,1
R-HSA-9694635,Translation of Structural Proteins,1/54,57/10899,0.24711654699388086,0.39887754669454706,0.3353687416763157,SRPK1,1
R-HSA-2644602,Signaling by NOTCH1 PEST Domain Mutants in Cancer,1/54,58/10899,0.2508663815688975,0.39887754669454706,0.3353687416763157,MYC,1
R-HSA-2644603,Signaling by NOTCH1 in Cancer,1/54,58/10899,0.2508663815688975,0.39887754669454706,0.3353687416763157,MYC,1
R-HSA-2644606,Constitutive Signaling by NOTCH1 PEST Domain Mutants,1/54,58/10899,0.2508663815688975,0.39887754669454706,0.3353687416763157,MYC,1
R-HSA-2894858,Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer,1/54,58/10899,0.2508663815688975,0.39887754669454706,0.3353687416763157,MYC,1
R-HSA-2894862,Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants,1/54,58/10899,0.2508663815688975,0.39887754669454706,0.3353687416763157,MYC,1
R-HSA-917937,Iron uptake and transport,1/54,58/10899,0.2508663815688975,0.39887754669454706,0.3353687416763157,GLRX3,1
R-HSA-983189,Kinesins,1/54,59/10899,0.2545978837730559,0.40279665193946157,0.3386638516803154,KIF5B,1
R-HSA-6790901,rRNA modification in the nucleus and cytosol,1/54,61/10899,0.2620062424200631,0.4124652727206934,0.3467930462464619,RPS6,1
R-HSA-6811442,Intra-Golgi and retrograde Golgi-to-ER traffic,2/54,202/10899,0.26451994989680694,0.4143711530403183,0.3483954745853719,ARF1/KIF5B,2
R-HSA-446219,Synthesis of substrates in N-glycan biosythesis,1/54,63/10899,0.2693423215110391,0.41780906458785577,0.3512860059758867,NUS1,1
R-HSA-913709,O-linked glycosylation of mucins,1/54,63/10899,0.2693423215110391,0.41780906458785577,0.3512860059758867,B3GNT2,1
R-HSA-174084,Autodegradation of Cdh1 by Cdh1:APC/C,1/54,64/10899,0.2729834727327449,0.4214016715000625,0.35430660232047634,UBE2D1,1
R-HSA-1234176,Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha,1/54,66/10899,0.28021242798719637,0.4304712661832292,0.36193214700609144,UBE2D1,1
R-HSA-174154,APC/C:Cdc20 mediated degradation of Securin,1/54,68/10899,0.2873708215594032,0.43934577526870294,0.36939366738911145,UBE2D1,1
R-HSA-9662360,Sensory processing of sound by inner hair cells of the cochlea,1/54,69/10899,0.2909237691760399,0.4426495626697641,0.37217142971903366,CTBP2,1
R-HSA-9013026,RHOB GTPase cycle,1/54,70/10899,0.29445932932973296,0.44378230676234637,0.3731238196545382,DIAPH1,1
R-HSA-9772573,Late SARS-CoV-2 Infection Events,1/54,70/10899,0.29445932932973296,0.44378230676234637,0.3731238196545382,SRPK1,1
R-HSA-199992,trans-Golgi Network Vesicle Budding,1/54,72/10899,0.30147862082791077,0.45198403804012677,0.38001968110623047,ARF1,1
R-HSA-5654738,Signaling by FGFR2,1/54,73/10899,0.30496251798088847,0.45198403804012677,0.38001968110623047,TIAL1,1
R-HSA-69017,CDK-mediated phosphorylation and removal of Cdc6,1/54,73/10899,0.30496251798088847,0.45198403804012677,0.38001968110623047,UBE2D1,1
R-HSA-174178,APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1,1/54,74/10899,0.30842935929153303,0.45198403804012677,0.38001968110623047,UBE2D1,1
R-HSA-1980143,Signaling by NOTCH1,1/54,74/10899,0.30842935929153303,0.45198403804012677,0.38001968110623047,MYC,1
R-HSA-9013106,RHOC GTPase cycle,1/54,74/10899,0.30842935929153303,0.45198403804012677,0.38001968110623047,DIAPH1,1
R-HSA-1234174,Cellular response to hypoxia,1/54,75/10899,0.31187922669091017,0.4549430921454561,0.3825075981626808,UBE2D1,1
R-HSA-9659379,Sensory processing of sound,1/54,76/10899,0.31531220172404817,0.45785059428423436,0.3849521712949207,CTBP2,1
R-HSA-446193,"Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein",1/54,78/10899,0.32212779895222055,0.4656210912127552,0.39148545901370346,NUS1,1
R-HSA-74752,Signaling by Insulin receptor,1/54,79/10899,0.32551058232312724,0.4662719152196147,0.3920326596020594,IDE,1
R-HSA-9759194,Nuclear events mediated by NFE2L2,1/54,79/10899,0.32551058232312724,0.4662719152196147,0.3920326596020594,MYC,1
R-HSA-68882,Mitotic Anaphase,2/54,236/10899,0.32704112057657375,0.46636357104641457,0.3921097220979454,BUB3/UBE2D1,2
R-HSA-2555396,Mitotic Metaphase and Anaphase,2/54,237/10899,0.3288664004924863,0.46687283641344035,0.39253790284347523,BUB3/UBE2D1,2
R-HSA-168928,DDX58/IFIH1-mediated induction of interferon-alpha/beta,1/54,82/10899,0.33555983056028627,0.47215940760252667,0.396982752502621,UBE2D1,1
R-HSA-2871837,FCERI mediated NF-kB activation,1/54,82/10899,0.33555983056028627,0.47215940760252667,0.396982752502621,UBE2D1,1
R-HSA-195253,Degradation of beta-catenin by the destruction complex,1/54,83/10899,0.33887681023577365,0.47264397217094745,0.3973901652811012,CTBP2,1
R-HSA-69202,Cyclin E associated events during G1/S transition ,1/54,83/10899,0.33887681023577365,0.47264397217094745,0.3973901652811012,MYC,1
R-HSA-1483255,PI Metabolism,1/54,84/10899,0.3421775362201732,0.4751635655808519,0.3995085920474558,ARF1,1
R-HSA-69656,Cyclin A:Cdk2-associated events at S phase entry,1/54,85/10899,0.345462086663457,0.47630036168498396,0.40046438883808655,MYC,1
R-HSA-5668914,Diseases of metabolism,2/54,249/10899,0.3506666669994274,0.47630036168498396,0.40046438883808655,NUS1/EXT1,2
R-HSA-190236,Signaling by FGFR,1/54,87/10899,0.3519829716854441,0.47630036168498396,0.40046438883808655,TIAL1,1
R-HSA-5368286,Mitochondrial translation initiation,1/54,87/10899,0.3519829716854441,0.47630036168498396,0.40046438883808655,MRPS16,1
R-HSA-5389840,Mitochondrial translation elongation,1/54,87/10899,0.3519829716854441,0.47630036168498396,0.40046438883808655,MRPS16,1
R-HSA-5419276,Mitochondrial translation termination,1/54,87/10899,0.3519829716854441,0.47630036168498396,0.40046438883808655,MRPS16,1
R-HSA-450531,Regulation of mRNA stability by proteins that bind AU-rich elements,1/54,88/10899,0.35521946072808086,0.47743712977918,0.4014201620784897,EXOSC7,1
R-HSA-5687128,MAPK6/MAPK4 signaling,1/54,89/10899,0.3584400831608514,0.47743712977918,0.4014201620784897,MYC,1
R-HSA-8876198,RAB GEFs exchange GTP for GDP on RABs,1/54,90/10899,0.3616449153078739,0.47743712977918,0.4014201620784897,GDI2,1
R-HSA-9616222,Transcriptional regulation of granulopoiesis,1/54,90/10899,0.3616449153078739,0.47743712977918,0.4014201620784897,MYC,1
R-HSA-201722,Formation of the beta-catenin:TCF transactivating complex,1/54,91/10899,0.364834033133147,0.47743712977918,0.4014201620784897,MYC,1
R-HSA-2980736,Peptide hormone metabolism,1/54,91/10899,0.364834033133147,0.47743712977918,0.4014201620784897,KIF5B,1
R-HSA-390466,Chaperonin-mediated protein folding,1/54,91/10899,0.364834033133147,0.47743712977918,0.4014201620784897,CCT8,1
R-HSA-5250924,B-WICH complex positively regulates rRNA expression,1/54,91/10899,0.364834033133147,0.47743712977918,0.4014201620784897,DDX21,1
R-HSA-6804756,Regulation of TP53 Activity through Phosphorylation,1/54,92/10899,0.36800751224221495,0.4776587301756096,0.40160647952533884,DYRK2,1
R-HSA-69052,Switching of origins to a post-replicative state,1/54,92/10899,0.36800751224221495,0.4776587301756096,0.40160647952533884,UBE2D1,1
R-HSA-5368287,Mitochondrial translation,1/54,93/10899,0.3711654278838289,0.4797992116547056,0.40340615610822655,MRPS16,1
R-HSA-1592230,Mitochondrial biogenesis,1/54,95/10899,0.3774348679856171,0.48405520037350325,0.40698451140307795,TFAM,1
R-HSA-141424,Amplification of signal from the kinetochores,1/54,96/10899,0.3805465411741378,0.48405520037350325,0.40698451140307795,BUB3,1
R-HSA-141444,Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal,1/54,96/10899,0.3805465411741378,0.48405520037350325,0.40698451140307795,BUB3,1
R-HSA-8878159,Transcriptional regulation by RUNX3,1/54,96/10899,0.3805465411741378,0.48405520037350325,0.40698451140307795,MYC,1
R-HSA-391251,Protein folding,1/54,97/10899,0.3836429483551608,0.4860496317806419,0.40866139183145667,CCT8,1
R-HSA-202424,Downstream TCR signaling,1/54,98/10899,0.3867241630180773,0.4880090628561452,0.4103088446390629,UBE2D1,1
R-HSA-15869,Metabolism of nucleotides,1/54,99/10899,0.38979025830527514,0.4899340005576186,0.41192729606631956,NT5C2,1
R-HSA-5607764,CLEC7A (Dectin-1) signaling,1/54,101/10899,0.39587738159669705,0.4935787557373798,0.4149917376937918,UBE2D1,1
R-HSA-6807878,COPI-mediated anterograde transport,1/54,101/10899,0.39587738159669705,0.4935787557373798,0.4149917376937918,ARF1,1
R-HSA-5689603,UCH proteinases,1/54,102/10899,0.3988985541651151,0.4935787557373798,0.4149917376937918,UCHL5,1
R-HSA-9755511,KEAP1-NFE2L2 pathway,1/54,102/10899,0.3988985541651151,0.4935787557373798,0.4149917376937918,MYC,1
R-HSA-168164,Toll Like Receptor 3 (TLR3) Cascade,1/54,105/10899,0.40787337579331806,0.5005583837957497,0.42086007773624773,UBE2D1,1
R-HSA-2187338,Visual phototransduction,1/54,105/10899,0.40787337579331806,0.5005583837957497,0.42086007773624773,METAP1,1
R-HSA-211945,Phase I - Functionalization of compounds,1/54,106/10899,0.4108356546248134,0.5005583837957497,0.42086007773624773,ALDH1B1,1
R-HSA-5250913,Positive epigenetic regulation of rRNA expression,1/54,106/10899,0.4108356546248134,0.5005583837957497,0.42086007773624773,DDX21,1
R-HSA-6785807,Interleukin-4 and Interleukin-13 signaling,1/54,108/10899,0.4167166427664317,0.5038627087442026,0.4236382920259102,MYC,1
R-HSA-9748784,Drug ADME,1/54,108/10899,0.4167166427664317,0.5038627087442026,0.4236382920259102,NT5C2,1
R-HSA-166166,MyD88-independent TLR4 cascade ,1/54,110/10899,0.422540003830139,0.5047737260804356,0.42440425827352085,UBE2D1,1
R-HSA-937061,TRIF(TICAM1)-mediated TLR4 signaling ,1/54,110/10899,0.422540003830139,0.5047737260804356,0.42440425827352085,UBE2D1,1
R-HSA-5173105,O-linked glycosylation,1/54,111/10899,0.4254302475777684,0.5047737260804356,0.42440425827352085,B3GNT2,1
R-HSA-977225,Amyloid fiber formation,1/54,111/10899,0.4254302475777684,0.5047737260804356,0.42440425827352085,GGA2,1
R-HSA-2559582,Senescence-Associated Secretory Phenotype (SASP),1/54,112/10899,0.42830629194473147,0.5047737260804356,0.42440425827352085,UBE2D1,1
R-HSA-69620,Cell Cycle Checkpoints,2/54,293/10899,0.42833130393183183,0.5047737260804356,0.42440425827352085,BUB3/UBE2D1,2
R-HSA-6798695,Neutrophil degranulation,3/54,482/10899,0.42969408512667717,0.5047737260804356,0.42440425827352085,DIAPH1/GDI2/CCT8,3
R-HSA-157579,Telomere Maintenance,1/54,113/10899,0.4311682053808106,0.5047737260804356,0.42440425827352085,PPP6C,1
R-HSA-71387,Metabolism of carbohydrates,2/54,295/10899,0.43175614306251087,0.5047737260804356,0.42440425827352085,B3GNT2/EXT1,2
R-HSA-1852241,Organelle biogenesis and maintenance,2/54,296/10899,0.43346467182529436,0.5049148924558374,0.4245229483077879,TFAM/CCT8,2
R-HSA-187037,Signaling by NTRK1 (TRKA),1/54,115/10899,0.4368499116426696,0.5070009923444122,0.4262769018718328,RALB,1
R-HSA-1989781,PPARA activates gene expression,1/54,117/10899,0.44247590751546684,0.5098091977895596,0.42863798821101684,NFYA,1
R-HSA-9648025,EML4 and NUDC in mitotic spindle formation,1/54,117/10899,0.44247590751546684,0.5098091977895596,0.42863798821101684,BUB3,1
R-HSA-400206,Regulation of lipid metabolism by PPARalpha,1/54,119/10899,0.4480467290444923,0.5143641149319442,0.4324676769040511,NFYA,1
R-HSA-202403,TCR signaling,1/54,120/10899,0.4508116155594827,0.5156765962155233,0.4335711864903772,UBE2D1,1
R-HSA-69239,Synthesis of DNA,1/54,121/10899,0.4535629072154611,0.5169641738154719,0.43465375752773866,UBE2D1,1
R-HSA-2500257,Resolution of Sister Chromatid Cohesion,1/54,126/10899,0.46711772743845137,0.5286243321189592,0.44445739939826434,BUB3,1
R-HSA-9705671,SARS-CoV-2 activates/modulates innate and adaptive immune responses,1/54,126/10899,0.46711772743845137,0.5286243321189592,0.44445739939826434,SEC24C,1
R-HSA-162909,Host Interactions of HIV factors,1/54,130/10899,0.477723484102174,0.5387094607960685,0.45293678597219944,ARF1,1
R-HSA-69206,G1/S Transition,1/54,131/10899,0.4803423838940285,0.5397486857890497,0.4538105468070792,MYC,1
R-HSA-166520,Signaling by NTRKs,1/54,134/10899,0.4881219907827381,0.5446413791891603,0.45792423142683464,RALB,1
R-HSA-2454202,Fc epsilon receptor (FCERI) signaling,1/54,134/10899,0.4881219907827381,0.5446413791891603,0.45792423142683464,UBE2D1,1
R-HSA-73886,Chromosome Maintenance,1/54,141/10899,0.5058325959803123,0.5624292500760115,0.47287993882590845,PPP6C,1
R-HSA-5621481,C-type lectin receptors (CLRs),1/54,142/10899,0.5083130793245269,0.5632179763944235,0.47354308508501686,UBE2D1,1
R-HSA-68867,Assembly of the pre-replicative complex,1/54,143/10899,0.5107813412671203,0.5639877309824454,0.47419028026991433,UBE2D1,1
R-HSA-166016,Toll Like Receptor 4 (TLR4) Cascade,1/54,146/10899,0.5181133881305875,0.5701040049326187,0.47933272841074204,UBE2D1,1
R-HSA-8980692,RHOA GTPase cycle,1/54,147/10899,0.5205333525164283,0.5707917451731869,0.47991096747431145,DIAPH1,1
R-HSA-212165,Epigenetic regulation of gene expression,1/54,149/10899,0.5253375526809936,0.5721141840840958,0.4810228492464758,DDX21,1
R-HSA-453279,Mitotic G1 phase and G1/S transition,1/54,149/10899,0.5253375526809936,0.5721141840840958,0.4810228492464758,MYC,1
R-HSA-9018519,Estrogen-dependent gene expression,1/54,150/10899,0.527721903579154,0.5727493697548498,0.4815569014158619,MYC,1
R-HSA-5633007,Regulation of TP53 Activity,1/54,160/10899,0.5509281017433192,0.5938818181504255,0.49932466670045705,DYRK2,1
R-HSA-69002,DNA Replication Pre-Initiation,1/54,160/10899,0.5509281017433192,0.5938818181504255,0.49932466670045705,UBE2D1,1
R-HSA-983169,Class I MHC mediated antigen processing & presentation,2/54,381/10899,0.5678765723130506,0.6068506503518468,0.5102286169790438,SEC24C/UBE2D1,2
R-HSA-168898,Toll-like Receptor Cascades,1/54,168/10899,0.5686839427825483,0.6068506503518468,0.5102286169790438,UBE2D1,1
R-HSA-983231,Factors involved in megakaryocyte development and platelet production,1/54,168/10899,0.5686839427825483,0.6068506503518468,0.5102286169790438,KIF5B,1
R-HSA-983712,Ion channel transport,1/54,186/10899,0.6061533672421883,0.6446714741906885,0.5420276545661532,CUTC,1
R-HSA-69306,DNA Replication,1/54,188/10899,0.610113995411415,0.6467208351360999,0.5437507187175419,UBE2D1,1
R-HSA-68886,M Phase,2/54,418/10899,0.6190228879917715,0.6539843135594131,0.5498577148099667,BUB3/UBE2D1,2
R-HSA-9711123,Cellular response to chemical stress,1/54,194/10899,0.6217627982510787,0.6547038736551094,0.5504627074094598,MYC,1
R-HSA-2559583,Cellular Senescence,1/54,197/10899,0.6274584098908405,0.658520707410189,0.5536718294676862,UBE2D1,1
R-HSA-5617833,Cilium Assembly,1/54,201/10899,0.6349217902745006,0.6641616095634578,0.5584145939394847,CCT8,1
R-HSA-68877,Mitotic Prometaphase,1/54,204/10899,0.6404228290681253,0.6677195398152912,0.5614060348000133,BUB3,1
R-HSA-1483257,Phospholipid metabolism,1/54,212/10899,0.6546976191775474,0.6803720356158827,0.5720440153804508,ARF1,1
R-HSA-211859,Biological oxidations,1/54,222/10899,0.6717608910243611,0.6952853112534251,0.5845828171412445,ALDH1B1,1
R-HSA-8939211,ESR-mediated signaling,1/54,223/10899,0.6734209932894808,0.6952853112534251,0.5845828171412445,MYC,1
R-HSA-162906,HIV Infection,1/54,231/10899,0.6864084683945622,0.7042042636232876,0.5920817046021684,ARF1,1
R-HSA-449147,Signaling by Interleukins,2/54,473/10899,0.6864884330918841,0.7042042636232876,0.5920817046021684,ARF1/MYC,2
R-HSA-201681,TCF dependent signaling in response to WNT,1/54,233/10899,0.6895752988702721,0.7050962863046513,0.5928317005010971,MYC,1
R-HSA-157118,Signaling by NOTCH,1/54,236/10899,0.6942667761119058,0.707618060267904,0.5949519606357088,MYC,1
R-HSA-8951664,Neddylation,1/54,240/10899,0.7004139737034095,0.7116026953280646,0.5983021668762941,UBE2D1,1
R-HSA-9006931,Signaling by Nuclear Receptors,1/54,299/10899,0.7781682550656428,0.7880812264677529,0.6626038779305172,MYC,1
R-HSA-983168,Antigen processing: Ubiquitination & Proteasome degradation,1/54,309/10899,0.7892181235164071,0.7967344865975157,0.6698793763514367,UBE2D1,1
R-HSA-5683057,MAPK family signaling cascades,1/54,325/10899,0.8057840699628962,0.8108839691398766,0.6817759952384266,MYC,1
R-HSA-3700989,Transcriptional Regulation by TP53,1/54,362/10899,0.8393531689380065,0.8420009707327636,0.707938585124535,DYRK2,1
R-HSA-9012999,RHO GTPase cycle,1/54,449/10899,0.8974484528304225,0.8974484528304225,0.7545577855641423,DIAPH1,1
HALLMARK_MYC_TARGETS_V1,HALLMARK_MYC_TARGETS_V1,8/28,200/4383,2.3080103040622966e-5,6.2316278209682e-4,6.073711326479728e-4,RPL6/RPS6/BUB3/DDX21/SRPK1/MYC/EXOSC7/NAP1L1,8
HALLMARK_PI3K_AKT_MTOR_SIGNALING,HALLMARK_PI3K_AKT_MTOR_SIGNALING,3/28,105/4383,0.028346793461566173,0.38268171173114335,0.3729841244942918,ARF1/SMAD2/RALB,3
HALLMARK_G2M_CHECKPOINT,HALLMARK_G2M_CHECKPOINT,3/28,200/4383,0.13327670112340934,0.6620340109287352,0.6452573205933092,KIF5B/BUB3/MYC,3
HALLMARK_UNFOLDED_PROTEIN_RESPONSE,HALLMARK_UNFOLDED_PROTEIN_RESPONSE,2/28,113/4383,0.16178924636583386,0.6620340109287352,0.6452573205933092,NFYA/KIF5B,2
HALLMARK_WNT_BETA_CATENIN_SIGNALING,HALLMARK_WNT_BETA_CATENIN_SIGNALING,1/28,42/4383,0.23695717162541796,0.6620340109287352,0.6452573205933092,MYC,1
HALLMARK_UV_RESPONSE_UP,HALLMARK_UV_RESPONSE_UP,2/28,158/4383,0.2676718749453709,0.6620340109287352,0.6452573205933092,DDX21/DNAJA1,2
HALLMARK_APOPTOSIS,HALLMARK_APOPTOSIS,2/28,161/4383,0.2748767050495352,0.6620340109287352,0.6452573205933092,VDAC2/DNAJA1,2
HALLMARK_MYC_TARGETS_V2,HALLMARK_MYC_TARGETS_V2,1/28,58/4383,0.31213130314543325,0.6620340109287352,0.6452573205933092,MYC,1
HALLMARK_ALLOGRAFT_REJECTION,HALLMARK_ALLOGRAFT_REJECTION,2/28,200/4383,0.36779667273818617,0.6620340109287352,0.6452573205933092,EIF3A/UBE2D1,2
HALLMARK_APICAL_JUNCTION,HALLMARK_APICAL_JUNCTION,2/28,200/4383,0.36779667273818617,0.6620340109287352,0.6452573205933092,MPZL1/TIAL1,2
HALLMARK_COMPLEMENT,HALLMARK_COMPLEMENT,2/28,200/4383,0.36779667273818617,0.6620340109287352,0.6452573205933092,DYRK2/XPNPEP1,2
HALLMARK_E2F_TARGETS,HALLMARK_E2F_TARGETS,2/28,200/4383,0.36779667273818617,0.6620340109287352,0.6452573205933092,MYC/NAP1L1,2
HALLMARK_GLYCOLYSIS,HALLMARK_GLYCOLYSIS,2/28,200/4383,0.36779667273818617,0.6620340109287352,0.6452573205933092,EXT1/ECD,2
HALLMARK_HYPOXIA,HALLMARK_HYPOXIA,2/28,200/4383,0.36779667273818617,0.6620340109287352,0.6452573205933092,XPNPEP1/EXT1,2
HALLMARK_MTORC1_SIGNALING,HALLMARK_MTORC1_SIGNALING,2/28,200/4383,0.36779667273818617,0.6620340109287352,0.6452573205933092,UCHL5/GGA2,2
HALLMARK_PROTEIN_SECRETION,HALLMARK_PROTEIN_SECRETION,1/28,96/4383,0.4631486308178452,0.7306850114698548,0.7121686271636012,ARF1,1
HALLMARK_PEROXISOME,HALLMARK_PEROXISOME,1/28,104/4383,0.49058861441397195,0.7306850114698548,0.7121686271636012,IDE,1
HALLMARK_SPERMATOGENESIS,HALLMARK_SPERMATOGENESIS,1/28,135/4383,0.5846925971374507,0.7306850114698548,0.7121686271636012,IDE,1
HALLMARK_UV_RESPONSE_DN,HALLMARK_UV_RESPONSE_DN,1/28,144/4383,0.6087118410333168,0.7306850114698548,0.7121686271636012,MYC,1
HALLMARK_FATTY_ACID_METABOLISM,HALLMARK_FATTY_ACID_METABOLISM,1/28,158/4383,0.6434338356553777,0.7306850114698548,0.7121686271636012,METAP1,1
HALLMARK_IL2_STAT5_SIGNALING,HALLMARK_IL2_STAT5_SIGNALING,1/28,199/4383,0.7288705697761964,0.7306850114698548,0.7121686271636012,MYC,1
HALLMARK_MITOTIC_SPINDLE,HALLMARK_MITOTIC_SPINDLE,1/28,199/4383,0.7288705697761964,0.7306850114698548,0.7121686271636012,KIF5B,1
HALLMARK_ESTROGEN_RESPONSE_EARLY,HALLMARK_ESTROGEN_RESPONSE_EARLY,1/28,200/4383,0.7306850114698548,0.7306850114698548,0.7121686271636012,MYC,1
HALLMARK_HEME_METABOLISM,HALLMARK_HEME_METABOLISM,1/28,200/4383,0.7306850114698548,0.7306850114698548,0.7121686271636012,MINPP1,1
HALLMARK_INFLAMMATORY_RESPONSE,HALLMARK_INFLAMMATORY_RESPONSE,1/28,200/4383,0.7306850114698548,0.7306850114698548,0.7121686271636012,MYC,1
HALLMARK_OXIDATIVE_PHOSPHORYLATION,HALLMARK_OXIDATIVE_PHOSPHORYLATION,1/28,200/4383,0.7306850114698548,0.7306850114698548,0.7121686271636012,VDAC2,1
HALLMARK_TNFA_SIGNALING_VIA_NFKB,HALLMARK_TNFA_SIGNALING_VIA_NFKB,1/28,200/4383,0.7306850114698548,0.7306850114698548,0.7121686271636012,MYC,1
JISON_SICKLE_CELL_DISEASE_DN,JISON_SICKLE_CELL_DISEASE_DN,12/77,187/21728,2.613093353113946e-12,3.862151975902412e-9,3.1934751399634645e-9,RPL37/BTF3/RPL6/EEF1G/RPS6/EIF3H/RPL30/NACA/DYRK2/RPL4/RPS24/NAP1L1,12
REACTOME_RRNA_PROCESSING,REACTOME_RRNA_PROCESSING,11/77,205/21728,1.562963458324132e-10,1.1550299957015336e-7,9.550529342706934e-8,RPL37/RPL6/RPL12/RPS6/RPL30/DDX21/EXOSC7/RPL4/RPP30/RPS24/RPP38,11
REACTOME_EUKARYOTIC_TRANSLATION_INITIATION,REACTOME_EUKARYOTIC_TRANSLATION_INITIATION,9/77,120/21728,4.1520800739315155e-10,2.0455914497569266e-7,1.6914263038015755e-7,RPL37/RPL6/RPL12/RPS6/EIF3H/RPL30/EIF3A/RPL4/RPS24,9
REACTOME_EUKARYOTIC_TRANSLATION_ELONGATION,REACTOME_EUKARYOTIC_TRANSLATION_ELONGATION,8/77,94/21728,1.492530862030614e-9,5.514901535203119e-7,4.560074554783008e-7,RPL37/RPL6/RPL12/EEF1G/RPS6/RPL30/RPL4/RPS24,8
IBRAHIM_NRF1_UP,IBRAHIM_NRF1_UP,13/77,419/21728,2.5448005991402098e-9,7.522430571058461e-7,6.220028411793229e-7,EIF3H/NACA/YME1L1/MPZL1/SEC24C/KIF5B/DDX21/SRPK1/CCT8/GTPBP4/ALDH1B1/UBE2D1/DNAJA1,13
BILANGES_SERUM_AND_RAPAMYCIN_SENSITIVE_GENES,BILANGES_SERUM_AND_RAPAMYCIN_SENSITIVE_GENES,7/77,69/21728,4.805602723076324e-9,1.1837801374511345e-6,9.788253967529145e-7,RPL6/EEF1G/RPS6/EIF3H/RPL30/RPL4/RPS24,7
REACTOME_TRANSLATION,REACTOME_TRANSLATION,11/77,295/21728,7.239336023329433e-9,1.528534091782986e-6,1.2638900936970635e-6,RPL37/RPL6/RPL12/EEF1G/RPS6/EIF3H/RPL30/EIF3A/RPL4/MRPS16/RPS24,11
LEE_LIVER_CANCER_SURVIVAL_DN,LEE_LIVER_CANCER_SURVIVAL_DN,9/77,180/21728,1.4950317788004535e-8,2.7620712113338378e-6,2.2838577568254297e-6,RPL12/RPS6/DYRK2/CTBP2/KIF5B/BUB3/GTPBP4/UBE2D1/NAP1L1,9
KEGG_RIBOSOME,KEGG_RIBOSOME,7/77,88/21728,2.6800006713155195e-8,4.389327867450511e-6,3.629378003069613e-6,RPL37/RPL6/RPL12/RPS6/RPL30/RPL4/RPS24,7
WP_CYTOPLASMIC_RIBOSOMAL_PROTEINS,WP_CYTOPLASMIC_RIBOSOMAL_PROTEINS,7/77,90/21728,3.136344435556282e-8,4.389327867450511e-6,3.629378003069613e-6,RPL37/RPL6/RPL12/RPS6/RPL30/RPL4/RPS24,7
TIEN_INTESTINE_PROBIOTICS_6HR_UP,TIEN_INTESTINE_PROBIOTICS_6HR_UP,6/77,53/21728,3.2667528106871186e-8,4.389327867450511e-6,3.629378003069613e-6,EEF1G/RPS6/MYC/RPL4/RPS24/NAP1L1,6
REACTOME_RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,REACTOME_RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,7/77,102/21728,7.493914954788193e-8,9.230005252647458e-6,7.631960756586923e-6,RPL37/RPL6/RPL12/RPS6/RPL30/RPL4/RPS24,7
BILANGES_SERUM_RESPONSE_TRANSLATION,BILANGES_SERUM_RESPONSE_TRANSLATION,5/77,34/21728,1.257912964341696e-7,1.4301502779207896e-5,1.1825400417819507e-5,RPL6/EEF1G/RPS6/EIF3H/RPL4,5
BORCZUK_MALIGNANT_MESOTHELIOMA_UP,BORCZUK_MALIGNANT_MESOTHELIOMA_UP,10/77,311/21728,1.468647357311051e-7,1.4970265182344822e-5,1.2378376096219884e-5,EIF3H/SMAD2/MPZL1/KIF5B/BUB3/SRPK1/GDI2/UBE2D1/NAP1L1/DNAJA1,10
REACTOME_SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,REACTOME_SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,7/77,113/21728,1.519309727572208e-7,1.4970265182344822e-5,1.2378376096219884e-5,RPL37/RPL6/RPL12/RPS6/RPL30/RPL4/RPS24,7
REACTOME_NONSENSE_MEDIATED_DECAY_NMD,REACTOME_NONSENSE_MEDIATED_DECAY_NMD,7/77,116/21728,1.818846362395847e-7,1.6801593272631635e-5,1.3892635702247226e-5,RPL37/RPL6/RPL12/RPS6/RPL30/RPL4/RPS24,7
REACTOME_SELENOAMINO_ACID_METABOLISM,REACTOME_SELENOAMINO_ACID_METABOLISM,7/77,118/21728,2.045017191352985e-7,1.7779620051880656e-5,1.470133101647564e-5,RPL37/RPL6/RPL12/RPS6/RPL30/RPL4/RPS24,7
OSMAN_BLADDER_CANCER_DN,OSMAN_BLADDER_CANCER_DN,11/77,427/21728,3.0958850501678156e-7,2.5420656134155733e-5,2.101943007745517e-5,RPL37/NFYA/RPL12/EEF1G/RPS6/MPZL1/OGA/CDC123/RPL4/RPS24/GGA2,11
MODY_HIPPOCAMPUS_PRENATAL,MODY_HIPPOCAMPUS_PRENATAL,5/77,44/21728,4.775770297432484e-7,3.715046578739585e-5,3.071838955855465e-5,RPL37/BTF3/RPL12/EEF1G/RPL30,5
BENPORATH_PROLIFERATION,BENPORATH_PROLIFERATION,7/77,147/21728,9.098651496055848e-7,6.723903455585272e-5,5.5597549404846524e-5,ARF1/SMAD2/SRPK1/GDI2/GTPBP4/CDC123/PRPF18,7
REACTOME_CELLULAR_RESPONSE_TO_STARVATION,REACTOME_CELLULAR_RESPONSE_TO_STARVATION,7/77,157/21728,1.4153652374918003e-6,9.186572801053155e-5,7.596048017963616e-5,RPL37/RPL6/RPL12/RPS6/RPL30/RPL4/RPS24,7
REACTOME_INFLUENZA_INFECTION,REACTOME_INFLUENZA_INFECTION,7/77,157/21728,1.4153652374918003e-6,9.186572801053155e-5,7.596048017963616e-5,RPL37/RPL6/RPL12/RPS6/RPL30/RPL4/RPS24,7
HSIAO_HOUSEKEEPING_GENES,HSIAO_HOUSEKEEPING_GENES,10/77,399/21728,1.429574928445349e-6,9.186572801053155e-5,7.596048017963616e-5,ARF1/RPL6/RPL12/EEF1G/RPS6/NACA/VDAC2/GDI2/RPL4/NAP1L1,10
REACTOME_REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,REACTOME_REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,7/77,172/21728,2.6007369342985265e-6,1.601620495372176e-4,1.3243226231230657e-4,RPL37/RPL6/RPL12/RPS6/RPL30/RPL4/RPS24,7
KARLSSON_TGFB1_TARGETS_UP,KARLSSON_TGFB1_TARGETS_UP,6/77,123/21728,4.970136737006418e-6,2.938344838918194e-4,2.4296121059639797e-4,EIF3A/DDX21/CCT8/GTPBP4/EXT1/MYC,6
TIEN_INTESTINE_PROBIOTICS_24HR_DN,TIEN_INTESTINE_PROBIOTICS_24HR_DN,7/77,215/21728,1.126289723516503e-5,6.402523889836121e-4,5.294017688269878e-4,RPL12/EEF1G/RPS6/RPL4/MARCHF5/RPS24/NAP1L1,7
BHATTACHARYA_EMBRYONIC_STEM_CELL,BHATTACHARYA_EMBRYONIC_STEM_CELL,5/77,84/21728,1.2157489330508795e-5,6.504513079100077e-4,5.378348895972645e-4,RPL6/DDX21/CCT8/RPL4/RPS24,5
REACTOME_SIGNALING_BY_ROBO_RECEPTORS,REACTOME_SIGNALING_BY_ROBO_RECEPTORS,7/77,218/21728,1.2322487565277548e-5,6.504513079100077e-4,5.378348895972645e-4,RPL37/RPL6/RPL12/RPS6/RPL30/RPL4/RPS24,7
NUTT_GBM_VS_AO_GLIOMA_DN,NUTT_GBM_VS_AO_GLIOMA_DN,4/77,46/21728,2.124677778931422e-5,0.0010828530197450489,8.953723779816265e-4,RPS6/RPL30/VDAC2/RPL4,4
SCHLOSSER_MYC_TARGETS_REPRESSED_BY_SERUM,SCHLOSSER_MYC_TARGETS_REPRESSED_BY_SERUM,6/77,162/21728,2.3973948495512216e-5,0.001181116529212235,9.766229545013925e-4,BTF3/TFAM/TIAL1/EIF3A/BUB3/CCT8,6
SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_DN,SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_DN,4/77,48/21728,2.519883298974909e-5,0.0012014153277048114,9.934073039422307e-4,DDX21/SRPK1/MYC/EXOSC7,4
CHNG_MULTIPLE_MYELOMA_HYPERPLOID_UP,CHNG_MULTIPLE_MYELOMA_HYPERPLOID_UP,4/77,54/21728,4.0301804147589804e-5,0.0018050323190950829,0.001492516574652369,RPL37/EEF1G/RPS6/RPL4,4
LEE_LIVER_CANCER_MYC_UP,LEE_LIVER_CANCER_MYC_UP,4/77,54/21728,4.0301804147589804e-5,0.0018050323190950829,0.001492516574652369,RPL12/DCLRE1A/RALB/RPS24,4
REACTOME_ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,REACTOME_ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,4/77,60/21728,6.115065247818006e-5,0.002658254834198533,0.0021980157129153884,RPS6/EIF3H/EIF3A/RPS24,4
WANG_TUMOR_INVASIVENESS_UP,WANG_TUMOR_INVASIVENESS_UP,8/77,384/21728,6.430038205335894e-5,0.0027153132764247004,0.002245195295156383,RPL6/RPS6/EIF3H/RPL30/NACA/ANXA7/VDAC2/NAP1L1,8
MANALO_HYPOXIA_DN,MANALO_HYPOXIA_DN,7/77,292/21728,7.932219174052932e-5,0.0032566166497917316,0.002692779666981127,TFAM/CUTC/DDX21/UCHL5/IDE/GTPBP4/RPP30,7
BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_UP,BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_UP,6/77,207/21728,9.392442341176242e-5,0.003751899940610401,0.0031023116808266333,ANXA7/DDX50/MINPP1/XPNPEP1/TIAL1/BUB3,6
PUJANA_BRCA2_PCC_NETWORK,PUJANA_BRCA2_PCC_NETWORK,8/77,425/21728,1.298331924711966e-4,0.004984167927856765,0.0041212299439083435,NFYA/EIF3H/METAP1/TIAL1/BUB3/SRPK1/RPP30/BTAF1,8
HOLLEMAN_ASPARAGINASE_RESISTANCE_B_ALL_UP,HOLLEMAN_ASPARAGINASE_RESISTANCE_B_ALL_UP,3/77,28/21728,1.3151728632369e-4,0.004984167927856765,0.0041212299439083435,RPL6/EEF1G/RPL4,3
MILI_PSEUDOPODIA_CHEMOTAXIS_DN,MILI_PSEUDOPODIA_CHEMOTAXIS_DN,8/77,428/21728,1.3625145012993766e-4,0.0050344910823011966,0.004162840357917306,RPL12/RPL30/B3GNT2/ANXA7/DIAPH1/MPZL1/OGA/RPS24,8
REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX,REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX,4/77,75/21728,1.464171633738811e-4,0.005278160182112104,0.004364321609167548,SMAD2/UCHL5/MYC/UBE2D1,4
GARY_CD5_TARGETS_DN,GARY_CD5_TARGETS_DN,8/77,440/21728,1.646083131641584e-4,0.005792644925157765,0.004789730616130024,DYRK2/TFAM/OGA/UCHL5/IDE/GTPBP4/MRPS16/DNAJA1,8
SIMBULAN_UV_RESPONSE_IMMORTALIZED_DN,SIMBULAN_UV_RESPONSE_IMMORTALIZED_DN,3/77,31/21728,1.790802603567612e-4,0.006155363367611466,0.0050896495048763715,DDX21/MYC/NAP1L1,3
SCHUHMACHER_MYC_TARGETS_UP,SCHUHMACHER_MYC_TARGETS_UP,4/77,80/21728,1.8798950636097895e-4,0.006314738418216521,0.005221431025959248,DDX21/SRPK1/MYC/EXOSC7,4
SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE,SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE,4/77,81/21728,1.9722669339134586e-4,0.006477801174053536,0.005356261778417604,B3GNT2/SRPK1/MYC/RPP30,4
OISHI_CHOLANGIOMA_STEM_CELL_LIKE_UP,OISHI_CHOLANGIOMA_STEM_CELL_LIKE_UP,7/77,347/21728,2.3002454614111866e-4,0.007390788678186377,0.006111178445534068,SMAD2/PPP2R3A/UCHL5/ALDH1B1/ECD/MRPS16/BCOR,7
PID_IL2_PI3K_PATHWAY,PID_IL2_PI3K_PATHWAY,3/77,34/21728,2.365865525237059e-4,0.00743989201340505,0.006151780234714951,RPS6/EIF3A/MYC,3
ENK_UV_RESPONSE_KERATINOCYTE_DN,ENK_UV_RESPONSE_KERATINOCYTE_DN,8/77,481/21728,3.006088541844175e-4,0.009256247635095189,0.0076536596427216825,ANXA7/YME1L1/DYRK2/BUB3/CDC123/RPP30/RPP38/DNAJA1,8
REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,7/77,374/21728,3.61816104515165e-4,0.01091355515251865,0.009024027869862656,RPL37/RPL6/RPL12/RPS6/RPL30/RPL4/RPS24,7
MARTINEZ_RESPONSE_TO_TRABECTEDIN_DN,MARTINEZ_RESPONSE_TO_TRABECTEDIN_DN,6/77,272/21728,4.104303061865932e-4,0.012132319850875695,0.010031780747002837,EIF3A/BUB3/DDX21/GDI2/MYC/BTAF1,6
REACTOME_SIGNALING_BY_TGFB_FAMILY_MEMBERS,REACTOME_SIGNALING_BY_TGFB_FAMILY_MEMBERS,4/77,104/21728,5.12573967296188e-4,0.014854594581642469,0.01228273221941949,SMAD2/UCHL5/MYC/UBE2D1,4
WP_WNT_SIGNALING_PATHWAY_AND_PLURIPOTENCY,WP_WNT_SIGNALING_PATHWAY_AND_PLURIPOTENCY,4/77,106/21728,5.508209192957197e-4,0.015642912427370825,0.012934564011236755,NFYA/PPP2R3A/CTBP2/MYC,4
IRITANI_MAD1_TARGETS_DN,IRITANI_MAD1_TARGETS_DN,3/77,46/21728,5.821110849156938e-4,0.015642912427370825,0.012934564011236755,RPL12/EEF1G/GGA2,3
REACTOME_TRANSCRIPTIONAL_ACTIVITY_OF_SMAD2_SMAD3_SMAD4_HETEROTRIMER,REACTOME_TRANSCRIPTIONAL_ACTIVITY_OF_SMAD2_SMAD3_SMAD4_HETEROTRIMER,3/77,46/21728,5.821110849156938e-4,0.015642912427370825,0.012934564011236755,SMAD2/MYC/UBE2D1,3
SESTO_RESPONSE_TO_UV_C5,SESTO_RESPONSE_TO_UV_C5,3/77,46/21728,5.821110849156938e-4,0.015642912427370825,0.012934564011236755,METAP1/EXT1/MYC,3
REACTOME_DEUBIQUITINATION,REACTOME_DEUBIQUITINATION,6/77,297/21728,6.518548872822568e-4,0.017017564478011178,0.014071214556634841,SMAD2/VDAC2/UCHL5/IDE/MYC/UBE2D1,6
APRELIKOVA_BRCA1_TARGETS,APRELIKOVA_BRCA1_TARGETS,3/77,48/21728,6.598894843391748e-4,0.017017564478011178,0.014071214556634841,ARF1/DDX21/DNAJA1,3
WP_NONHOMOLOGOUS_END_JOINING,WP_NONHOMOLOGOUS_END_JOINING,2/77,11/21728,6.6780699575416e-4,0.017017564478011178,0.014071214556634841,DCLRE1C/NHEJ1,2
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP,5/77,203/21728,7.761580032309656e-4,0.019372178928695104,0.01601816091176912,GLRX3/GTPBP4/EXT1/CDC123/NAP1L1,5
FUNG_IL2_SIGNALING_2,FUNG_IL2_SIGNALING_2,2/77,12/21728,7.995283590327478e-4,0.019372178928695104,0.01601816091176912,DDX21/MYC,2
TURJANSKI_MAPK1_AND_MAPK2_TARGETS,TURJANSKI_MAPK1_AND_MAPK2_TARGETS,2/77,12/21728,7.995283590327478e-4,0.019372178928695104,0.01601816091176912,SMAD2/MYC,2
FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_UP,FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_UP,3/77,52/21728,8.346464193587594e-4,0.01958106996527375,0.0161908854281624,RPL6/EEF1G/RPS6,3
KENNY_CTNNB1_TARGETS_DN,KENNY_CTNNB1_TARGETS_DN,3/77,52/21728,8.346464193587594e-4,0.01958106996527375,0.0161908854281624,RPS6/XPNPEP1/KIF5B,3
WP_TRANSLATION_FACTORS,WP_TRANSLATION_FACTORS,3/77,53/21728,8.824802027058351e-4,0.020066242147680376,0.01659205692860688,EEF1G/EIF3H/EIF3A,3
YAMASHITA_LIVER_CANCER_WITH_EPCAM_UP,YAMASHITA_LIVER_CANCER_WITH_EPCAM_UP,3/77,53/21728,8.824802027058351e-4,0.020066242147680376,0.01659205692860688,RPL6/SRPK1/RPS24,3
WANG_TUMOR_INVASIVENESS_DN,WANG_TUMOR_INVASIVENESS_DN,5/77,211/21728,9.229629673011162e-4,0.020668776752591662,0.01709027121270488,ARF1/YME1L1/GDI2/MYC/CDC123,5
KEGG_NON_HOMOLOGOUS_END_JOINING,KEGG_NON_HOMOLOGOUS_END_JOINING,2/77,13/21728,9.427281123463654e-4,0.020796300746984003,0.017195716236200004,DCLRE1C/NHEJ1,2
REACTOME_SIGNALING_BY_ALK_IN_CANCER,REACTOME_SIGNALING_BY_ALK_IN_CANCER,3/77,55/21728,9.832897493015137e-4,0.02137209190393584,0.017671817321038043,EEF1G/RPS6/KIF5B,3
DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN,DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN,6/77,325/21728,0.001039838715339649,0.022084426631158425,0.018260821393615078,B3GNT2/YME1L1/DYRK2/DCLRE1C/OGA/GGA2,6
KIM_WT1_TARGETS_12HR_DN,KIM_WT1_TARGETS_12HR_DN,5/77,217/21728,0.0010459471340873408,0.022084426631158425,0.018260821393615078,RPS6/CTBP2/EXT1/MYC/NAP1L1,5
REACTOME_REPRESSION_OF_WNT_TARGET_GENES,REACTOME_REPRESSION_OF_WNT_TARGET_GENES,2/77,14/21728,0.0010973253746158636,0.022842914136369668,0.018887987545278248,CTBP2/MYC,2
WONG_EMBRYONIC_STEM_CELL_CORE,WONG_EMBRYONIC_STEM_CELL_CORE,6/77,335/21728,0.0012146601397745762,0.024934273424816997,0.020617257635647417,BTF3/EIF3A/BUB3/MYC/EXOSC7/NAP1L1,6
KAUFFMANN_MELANOMA_RELAPSE_UP,KAUFFMANN_MELANOMA_RELAPSE_UP,3/77,61/21728,0.001328516262504311,0.026534419405153668,0.021940361035099647,TFAM/DCLRE1A/CTBP2,3
LEE_LIVER_CANCER_MYC_TGFA_UP,LEE_LIVER_CANCER_MYC_TGFA_UP,3/77,61/21728,0.001328516262504311,0.026534419405153668,0.021940361035099647,RPL12/RALB/RPS24,3
PID_DNA_PK_PATHWAY,PID_DNA_PK_PATHWAY,2/77,16/21728,0.0014403909806831366,0.02836304213844782,0.023452383678326277,DCLRE1C/NHEJ1,2
PID_MYC_REPRESS_PATHWAY,PID_MYC_REPRESS_PATHWAY,3/77,63/21728,0.001458451422545355,0.02836304213844782,0.023452383678326277,NFYA/SMAD2/MYC,3
GENTILE_UV_LOW_DOSE_DN,GENTILE_UV_LOW_DOSE_DN,3/77,64/21728,0.0015263017477085447,0.029297064715756223,0.024224693494048127,PPP2R3A/EXT1/NAP1L1,3
WELCSH_BRCA1_TARGETS_DN,WELCSH_BRCA1_TARGETS_DN,4/77,141/21728,0.0015935061303146076,0.029718741500662834,0.02457336292448512,SEC24C/SRPK1/MYC/CDC123,4
ALFANO_MYC_TARGETS,ALFANO_MYC_TARGETS,5/77,239/21728,0.0016029275752183598,0.029718741500662834,0.02457336292448512,ANXA7/METAP1/DDX21/MYC/PPP6C,5
COLLIS_PRKDC_SUBSTRATES,COLLIS_PRKDC_SUBSTRATES,2/77,17/21728,0.001628699635692618,0.029718741500662834,0.02457336292448512,DCLRE1C/MYC,2
WP_NSP1_FROM_SARSCOV2_INHIBITS_TRANSLATION_INITIATION_IN_THE_HOST_CELL,WP_NSP1_FROM_SARSCOV2_INHIBITS_TRANSLATION_INITIATION_IN_THE_HOST_CELL,2/77,17/21728,0.001628699635692618,0.029718741500662834,0.02457336292448512,EIF3H/EIF3A,2
WP_ENDODERM_DIFFERENTIATION,WP_ENDODERM_DIFFERENTIATION,4/77,145/21728,0.00176539992814203,0.03182025724138927,0.02631103102147493,SMAD2/CTBP2/EXT1/BTAF1,4
PUIFFE_INVASION_INHIBITED_BY_ASCITES_DN,PUIFFE_INVASION_INHIBITED_BY_ASCITES_DN,4/77,146/21728,0.0018103049927161315,0.03223651541246316,0.026655219994209625,NFYA/CTBP2/PRPF18/NAP1L1,4
REACTOME_NUCLEAR_EVENTS_STIMULATED_BY_ALK_SIGNALING_IN_CANCER,REACTOME_NUCLEAR_EVENTS_STIMULATED_BY_ALK_SIGNALING_IN_CANCER,2/77,19/21728,0.0020384725098201942,0.03586740916088389,0.029657475988737414,RPS6/KIF5B,2
WP_STEROL_REGULATORY_ELEMENTBINDING_PROTEINS_SREBP_SIGNALING,WP_STEROL_REGULATORY_ELEMENTBINDING_PROTEINS_SREBP_SIGNALING,3/77,73/21728,0.0022270688508931017,0.03872479719552946,0.03202014781284076,NFYA/SEC24C/SAR1A,3
HOLLEMAN_VINCRISTINE_RESISTANCE_ALL_DN,HOLLEMAN_VINCRISTINE_RESISTANCE_ALL_DN,2/77,20/21728,0.002259779498088693,0.03883667556017545,0.0321126560254709,RPL12/RPS24,2
TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_UP,TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_UP,3/77,74/21728,0.0023152979635219263,0.03888648170551599,0.03215383894316934,GLRX3/UBE2D1/RMND1,3
WP_CHROMOSOMAL_AND_MICROSATELLITE_INSTABILITY_IN_COLORECTAL_CANCER,WP_CHROMOSOMAL_AND_MICROSATELLITE_INSTABILITY_IN_COLORECTAL_CANCER,3/77,74/21728,0.0023152979635219263,0.03888648170551599,0.03215383894316934,SMAD2/RALB/MYC,3
NIKOLSKY_BREAST_CANCER_8Q23_Q24_AMPLICON,NIKOLSKY_BREAST_CANCER_8Q23_Q24_AMPLICON,4/77,157/21728,0.002357768638124932,0.039154854462344374,0.032375746763607875,EIF3H/EXT1/MYC/DERL1,4
JAIN_NFKB_SIGNALING,JAIN_NFKB_SIGNALING,3/77,75/21728,0.002405667996861423,0.039506414437346475,0.03266643911527617,METAP1/MYC/NAP1L1,3
RAMPON_ENRICHED_LEARNING_ENVIRONMENT_LATE_UP,RAMPON_ENRICHED_LEARNING_ENVIRONMENT_LATE_UP,2/77,21/21728,0.002491929376242394,0.0400333871531115,0.03310217397960434,BTF3/XPNPEP1,2
REACTOME_INHIBITION_OF_THE_PROTEOLYTIC_ACTIVITY_OF_APC_C_REQUIRED_FOR_THE_ONSET_OF_ANAPHASE_BY_MITOTIC_SPINDLE_CHECKPOINT_COMPONENTS,REACTOME_INHIBITION_OF_THE_PROTEOLYTIC_ACTIVITY_OF_APC_C_REQUIRED_FOR_THE_ONSET_OF_ANAPHASE_BY_MITOTIC_SPINDLE_CHECKPOINT_COMPONENTS,2/77,21/21728,0.002491929376242394,0.0400333871531115,0.03310217397960434,BUB3/UBE2D1,2
LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN,LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN,4/77,164/21728,0.0027600470026286276,0.043863972794463565,0.03626954804812492,BUB3/SRPK1/BTAF1/NAP1L1,4
CLIMENT_BREAST_CANCER_COPY_NUMBER_UP,CLIMENT_BREAST_CANCER_COPY_NUMBER_UP,2/77,23/21728,0.0029884477888413477,0.046092333336113116,0.038112099567856515,EXT1/MYC,2
REACTOME_MITOCHONDRIAL_CALCIUM_ION_TRANSPORT,REACTOME_MITOCHONDRIAL_CALCIUM_ION_TRANSPORT,2/77,23/21728,0.0029884477888413477,0.046092333336113116,0.038112099567856515,YME1L1/VDAC2,2
SAKAI_TUMOR_INFILTRATING_MONOCYTES_DN,SAKAI_TUMOR_INFILTRATING_MONOCYTES_DN,3/77,81/21728,0.0029938186740641804,0.046092333336113116,0.038112099567856515,CCT8/PPP6C/DNAJA1,3
SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP,SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP,3/77,82/21728,0.003099655327195971,0.04722979972779016,0.03905262978702683,YME1L1/MYC/UBE2D1,3
ONDER_CDH1_TARGETS_1_DN,ONDER_CDH1_TARGETS_1_DN,4/77,170/21728,0.003140389271606735,0.047362197381987284,0.03916210466525692,B3GNT2/KIF5B/NAP1L1/DNAJA1,4
FOURNIER_ACINAR_DEVELOPMENT_LATE_2,FOURNIER_ACINAR_DEVELOPMENT_LATE_2,5/77,281/21728,0.0032311901212227047,0.04807434906485101,0.03975095738500963,RAI14/CUTC/UCHL5/SRPK1/NAP1L1,5
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREEN_DN,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREEN_DN,2/77,24/21728,0.0032526623183255082,0.04807434906485101,0.03975095738500963,NFYA/DYRK2,2
YAGI_AML_WITH_INV_16_TRANSLOCATION,YAGI_AML_WITH_INV_16_TRANSLOCATION,6/77,411/21728,0.003381886772371129,0.049489392569945834,0.040921006177414086,RPL37/RPS6/NACA/TIAL1/SAR1A/BTAF1,6
MILI_PSEUDOPODIA_CHEMOTAXIS_UP,MILI_PSEUDOPODIA_CHEMOTAXIS_UP,3/77,85/21728,0.003430877890476638,0.04971409335416148,0.04110680320787799,EIF3A/KIF5B/NAP1L1,3
COLDREN_GEFITINIB_RESISTANCE_UP,COLDREN_GEFITINIB_RESISTANCE_UP,3/77,86/21728,0.003545907572864928,0.05039280185283042,0.04166800295643908,IDE/ALDH1B1/NAP1L1,3
LEIN_MEDULLA_MARKERS,LEIN_MEDULLA_MARKERS,3/77,86/21728,0.003545907572864928,0.05039280185283042,0.04166800295643908,GLRX3/CCT8/MYC,3
ALCALA_APOPTOSIS,ALCALA_APOPTOSIS,3/77,87/21728,0.0036632733741059883,0.05156493378027286,0.04263719686553437,ANXA7/METAP1/RALB,3
GENTILE_UV_RESPONSE_CLUSTER_D9,GENTILE_UV_RESPONSE_CLUSTER_D9,2/77,26/21728,0.0038126199974675076,0.052176410706083115,0.043142805234500745,DYRK2/NAP1L1,2
REACTOME_APC_CDC20_MEDIATED_DEGRADATION_OF_NEK2A,REACTOME_APC_CDC20_MEDIATED_DEGRADATION_OF_NEK2A,2/77,26/21728,0.0038126199974675076,0.052176410706083115,0.043142805234500745,BUB3/UBE2D1,2
REACTOME_DOWNREGULATION_OF_TGF_BETA_RECEPTOR_SIGNALING,REACTOME_DOWNREGULATION_OF_TGF_BETA_RECEPTOR_SIGNALING,2/77,26/21728,0.0038126199974675076,0.052176410706083115,0.043142805234500745,SMAD2/UCHL5,2
REACTOME_ATF4_ACTIVATES_GENES_IN_RESPONSE_TO_ENDOPLASMIC_RETICULUM_STRESS,REACTOME_ATF4_ACTIVATES_GENES_IN_RESPONSE_TO_ENDOPLASMIC_RETICULUM_STRESS,2/77,27/21728,0.0041082115235897354,0.05536153813699035,0.045776473026882564,NFYA/EXOSC7,2
SHEN_SMARCA2_TARGETS_UP,SHEN_SMARCA2_TARGETS_UP,6/77,428/21728,0.004120276857286156,0.05536153813699035,0.045776473026882564,ANXA7/SMAD2/BUB3/VPS26A/RALB/IDE,6
LEIN_PONS_MARKERS,LEIN_PONS_MARKERS,3/77,92/21728,0.004285649021918819,0.056878488429904644,0.04703078489218667,KIF5B/VDAC2/CCT8,3
REACTOME_DISEASES_OF_SIGNAL_TRANSDUCTION_BY_GROWTH_FACTOR_RECEPTORS_AND_SECOND_MESSENGERS,REACTOME_DISEASES_OF_SIGNAL_TRANSDUCTION_BY_GROWTH_FACTOR_RECEPTORS_AND_SECOND_MESSENGERS,6/77,432/21728,0.0043101425603175375,0.056878488429904644,0.04703078489218667,EEF1G/RPS6/SMAD2/CTBP2/KIF5B/MYC,6
CHIN_BREAST_CANCER_COPY_NUMBER_UP,CHIN_BREAST_CANCER_COPY_NUMBER_UP,2/77,28/21728,0.004414111080302506,0.05722856295339565,0.04732024897720415,EXT1/MYC,2
REACTOME_DOWNREGULATION_OF_SMAD2_3_SMAD4_TRANSCRIPTIONAL_ACTIVITY,REACTOME_DOWNREGULATION_OF_SMAD2_3_SMAD4_TRANSCRIPTIONAL_ACTIVITY,2/77,28/21728,0.004414111080302506,0.05722856295339565,0.04732024897720415,SMAD2/UBE2D1,2
REACTOME_ASPARAGINE_N_LINKED_GLYCOSYLATION,REACTOME_ASPARAGINE_N_LINKED_GLYCOSYLATION,5/77,305/21728,0.004572270030794513,0.058699556247305155,0.04853656064605177,ARF1/NUS1/SEC24C/DERL1/PPP6C,5
WP_VEGFAVEGFR2_SIGNALING_PATHWAY,WP_VEGFAVEGFR2_SIGNALING_PATHWAY,6/77,438/21728,0.004607001708178213,0.058699556247305155,0.04853656064605177,RPS6/EIF3H/TFAM/SRPK1/NAP1L1/DNAJA1,6
GRYDER_PAX3FOXO1_TOP_ENHANCERS,GRYDER_PAX3FOXO1_TOP_ENHANCERS,6/77,441/21728,0.004760976306913114,0.06014293146681694,0.0497300359183637,NACA/GDI2/CDC123/BTAF1/BCOR/GGA2,6
KASLER_HDAC7_TARGETS_1_UP,KASLER_HDAC7_TARGETS_1_UP,4/77,192/21728,0.004839755378561435,0.06061998686028645,0.05012449593675135,DDX21/IDE/NHEJ1/BCOR,4
CHNG_MULTIPLE_MYELOMA_HYPERPLOID_DN,CHNG_MULTIPLE_MYELOMA_HYPERPLOID_DN,2/77,30/21728,0.005056535348154209,0.06227966037143267,0.051496820519359963,YME1L1/UBE2D1,2
TIEN_INTESTINE_PROBIOTICS_2HR_UP,TIEN_INTESTINE_PROBIOTICS_2HR_UP,2/77,30/21728,0.005056535348154209,0.06227966037143267,0.051496820519359963,RPS6/NAP1L1,2
GAVIN_FOXP3_TARGETS_CLUSTER_T7,GAVIN_FOXP3_TARGETS_CLUSTER_T7,3/77,101/21728,0.005559471827219318,0.06626487449841782,0.05479205134439364,EIF3H/SAR1A/GDI2,3
SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE,SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE,3/77,101/21728,0.005559471827219318,0.06626487449841782,0.05479205134439364,B3GNT2/MPZL1/MYC,3
CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN,CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN,6/77,456/21728,0.005588478110784883,0.06626487449841782,0.05479205134439364,CLIP4/CHMP1B/MPZL1/RALB/EXT1/NAP1L1,6
TANAKA_METHYLATED_IN_ESOPHAGEAL_CARCINOMA,TANAKA_METHYLATED_IN_ESOPHAGEAL_CARCINOMA,3/77,102/21728,0.005713508642528613,0.06626487449841782,0.05479205134439364,NFYA/BUB3/ONECUT2,3
REACTOME_PERK_REGULATES_GENE_EXPRESSION,REACTOME_PERK_REGULATES_GENE_EXPRESSION,2/77,32/21728,0.0057392988047640075,0.06626487449841782,0.05479205134439364,NFYA/EXOSC7,2
REACTOME_SMAD2_SMAD3_SMAD4_HETEROTRIMER_REGULATES_TRANSCRIPTION,REACTOME_SMAD2_SMAD3_SMAD4_HETEROTRIMER_REGULATES_TRANSCRIPTION,2/77,32/21728,0.0057392988047640075,0.06626487449841782,0.05479205134439364,SMAD2/MYC,2
REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS,REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS,2/77,32/21728,0.0057392988047640075,0.06626487449841782,0.05479205134439364,SMAD2/UCHL5,2
SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6,SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6,6/77,459/21728,0.005765885879253589,0.06626487449841782,0.05479205134439364,YME1L1/XPNPEP1/BUB3/SAR1A/UBE2D1/DNAJA1,6
KIM_MYC_AMPLIFICATION_TARGETS_UP,KIM_MYC_AMPLIFICATION_TARGETS_UP,4/77,202/21728,0.005783605419685994,0.06626487449841782,0.05479205134439364,CLIP4/RPL12/DDX21/MYC,4
DER_IFN_BETA_RESPONSE_UP,DER_IFN_BETA_RESPONSE_UP,3/77,103/21728,0.005870088568192935,0.06673839156760891,0.05518358564916598,EIF3A/DDX21/NAP1L1,3
PROVENZANI_METASTASIS_UP,PROVENZANI_METASTASIS_UP,4/77,204/21728,0.005986073148851366,0.06753752758780396,0.05584436260198021,BTF3/DDX50/SAR1A/VPS26A,4
WP_HAIR_FOLLICLE_DEVELOPMENT_ORGANOGENESIS_PART_2_OF_3,WP_HAIR_FOLLICLE_DEVELOPMENT_ORGANOGENESIS_PART_2_OF_3,2/77,33/21728,0.006095623792637962,0.06825251489029475,0.056435559994040464,GTPBP4/MYC,2
ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_DN,ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_DN,3/77,105/21728,0.006190921784203288,0.06879836388761247,0.05688690297950152,DCLRE1A/BCOR/GGA2,3
GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN,GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN,4/77,207/21728,0.006298557982038945,0.06947215445860866,0.05744403626981316,ANXA7/TFAM/GDI2/MYC,4
CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_DN,CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_DN,3/77,106/21728,0.006355196566676324,0.06957763352257487,0.057531253129911995,BTF3/RPL12/NAP1L1,3
VANTVEER_BREAST_CANCER_BRCA1_UP,VANTVEER_BREAST_CANCER_BRCA1_UP,2/77,34/21728,0.00646181362014511,0.07022470978363582,0.05806629731415226,UCHL5/MYC,2
GUTIERREZ_MULTIPLE_MYELOMA_UP,GUTIERREZ_MULTIPLE_MYELOMA_UP,2/77,36/21728,0.007223498074903782,0.07792941718764809,0.06443704391059003,ARF1/VDAC2,2
SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP,SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP,6/77,484/21728,0.007408759126062498,0.07934888397333603,0.06561075015529032,RPL37/ARF1/NACA/ANXA7/RPL4/NAP1L1,6
REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES,REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES,4/77,219/21728,0.007656811260375865,0.08141559023622683,0.0673196355418128,SMAD2/VDAC2/IDE/MYC,4
DAZARD_RESPONSE_TO_UV_SCC_DN,DAZARD_RESPONSE_TO_UV_SCC_DN,3/77,115/21728,0.00795122902759741,0.08394226073420694,0.06940884888000445,EXT1/MYC/RPP38,3
ZHENG_BOUND_BY_FOXP3,ZHENG_BOUND_BY_FOXP3,6/77,496/21728,0.008307604506685941,0.08708254936795617,0.07200544107698678,RPL37/B3GNT2/NUS1/SRPK1/GDI2/EXT1,6
DAIRKEE_CANCER_PRONE_RESPONSE_BPA_E2,DAIRKEE_CANCER_PRONE_RESPONSE_BPA_E2,3/77,118/21728,0.008530991208042456,0.08817346157683041,0.07290747730980708,RPS6/EIF3A/RPL4,3
PUJANA_BRCA_CENTERED_NETWORK,PUJANA_BRCA_CENTERED_NETWORK,3/77,118/21728,0.008530991208042456,0.08817346157683041,0.07290747730980708,EIF3H/METAP1/BUB3,3
YOSHIMURA_MAPK8_TARGETS_DN,YOSHIMURA_MAPK8_TARGETS_DN,5/77,357/21728,0.008762251685289069,0.08993477771428642,0.07436384653962434,SMAD2/MPZL1/VPS26A/IDE/MYC,5
WP_IL5_SIGNALING_PATHWAY,WP_IL5_SIGNALING_PATHWAY,2/77,40/21728,0.008862079247111692,0.09033209053262814,0.07469237027874175,RPS6/MYC,2
GRUETZMANN_PANCREATIC_CANCER_UP,GRUETZMANN_PANCREATIC_CANCER_UP,5/77,359/21728,0.008963047252869795,0.0907355057516545,0.0750259398744184,DYRK2/TIAL1/RALB/EXOSC7/DNAJA1,5
WP_CELL_CYCLE,WP_CELL_CYCLE,3/77,122/21728,0.009341782262749888,0.09392621894111793,0.0776642263304878,SMAD2/BUB3/MYC,3
BARRIER_COLON_CANCER_RECURRENCE_UP,BARRIER_COLON_CANCER_RECURRENCE_UP,2/77,42/21728,0.009737842584095753,0.09620306716035515,0.07954687057415591,XPNPEP1/SAR1A,2
WP_IL2_SIGNALING_PATHWAY,WP_IL2_SIGNALING_PATHWAY,2/77,42/21728,0.009737842584095753,0.09620306716035515,0.07954687057415591,RPS6/MYC,2
YAGI_AML_SURVIVAL,YAGI_AML_SURVIVAL,3/77,124/21728,0.009763504786233607,0.09620306716035515,0.07954687057415591,TIAL1/UBE2D1/BTAF1,3
FISCHER_G2_M_CELL_CYCLE,FISCHER_G2_M_CELL_CYCLE,4/77,236/21728,0.00989196684174321,0.0963933534721233,0.07970421150996024,DCLRE1C/KIF5B/BUB3/UBE2D1,4
KEGG_CELL_CYCLE,KEGG_CELL_CYCLE,3/77,125/21728,0.009978472991363238,0.0963933534721233,0.07970421150996024,SMAD2/BUB3/MYC,3
LIU_VMYB_TARGETS_UP,LIU_VMYB_TARGETS_UP,3/77,125/21728,0.009978472991363238,0.0963933534721233,0.07970421150996024,ERLIN1/MARCHF5/BCOR,3
REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION,REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION,3/77,126/21728,0.010196188278207787,0.09785692386487733,0.08091438544770499,ARF1/SEC24C/KIF5B,3
VERHAAK_GLIOBLASTOMA_NEURAL,VERHAAK_GLIOBLASTOMA_NEURAL,3/77,128/21728,0.01063988639651951,0.10145646512294086,0.08389071719089407,ANXA7/CUTC/SAR1A,3
DESERT_STEM_CELL_HEPATOCELLULAR_CARCINOMA_SUBCLASS_UP,DESERT_STEM_CELL_HEPATOCELLULAR_CARCINOMA_SUBCLASS_UP,4/77,242/21728,0.010772011750213242,0.10205790619753315,0.08438802727393775,EIF3H/XPNPEP1/EXT1/NAP1L1,4
CHENG_RESPONSE_TO_NICKEL_ACETATE,CHENG_RESPONSE_TO_NICKEL_ACETATE,2/77,45/21728,0.011120507561773806,0.10208764084659433,0.08441261379025426,TIAL1/GDI2,2
PARK_HSC_AND_MULTIPOTENT_PROGENITORS,PARK_HSC_AND_MULTIPOTENT_PROGENITORS,2/77,45/21728,0.011120507561773806,0.10208764084659433,0.08441261379025426,GDI2/CCT8,2
PID_ILK_PATHWAY,PID_ILK_PATHWAY,2/77,45/21728,0.011120507561773806,0.10208764084659433,0.08441261379025426,NACA/DIAPH1,2
WANG_TARGETS_OF_MLL_CBP_FUSION_DN,WANG_TARGETS_OF_MLL_CBP_FUSION_DN,2/77,45/21728,0.011120507561773806,0.10208764084659433,0.08441261379025426,GLRX3/GTPBP4,2
WP_INTEGRATED_CANCER_PATHWAY,WP_INTEGRATED_CANCER_PATHWAY,2/77,45/21728,0.011120507561773806,0.10208764084659433,0.08441261379025426,SMAD2/MYC,2
WP_ENVELOPE_PROTEINS_AND_THEIR_POTENTIAL_ROLES_IN_EDMD_PHYSIOPATHOLOGY,WP_ENVELOPE_PROTEINS_AND_THEIR_POTENTIAL_ROLES_IN_EDMD_PHYSIOPATHOLOGY,2/77,46/21728,0.01159952558344919,0.10582777044653026,0.08750519299795004,SMAD2/KIF5B,2
WP_TGFBETA_SIGNALING_PATHWAY,WP_TGFBETA_SIGNALING_PATHWAY,3/77,133/21728,0.011797647664253286,0.10697498925010035,0.08845378713721708,SMAD2/UCHL5/MYC,3
WP_THYMIC_STROMAL_LYMPHOPOIETIN_TSLP_SIGNALING_PATHWAY,WP_THYMIC_STROMAL_LYMPHOPOIETIN_TSLP_SIGNALING_PATHWAY,2/77,47/21728,0.012087494661885585,0.10893486042845667,0.09007433441880079,RPS6/MYC,2
YEGNASUBRAMANIAN_PROSTATE_CANCER,YEGNASUBRAMANIAN_PROSTATE_CANCER,3/77,135/21728,0.012280279507089004,0.11000153400895483,0.09095632859796068,TFAM/ECD/BCOR,3
BROWNE_HCMV_INFECTION_2HR_DN,BROWNE_HCMV_INFECTION_2HR_DN,2/77,48/21728,0.012584347060909353,0.11137523925762888,0.09209219626672399,MYC/NAP1L1,2
SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_UP,SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_UP,2/77,48/21728,0.012584347060909353,0.11137523925762888,0.09209219626672399,METAP1/MYC,2
EPPERT_PROGENITOR,EPPERT_PROGENITOR,3/77,138/21728,0.013025280908290532,0.11380613389865897,0.09410221597916323,MINPP1/IDE/MARCHF5,3
BOYLAN_MULTIPLE_MYELOMA_C_UP,BOYLAN_MULTIPLE_MYELOMA_C_UP,2/77,49/21728,0.013090015401063618,0.11380613389865897,0.09410221597916323,NFYA/DYRK2,2
VANTVEER_BREAST_CANCER_POOR_PROGNOSIS,VANTVEER_BREAST_CANCER_POOR_PROGNOSIS,2/77,49/21728,0.013090015401063618,0.11380613389865897,0.09410221597916323,UCHL5/EXT1,2
CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_UP,CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_UP,2/77,50/21728,0.013604432657984625,0.11758685069298992,0.09722835528421145,MYC/DNAJA1,2
FRASOR_TAMOXIFEN_RESPONSE_UP,FRASOR_TAMOXIFEN_RESPONSE_UP,2/77,51/21728,0.014127532160784639,0.12069648863375547,0.09979960352096724,B3GNT2/GGA2,2
HU_GENOTOXIN_ACTION_DIRECT_VS_INDIRECT_24HR,HU_GENOTOXIN_ACTION_DIRECT_VS_INDIRECT_24HR,2/77,51/21728,0.014127532160784639,0.12069648863375547,0.09979960352096724,GLRX3/NUS1,2
DURCHDEWALD_SKIN_CARCINOGENESIS_DN,DURCHDEWALD_SKIN_CARCINOGENESIS_DN,4/77,265/21728,0.01460973941764981,0.12409882103038171,0.10261287031997236,CLIP4/OGA/KIF5B/RALB,4
KAUFFMANN_DNA_REPLICATION_GENES,KAUFFMANN_DNA_REPLICATION_GENES,3/77,146/21728,0.015136330597795823,0.1269202270156708,0.10494578987621522,TFAM/CTBP2/NAP1L1,3
WEI_MIR34A_TARGETS,WEI_MIR34A_TARGETS,3/77,146/21728,0.015136330597795823,0.1269202270156708,0.10494578987621522,METAP1/ERLIN1/SAR1A,3
JI_RESPONSE_TO_FSH_DN,JI_RESPONSE_TO_FSH_DN,2/77,53/21728,0.01519951297819603,0.1269202270156708,0.10494578987621522,KIF5B/GDI2,2
SESTO_RESPONSE_TO_UV_C2,SESTO_RESPONSE_TO_UV_C2,2/77,54/21728,0.015748262703953443,0.13076366447439994,0.10812379065221732,TIAL1/KIF5B,2
GOLDRATH_HOMEOSTATIC_PROLIFERATION,GOLDRATH_HOMEOSTATIC_PROLIFERATION,3/77,150/21728,0.0162601636864089,0.13388570971755134,0.11070529804292936,YME1L1/TIAL1/VDAC2,3
REACTOME_REGULATION_OF_CHOLESTEROL_BIOSYNTHESIS_BY_SREBP_SREBF,REACTOME_REGULATION_OF_CHOLESTEROL_BIOSYNTHESIS_BY_SREBP_SREBF,2/77,55/21728,0.016305431494695023,0.13388570971755134,0.11070529804292936,NFYA/SEC24C,2
KEGG_WNT_SIGNALING_PATHWAY,KEGG_WNT_SIGNALING_PATHWAY,3/77,151/21728,0.016548272856227727,0.1351289905055502,0.11173332239651289,SMAD2/CTBP2/MYC,3
WP_CCL18_SIGNALING_PATHWAY,WP_CCL18_SIGNALING_PATHWAY,2/77,56/21728,0.016870954422893786,0.1370069815221814,0.11328616590503,KIF5B/MYC,2
WP_OREXIN_RECEPTOR_PATHWAY,WP_OREXIN_RECEPTOR_PATHWAY,3/77,154/21728,0.01742980556113481,0.1401269863342298,0.11586598613634413,BTF3/TFAM/MYC,3
NAGASHIMA_EGF_SIGNALING_UP,NAGASHIMA_EGF_SIGNALING_UP,2/77,57/21728,0.017444766904937944,0.1401269863342298,0.11586598613634413,MYC/NAP1L1,2
REACTOME_ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,REACTOME_ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,3/77,155/21728,0.01772939276733295,0.1408819489791296,0.11649023770726404,ARF1/SEC24C/PPP6C,3
WP_MESODERMAL_COMMITMENT_PATHWAY,WP_MESODERMAL_COMMITMENT_PATHWAY,3/77,155/21728,0.01772939276733295,0.1408819489791296,0.11649023770726404,SMAD2/CTBP2/EXT1,3
THUM_SYSTOLIC_HEART_FAILURE_UP,THUM_SYSTOLIC_HEART_FAILURE_UP,5/77,430/21728,0.01831361854492954,0.14474614015725057,0.1196853989905049,ARF1/B3GNT2/RALB/GDI2/NAP1L1,5
PID_P53_REGULATION_PATHWAY,PID_P53_REGULATION_PATHWAY,2/77,59/21728,0.018617003906275725,0.144820693544608,0.11974704451626658,DYRK2/UBE2D1,2
REACTOME_E3_UBIQUITIN_LIGASES_UBIQUITINATE_TARGET_PROTEINS,REACTOME_E3_UBIQUITIN_LIGASES_UBIQUITINATE_TARGET_PROTEINS,2/77,59/21728,0.018617003906275725,0.144820693544608,0.11974704451626658,DERL1/UBE2D1,2
REACTOME_TRNA_PROCESSING_IN_THE_NUCLEUS,REACTOME_TRNA_PROCESSING_IN_THE_NUCLEUS,2/77,59/21728,0.018617003906275725,0.144820693544608,0.11974704451626658,RPP30/RPP38,2
WP_OVERLAP_BETWEEN_SIGNAL_TRANSDUCTION_PATHWAYS_CONTRIBUTING_TO_LMNA_LAMINOPATHIES,WP_OVERLAP_BETWEEN_SIGNAL_TRANSDUCTION_PATHWAYS_CONTRIBUTING_TO_LMNA_LAMINOPATHIES,2/77,60/21728,0.01921530096382239,0.14825723680927333,0.1225885990567384,SMAD2/NAP1L1,2
BAELDE_DIABETIC_NEPHROPATHY_DN,BAELDE_DIABETIC_NEPHROPATHY_DN,5/77,437/21728,0.01948878979392252,0.14825723680927333,0.1225885990567384,RAI14/TIAL1/KIF5B/VPS26A/DNAJA1,5
MULLIGHAN_NPM1_SIGNATURE_3_DN,MULLIGHAN_NPM1_SIGNATURE_3_DN,3/77,161/21728,0.019587356707360178,0.14825723680927333,0.1225885990567384,XPNPEP1/GDI2/RPL4,3
PURBEY_TARGETS_OF_CTBP1_AND_SATB1_DN,PURBEY_TARGETS_OF_CTBP1_AND_SATB1_DN,3/77,161/21728,0.019587356707360178,0.14825723680927333,0.1225885990567384,MPZL1/TIAL1/ALDH1B1,3
BENPORATH_OCT4_TARGETS,BENPORATH_OCT4_TARGETS,4/77,290/21728,0.01965920663600355,0.14825723680927333,0.1225885990567384,PPP2R3A/OGA/BUB3/CDC123,4
GRYDER_PAX3FOXO1_ENHANCERS_KO_DOWN,GRYDER_PAX3FOXO1_ENHANCERS_KO_DOWN,5/77,438/21728,0.019660634921933408,0.14825723680927333,0.1225885990567384,NFYA/DYRK2/KIF5B/CDC123/BCOR,5
REACTOME_DEFECTIVE_CFTR_CAUSES_CYSTIC_FIBROSIS,REACTOME_DEFECTIVE_CFTR_CAUSES_CYSTIC_FIBROSIS,2/77,61/21728,0.019821632648612853,0.14871255357690252,0.12296508418402097,ERLIN1/DERL1,2
DAZARD_UV_RESPONSE_CLUSTER_G1,DAZARD_UV_RESPONSE_CLUSTER_G1,2/77,62/21728,0.02043593607318913,0.1502702164983758,0.12425305986369511,RPL37/RPL30,2
DIRMEIER_LMP1_RESPONSE_EARLY,DIRMEIER_LMP1_RESPONSE_EARLY,2/77,62/21728,0.02043593607318913,0.1502702164983758,0.12425305986369511,SEC24C/MYC,2
KEGG_COLORECTAL_CANCER,KEGG_COLORECTAL_CANCER,2/77,62/21728,0.02043593607318913,0.1502702164983758,0.12425305986369511,SMAD2/MYC,2
NAKAMURA_ADIPOGENESIS_EARLY_UP,NAKAMURA_ADIPOGENESIS_EARLY_UP,2/77,62/21728,0.02043593607318913,0.1502702164983758,0.12425305986369511,CHMP1B/MYC,2
AMIT_EGF_RESPONSE_480_HELA,AMIT_EGF_RESPONSE_480_HELA,3/77,164/21728,0.020555263436699205,0.15039940276951203,0.12435987936429277,GLRX3/DIAPH1/EXT1,3
PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_UP,PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_UP,4/77,296/21728,0.021012884214982545,0.15256835174492858,0.12615330558782287,ARF1/RANBP17/ALDH1B1/EXOSC7,4
REACTOME_PEROXISOMAL_PROTEIN_IMPORT,REACTOME_PEROXISOMAL_PROTEIN_IMPORT,2/77,63/21728,0.02105814868468568,0.15256835174492858,0.12615330558782287,IDE/UBE2D1,2
MUELLER_PLURINET,MUELLER_PLURINET,4/77,299/21728,0.021710748698914508,0.15594677981235827,0.12894680675318565,DIAPH1/CTBP2/MYC/EXOSC7,4
MOOTHA_MITOCHONDRIA,MOOTHA_MITOCHONDRIA,5/77,450/21728,0.021801160742794316,0.15594677981235827,0.12894680675318565,ANXA7/YME1L1/TFAM/VDAC2/MRPS16,5
PUJANA_XPRSS_INT_NETWORK,PUJANA_XPRSS_INT_NETWORK,3/77,168/21728,0.021886238864532764,0.15594677981235827,0.12894680675318565,EIF3H/METAP1/BUB3,3
DAZARD_RESPONSE_TO_UV_NHEK_DN,DAZARD_RESPONSE_TO_UV_NHEK_DN,4/77,300/21728,0.021946502165744602,0.15594677981235827,0.12894680675318565,NFYA/DYRK2/CTBP2/MYC,4
TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C,TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C,5/77,454/21728,0.02254719433612411,0.1594485800420643,0.13184231994077109,SMAD2/DIAPH1/DCLRE1C/ERLIN1/DDX21,5
REACTOME_FOXO_MEDIATED_TRANSCRIPTION,REACTOME_FOXO_MEDIATED_TRANSCRIPTION,2/77,66/21728,0.02297162109881517,0.1601512074719284,0.13242329739684416,NFYA/SMAD2,2
WP_AGERAGE_PATHWAY,WP_AGERAGE_PATHWAY,2/77,66/21728,0.02297162109881517,0.1601512074719284,0.13242329739684416,SMAD2/DIAPH1,2
WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA,WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA,2/77,66/21728,0.02297162109881517,0.1601512074719284,0.13242329739684416,MYC/BCOR,2
NAGASHIMA_NRG1_SIGNALING_UP,NAGASHIMA_NRG1_SIGNALING_UP,3/77,173/21728,0.02361498785405034,0.16240711914930514,0.1342886299639223,GTPBP4/MYC/NAP1L1,3
ELVIDGE_HIF1A_TARGETS_UP,ELVIDGE_HIF1A_TARGETS_UP,2/77,67/21728,0.02362485156772707,0.16240711914930514,0.1342886299639223,IDE/DNAJA1,2
ZHANG_RESPONSE_TO_CANTHARIDIN_DN,ZHANG_RESPONSE_TO_CANTHARIDIN_DN,2/77,67/21728,0.02362485156772707,0.16240711914930514,0.1342886299639223,MYC/RPL4,2
LEE_CALORIE_RESTRICTION_NEOCORTEX_DN,LEE_CALORIE_RESTRICTION_NEOCORTEX_DN,2/77,68/21728,0.024285683424750872,0.16465247753110915,0.1361452363888738,KIF5B/BUB3,2
REACTOME_COPII_MEDIATED_VESICLE_TRANSPORT,REACTOME_COPII_MEDIATED_VESICLE_TRANSPORT,2/77,68/21728,0.024285683424750872,0.16465247753110915,0.1361452363888738,SEC24C/PPP6C,2
WP_THYROID_STIMULATING_HORMONE_TSH_SIGNALING_PATHWAY,WP_THYROID_STIMULATING_HORMONE_TSH_SIGNALING_PATHWAY,2/77,68/21728,0.024285683424750872,0.16465247753110915,0.1361452363888738,RPS6/MYC,2
REACTOME_NONHOMOLOGOUS_END_JOINING_NHEJ,REACTOME_NONHOMOLOGOUS_END_JOINING_NHEJ,2/77,69/21728,0.02495405609264574,0.1684113922599562,0.1392533483468479,DCLRE1C/NHEJ1,2
BRUINS_UVC_RESPONSE_EARLY_LATE,BRUINS_UVC_RESPONSE_EARLY_LATE,4/77,314/21728,0.025412951755686437,0.16911163380477506,0.13983235300003125,DYRK2/EIF3A/EXOSC7/RMND1,4
BILANGES_RAPAMYCIN_SENSITIVE_VIA_TSC1_AND_TSC2,BILANGES_RAPAMYCIN_SENSITIVE_VIA_TSC1_AND_TSC2,2/77,70/21728,0.02562990931817971,0.16911163380477506,0.13983235300003125,BTF3/NAP1L1,2
DITTMER_PTHLH_TARGETS_DN,DITTMER_PTHLH_TARGETS_DN,2/77,70/21728,0.02562990931817971,0.16911163380477506,0.13983235300003125,YME1L1/RPP30,2
KEGG_PANCREATIC_CANCER,KEGG_PANCREATIC_CANCER,2/77,70/21728,0.02562990931817971,0.16911163380477506,0.13983235300003125,SMAD2/RALB,2
MAHAJAN_RESPONSE_TO_IL1A_DN,MAHAJAN_RESPONSE_TO_IL1A_DN,2/77,70/21728,0.02562990931817971,0.16911163380477506,0.13983235300003125,DYRK2/VDAC2,2
BENPORATH_NOS_TARGETS,BENPORATH_NOS_TARGETS,3/77,179/21728,0.02578486174583701,0.1693778918237649,0.14005251221949366,PPP2R3A/OGA/BUB3,3
LIN_MELANOMA_COPY_NUMBER_UP,LIN_MELANOMA_COPY_NUMBER_UP,2/77,72/21728,0.027003818040368117,0.17660019054718618,0.14602437235615925,MYC/DERL1,2
LI_AMPLIFIED_IN_LUNG_CANCER,LI_AMPLIFIED_IN_LUNG_CANCER,3/77,183/21728,0.027289191286810163,0.1776802851185261,0.14691746387195273,RPL37/RPL30/NACA,3
TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_DN,TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_DN,4/77,322/21728,0.02753423763005604,0.17848948779483698,0.14758656458215635,MPZL1/CTBP2/RALB/UBE2D1,4
KEGG_CHRONIC_MYELOID_LEUKEMIA,KEGG_CHRONIC_MYELOID_LEUKEMIA,2/77,73/21728,0.027701754637254758,0.17868792377742695,0.14775064418887024,CTBP2/MYC,2
GRESHOCK_CANCER_COPY_NUMBER_UP,GRESHOCK_CANCER_COPY_NUMBER_UP,4/77,323/21728,0.027806645784038027,0.17868792377742695,0.14775064418887024,NACA/RANBP17/EXT1/MYC,4
KEGG_PATHWAYS_IN_CANCER,KEGG_PATHWAYS_IN_CANCER,4/77,325/21728,0.028356311933182637,0.180453696713198,0.14921069858558716,SMAD2/CTBP2/RALB/MYC,4
KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_DN,KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_DN,3/77,186/21728,0.02844770726263541,0.180453696713198,0.14921069858558716,KIF5B/CDC123/PPP6C,3
REACTOME_TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION,REACTOME_TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION,3/77,186/21728,0.02844770726263541,0.180453696713198,0.14921069858558716,ARF1/SEC24C/PPP6C,3
FARMER_BREAST_CANCER_BASAL_VS_LULMINAL,FARMER_BREAST_CANCER_BASAL_VS_LULMINAL,4/77,329/21728,0.02947508625198941,0.18617169863436045,0.1539387095751674,NT5C2/SRPK1/GTPBP4/MYC,4
WP_PROLACTIN_SIGNALING_PATHWAY,WP_PROLACTIN_SIGNALING_PATHWAY,2/77,76/21728,0.029838786652618514,0.18766692201093688,0.1551750562315346,RPS6/MYC,2
GROSS_HYPOXIA_VIA_HIF1A_UP,GROSS_HYPOXIA_VIA_HIF1A_UP,2/77,77/21728,0.03056534359726052,0.1898133522552565,0.15694986252286364,DDX21/NAP1L1,2
KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_UP,KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_UP,2/77,77/21728,0.03056534359726052,0.1898133522552565,0.15694986252286364,RPS6/TIAL1,2
MALONEY_RESPONSE_TO_17AAG_DN,MALONEY_RESPONSE_TO_17AAG_DN,2/77,77/21728,0.03056534359726052,0.1898133522552565,0.15694986252286364,RPL30/NACA,2
SENESE_HDAC3_TARGETS_UP,SENESE_HDAC3_TARGETS_UP,5/77,495/21728,0.03116363417020836,0.19115615623570278,0.15806017903970582,NFYA/TFAM/OGA/NAP1L1/GGA2,5
MULLIGHAN_NPM1_SIGNATURE_3_UP,MULLIGHAN_NPM1_SIGNATURE_3_UP,4/77,335/21728,0.031202021799986542,0.19115615623570278,0.15806017903970582,YME1L1/CTBP2/IDE/EXOSC7,4
FONTAINE_FOLLICULAR_THYROID_ADENOMA_UP,FONTAINE_FOLLICULAR_THYROID_ADENOMA_UP,2/77,78/21728,0.03129891056092021,0.19115615623570278,0.15806017903970582,NT5C2/CTBP2,2
REACTOME_ABC_TRANSPORTER_DISORDERS,REACTOME_ABC_TRANSPORTER_DISORDERS,2/77,78/21728,0.03129891056092021,0.19115615623570278,0.15806017903970582,ERLIN1/DERL1,2
ALONSO_METASTASIS_UP,ALONSO_METASTASIS_UP,3/77,194/21728,0.031663567954591416,0.19258746270323504,0.15924367509326678,BTF3/EIF3H/IDE,3
PID_P73PATHWAY,PID_P73PATHWAY,2/77,79/21728,0.032039430140293756,0.19328276631573132,0.15981859674707222,BUB3/MYC,2
REACTOME_PROTEIN_UBIQUITINATION,REACTOME_PROTEIN_UBIQUITINATION,2/77,79/21728,0.032039430140293756,0.19328276631573132,0.15981859674707222,DERL1/UBE2D1,2
HUANG_DASATINIB_SENSITIVITY_UP,HUANG_DASATINIB_SENSITIVITY_UP,2/77,80/21728,0.03278684524149878,0.19698763116640325,0.16288201679666275,RAI14/EXT1,2
JOHNSTONE_PARVB_TARGETS_2_DN,JOHNSTONE_PARVB_TARGETS_2_DN,4/77,342/21728,0.03329107414248735,0.19869706503984177,0.164295486440607,NFYA/CTBP2/UCHL5/SRPK1,4
ZHENG_FOXP3_TARGETS_IN_THYMUS_UP,ZHENG_FOXP3_TARGETS_IN_THYMUS_UP,3/77,198/21728,0.03334023824755126,0.19869706503984177,0.164295486440607,B3GNT2/GDI2/EXT1,3
GRUETZMANN_PANCREATIC_CANCER_DN,GRUETZMANN_PANCREATIC_CANCER_DN,3/77,200/21728,0.0341956881091321,0.19984751091871117,0.16524674893285637,EIF3A/MYC/RPS24,3
PID_SMAD2_3NUCLEAR_PATHWAY,PID_SMAD2_3NUCLEAR_PATHWAY,2/77,82/21728,0.034302135172435334,0.19984751091871117,0.16524674893285637,SMAD2/MYC,2
WELCSH_BRCA1_TARGETS_UP,WELCSH_BRCA1_TARGETS_UP,3/77,201/21728,0.03462768170724576,0.19984751091871117,0.16524674893285637,ANXA7/KIF5B/PPP6C,3
BAKER_HEMATOPOESIS_STAT1_TARGETS,BAKER_HEMATOPOESIS_STAT1_TARGETS,1/77,10/21728,0.034885424774714124,0.19984751091871117,0.16524674893285637,MYC,1
KEGG_LIMONENE_AND_PINENE_DEGRADATION,KEGG_LIMONENE_AND_PINENE_DEGRADATION,1/77,10/21728,0.034885424774714124,0.19984751091871117,0.16524674893285637,ALDH1B1,1
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_27,MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_27,1/77,10/21728,0.034885424774714124,0.19984751091871117,0.16524674893285637,RANBP17,1
REACTOME_ABACAVIR_TRANSPORT_AND_METABOLISM,REACTOME_ABACAVIR_TRANSPORT_AND_METABOLISM,1/77,10/21728,0.034885424774714124,0.19984751091871117,0.16524674893285637,NT5C2,1
REACTOME_ATF6_ATF6_ALPHA_ACTIVATES_CHAPERONE_GENES,REACTOME_ATF6_ATF6_ALPHA_ACTIVATES_CHAPERONE_GENES,1/77,10/21728,0.034885424774714124,0.19984751091871117,0.16524674893285637,NFYA,1
REACTOME_FOLDING_OF_ACTIN_BY_CCT_TRIC,REACTOME_FOLDING_OF_ACTIN_BY_CCT_TRIC,1/77,10/21728,0.034885424774714124,0.19984751091871117,0.16524674893285637,CCT8,1
WP_MAMMARY_GLAND_DEVELOPMENT_PATHWAY_INVOLUTION_STAGE_4_OF_4,WP_MAMMARY_GLAND_DEVELOPMENT_PATHWAY_INVOLUTION_STAGE_4_OF_4,1/77,10/21728,0.034885424774714124,0.19984751091871117,0.16524674893285637,MYC,1
NGUYEN_NOTCH1_TARGETS_DN,NGUYEN_NOTCH1_TARGETS_DN,2/77,83/21728,0.03506989734871249,0.20012860340307745,0.16547917424041947,EXT1/MYC,2
ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_UP,ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_UP,2/77,84/21728,0.0358443297370919,0.20220579905122835,0.16719673292392007,MPZL1/CUTC,2
DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_DN,DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_DN,2/77,84/21728,0.0358443297370919,0.20220579905122835,0.16719673292392007,EIF3A/BTAF1,2
WP_EGFR_TYROSINE_KINASE_INHIBITOR_RESISTANCE,WP_EGFR_TYROSINE_KINASE_INHIBITOR_RESISTANCE,2/77,84/21728,0.0358443297370919,0.20220579905122835,0.16719673292392007,RPS6/MYC,2
REACTOME_DEGRADATION_OF_BETA_CATENIN_BY_THE_DESTRUCTION_COMPLEX,REACTOME_DEGRADATION_OF_BETA_CATENIN_BY_THE_DESTRUCTION_COMPLEX,2/77,85/21728,0.03662537676954046,0.20582626184555436,0.17019036393610756,CTBP2/MYC,2
ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_DN,ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_DN,4/77,354/21728,0.03705939194540328,0.20739202096981044,0.17148503407588483,RPL12/DIAPH1/ERLIN1/DNAJA1,4
KEGG_TGF_BETA_SIGNALING_PATHWAY,KEGG_TGF_BETA_SIGNALING_PATHWAY,2/77,86/21728,0.037412983178985115,0.20739202096981044,0.17148503407588483,SMAD2/MYC,2
HUMMERICH_SKIN_CANCER_PROGRESSION_UP,HUMMERICH_SKIN_CANCER_PROGRESSION_UP,2/77,87/21728,0.03820709399792346,0.20739202096981044,0.17148503407588483,IDE/MYC,2
ZHANG_TARGETS_OF_EWSR1_FLI1_FUSION,ZHANG_TARGETS_OF_EWSR1_FLI1_FUSION,2/77,87/21728,0.03820709399792346,0.20739202096981044,0.17148503407588483,XPNPEP1/MYC,2
DORN_ADENOVIRUS_INFECTION_32HR_UP,DORN_ADENOVIRUS_INFECTION_32HR_UP,1/77,11/21728,0.03830718655261045,0.20739202096981044,0.17148503407588483,MYC,1
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TAN_DN,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TAN_DN,1/77,11/21728,0.03830718655261045,0.20739202096981044,0.17148503407588483,EXT1,1
REACTOME_RHO_GTPASES_ACTIVATE_KTN1,REACTOME_RHO_GTPASES_ACTIVATE_KTN1,1/77,11/21728,0.03830718655261045,0.20739202096981044,0.17148503407588483,KIF5B,1
ROZANOV_MMP14_CORRELATED,ROZANOV_MMP14_CORRELATED,1/77,11/21728,0.03830718655261045,0.20739202096981044,0.17148503407588483,ANXA7,1
WILLIAMS_ESR2_TARGETS_DN,WILLIAMS_ESR2_TARGETS_DN,1/77,11/21728,0.03830718655261045,0.20739202096981044,0.17148503407588483,MRPS16,1
WP_NAD_METABOLISM_SIRTUINS_AND_AGING,WP_NAD_METABOLISM_SIRTUINS_AND_AGING,1/77,11/21728,0.03830718655261045,0.20739202096981044,0.17148503407588483,TFAM,1
MORI_LARGE_PRE_BII_LYMPHOCYTE_UP,MORI_LARGE_PRE_BII_LYMPHOCYTE_UP,2/77,88/21728,0.03900765455704008,0.20964841249201907,0.1733507634094681,BUB3/IDE,2
REACTOME_APC_C_MEDIATED_DEGRADATION_OF_CELL_CYCLE_PROTEINS,REACTOME_APC_C_MEDIATED_DEGRADATION_OF_CELL_CYCLE_PROTEINS,2/77,88/21728,0.03900765455704008,0.20964841249201907,0.1733507634094681,BUB3/UBE2D1,2
WNT_SIGNALING,WNT_SIGNALING,2/77,89/21728,0.03981461048382894,0.21244041261768656,0.17565936831360596,CTBP2/MYC,2
WP_PANCREATIC_ADENOCARCINOMA_PATHWAY,WP_PANCREATIC_ADENOCARCINOMA_PATHWAY,2/77,89/21728,0.03981461048382894,0.21244041261768656,0.17565936831360596,SMAD2/RALB,2
CAIRO_HEPATOBLASTOMA_UP,CAIRO_HEPATOBLASTOMA_UP,3/77,213/21728,0.040032295890003476,0.21281041855538985,0.17596531297116136,MINPP1/MPZL1/NAP1L1,3
TIEN_INTESTINE_PROBIOTICS_2HR_DN,TIEN_INTESTINE_PROBIOTICS_2HR_DN,2/77,90/21728,0.04062790770122128,0.21281041855538985,0.17596531297116136,TIAL1/UBE2D1,2
WP_NCRNAS_INVOLVED_IN_WNT_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,WP_NCRNAS_INVOLVED_IN_WNT_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,2/77,90/21728,0.04062790770122128,0.21281041855538985,0.17596531297116136,CTBP2/MYC,2
KIM_WT1_TARGETS_UP,KIM_WT1_TARGETS_UP,3/77,216/21728,0.041446670801738875,0.21281041855538985,0.17596531297116136,B3GNT2/RAI14/MYC,3
BOYERINAS_ONCOFETAL_TARGETS_OF_LET7A1,BOYERINAS_ONCOFETAL_TARGETS_OF_LET7A1,1/77,12/21728,0.041716973661117485,0.21281041855538985,0.17596531297116136,NAP1L1,1
CAFFAREL_RESPONSE_TO_THC_8HR_5_DN,CAFFAREL_RESPONSE_TO_THC_8HR_5_DN,1/77,12/21728,0.041716973661117485,0.21281041855538985,0.17596531297116136,DNAJA1,1
DORN_ADENOVIRUS_INFECTION_24HR_UP,DORN_ADENOVIRUS_INFECTION_24HR_UP,1/77,12/21728,0.041716973661117485,0.21281041855538985,0.17596531297116136,MYC,1
HOEGERKORP_CD44_TARGETS_TEMPORAL_UP,HOEGERKORP_CD44_TARGETS_TEMPORAL_UP,1/77,12/21728,0.041716973661117485,0.21281041855538985,0.17596531297116136,PRPF18,1
NEBEN_AML_WITH_FLT3_OR_NRAS_DN,NEBEN_AML_WITH_FLT3_OR_NRAS_DN,1/77,12/21728,0.041716973661117485,0.21281041855538985,0.17596531297116136,CCT8,1
REACTOME_ATF6_ATF6_ALPHA_ACTIVATES_CHAPERONES,REACTOME_ATF6_ATF6_ALPHA_ACTIVATES_CHAPERONES,1/77,12/21728,0.041716973661117485,0.21281041855538985,0.17596531297116136,NFYA,1
REACTOME_ETHANOL_OXIDATION,REACTOME_ETHANOL_OXIDATION,1/77,12/21728,0.041716973661117485,0.21281041855538985,0.17596531297116136,ALDH1B1,1
ZHENG_RESPONSE_TO_ARSENITE_DN,ZHENG_RESPONSE_TO_ARSENITE_DN,1/77,12/21728,0.041716973661117485,0.21281041855538985,0.17596531297116136,MYC,1
RHEIN_ALL_GLUCOCORTICOID_THERAPY_DN,RHEIN_ALL_GLUCOCORTICOID_THERAPY_DN,4/77,368/21728,0.04175576548109815,0.21281041855538985,0.17596531297116136,DYRK2/GDI2/CCT8/NAP1L1,4
REACTOME_UNFOLDED_PROTEIN_RESPONSE_UPR,REACTOME_UNFOLDED_PROTEIN_RESPONSE_UPR,2/77,92/21728,0.04227331116853738,0.21341979452239748,0.1764691841325429,NFYA/EXOSC7,2
WONG_MITOCHONDRIA_GENE_MODULE,WONG_MITOCHONDRIA_GENE_MODULE,3/77,218/21728,0.042403522467512424,0.21341979452239748,0.1764691841325429,TFAM/VDAC2/MRPS16,3
WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN,WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN,4/77,371/21728,0.042804254000458904,0.21341979452239748,0.1764691841325429,TFAM/MYC/ALDH1B1/DNAJA1,4
YAGI_AML_WITH_T_8_21_TRANSLOCATION,YAGI_AML_WITH_T_8_21_TRANSLOCATION,4/77,371/21728,0.042804254000458904,0.21341979452239748,0.1764691841325429,NT5C2/RALB/RPP30/NAP1L1,4
AMUNDSON_RESPONSE_TO_ARSENITE,AMUNDSON_RESPONSE_TO_ARSENITE,3/77,219/21728,0.04288611567872263,0.21341979452239748,0.1764691841325429,CCT8/EXT1/DNAJA1,3
WANG_CISPLATIN_RESPONSE_AND_XPC_DN,WANG_CISPLATIN_RESPONSE_AND_XPC_DN,3/77,219/21728,0.04288611567872263,0.21341979452239748,0.1764691841325429,CHMP1B/NT5C2/UBE2D1,3
WP_CILIARY_LANDSCAPE,WP_CILIARY_LANDSCAPE,3/77,219/21728,0.04288611567872263,0.21341979452239748,0.1764691841325429,CTBP2/RALB/EXOSC7,3
VANOEVELEN_MYOGENESIS_SIN3A_TARGETS,VANOEVELEN_MYOGENESIS_SIN3A_TARGETS,3/77,220/21728,0.043371481127634844,0.21511090304243055,0.17786750119810688,MRPS16/RPS24/RPP38,3
FU_INTERACT_WITH_ALKBH8,FU_INTERACT_WITH_ALKBH8,1/77,13/21728,0.045114827456848916,0.22152729229642093,0.18317298365938658,CCT8,1
REACTOME_P38MAPK_EVENTS,REACTOME_P38MAPK_EVENTS,1/77,13/21728,0.045114827456848916,0.22152729229642093,0.18317298365938658,RALB,1
WP_MAMMARY_GLAND_DEVELOPMENT_PATHWAY_PUBERTY_STAGE_2_OF_4,WP_MAMMARY_GLAND_DEVELOPMENT_PATHWAY_PUBERTY_STAGE_2_OF_4,1/77,13/21728,0.045114827456848916,0.22152729229642093,0.18317298365938658,MYC,1
TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_UP,TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_UP,2/77,96/21728,0.04563786667445569,0.2227874242747722,0.18421494165872127,SMAD2/PPP6C,2
BENPORATH_ES_1,BENPORATH_ES_1,4/77,379/21728,0.04567292933373205,0.2227874242747722,0.18421494165872127,TFAM/BUB3/DDX21/RPS24,4
PHONG_TNF_RESPONSE_VIA_P38_COMPLETE,PHONG_TNF_RESPONSE_VIA_P38_COMPLETE,3/77,225/21728,0.04583972830396505,0.2228655211620406,0.18427951717764346,DYRK2/GTPBP4/EXT1,3
LINDGREN_BLADDER_CANCER_CLUSTER_3_DN,LINDGREN_BLADDER_CANCER_CLUSTER_3_DN,3/77,226/21728,0.04634162799818476,0.22383786826250784,0.1850835161689136,BTF3/EXT1/MYC,3
GAVIN_FOXP3_TARGETS_CLUSTER_T4,GAVIN_FOXP3_TARGETS_CLUSTER_T4,2/77,97/21728,0.046494063299451896,0.22383786826250784,0.1850835161689136,ARF1/MYC,2
HOEBEKE_LYMPHOID_STEM_CELL_UP,HOEBEKE_LYMPHOID_STEM_CELL_UP,2/77,97/21728,0.046494063299451896,0.22383786826250784,0.1850835161689136,NACA/DDX21,2
QI_PLASMACYTOMA_DN,QI_PLASMACYTOMA_DN,2/77,98/21728,0.04735617907151925,0.22724815801203066,0.1879033626180241,UCHL5/MYC,2
WANG_SMARCE1_TARGETS_DN,WANG_SMARCE1_TARGETS_DN,4/77,385/21728,0.04789379432599033,0.22756878213270734,0.18816847521976587,GLRX3/TIAL1/UCHL5/SRPK1,4
BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_24HR_UP,BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_24HR_UP,1/77,14/21728,0.04850078915548228,0.22756878213270734,0.18816847521976587,EEF1G,1
DORN_ADENOVIRUS_INFECTION_48HR_UP,DORN_ADENOVIRUS_INFECTION_48HR_UP,1/77,14/21728,0.04850078915548228,0.22756878213270734,0.18816847521976587,MYC,1
GALLUZZI_PREVENT_MITOCHONDIAL_PERMEABILIZATION,GALLUZZI_PREVENT_MITOCHONDIAL_PERMEABILIZATION,1/77,14/21728,0.04850078915548228,0.22756878213270734,0.18816847521976587,VDAC2,1
MARIADASON_RESPONSE_TO_CURCUMIN_SULINDAC_7,MARIADASON_RESPONSE_TO_CURCUMIN_SULINDAC_7,1/77,14/21728,0.04850078915548228,0.22756878213270734,0.18816847521976587,DDX21,1
REACTOME_DEFECTIVE_EXT2_CAUSES_EXOSTOSES_2,REACTOME_DEFECTIVE_EXT2_CAUSES_EXOSTOSES_2,1/77,14/21728,0.04850078915548228,0.22756878213270734,0.18816847521976587,EXT1,1
XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_DN,XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_DN,1/77,14/21728,0.04850078915548228,0.22756878213270734,0.18816847521976587,MYC,1
REACTOME_COPI_DEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC,REACTOME_COPI_DEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC,2/77,100/21728,0.0490979624232216,0.228917313758743,0.18928352772160148,ARF1/KIF5B,2
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_11,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_11,2/77,100/21728,0.0490979624232216,0.228917313758743,0.18928352772160148,XPNPEP1/DDX21,2
WP_NEURAL_CREST_DIFFERENTIATION,WP_NEURAL_CREST_DIFFERENTIATION,2/77,102/21728,0.05086280827475309,0.23163474909983042,0.19153047767602246,CTBP2/MYC,2
GAL_LEUKEMIC_STEM_CELL_DN,GAL_LEUKEMIC_STEM_CELL_DN,3/77,236/21728,0.05151038070311988,0.23163474909983042,0.19153047767602246,MINPP1/ONECUT2/NAP1L1,3
REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT,REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT,2/77,103/21728,0.051753753219437426,0.23163474909983042,0.19153047767602246,ERLIN1/DERL1,2
WP_LNCRNA_IN_CANONICAL_WNT_SIGNALING_AND_COLORECTAL_CANCER,WP_LNCRNA_IN_CANONICAL_WNT_SIGNALING_AND_COLORECTAL_CANCER,2/77,103/21728,0.051753753219437426,0.23163474909983042,0.19153047767602246,CTBP2/MYC,2
BAKER_HEMATOPOIESIS_STAT3_TARGETS,BAKER_HEMATOPOIESIS_STAT3_TARGETS,1/77,15/21728,0.051874899832235366,0.23163474909983042,0.19153047767602246,MYC,1
KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_KERATAN_SULFATE,KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_KERATAN_SULFATE,1/77,15/21728,0.051874899832235366,0.23163474909983042,0.19153047767602246,B3GNT2,1
PARK_HSC_VS_MULTIPOTENT_PROGENITORS_DN,PARK_HSC_VS_MULTIPOTENT_PROGENITORS_DN,1/77,15/21728,0.051874899832235366,0.23163474909983042,0.19153047767602246,RPL6,1
PID_ARF6_DOWNSTREAM_PATHWAY,PID_ARF6_DOWNSTREAM_PATHWAY,1/77,15/21728,0.051874899832235366,0.23163474909983042,0.19153047767602246,ARF1,1
REACTOME_ERBB2_REGULATES_CELL_MOTILITY,REACTOME_ERBB2_REGULATES_CELL_MOTILITY,1/77,15/21728,0.051874899832235366,0.23163474909983042,0.19153047767602246,DIAPH1,1
REACTOME_MATURATION_OF_SARS_COV_2_NUCLEOPROTEIN,REACTOME_MATURATION_OF_SARS_COV_2_NUCLEOPROTEIN,1/77,15/21728,0.051874899832235366,0.23163474909983042,0.19153047767602246,SRPK1,1
REACTOME_SIGNALING_BY_ACTIVIN,REACTOME_SIGNALING_BY_ACTIVIN,1/77,15/21728,0.051874899832235366,0.23163474909983042,0.19153047767602246,SMAD2,1
SA_G1_AND_S_PHASES,SA_G1_AND_S_PHASES,1/77,15/21728,0.051874899832235366,0.23163474909983042,0.19153047767602246,ARF1,1
SPIRA_SMOKERS_LUNG_CANCER_DN,SPIRA_SMOKERS_LUNG_CANCER_DN,1/77,15/21728,0.051874899832235366,0.23163474909983042,0.19153047767602246,DCLRE1C,1
WP_LET7_INHIBITION_OF_ES_CELL_REPROGRAMMING,WP_LET7_INHIBITION_OF_ES_CELL_REPROGRAMMING,1/77,15/21728,0.051874899832235366,0.23163474909983042,0.19153047767602246,MYC,1
LEE_RECENT_THYMIC_EMIGRANT,LEE_RECENT_THYMIC_EMIGRANT,3/77,237/21728,0.05204211295655405,0.2316814546680328,0.19156909683753728,EIF3H/B3GNT2/BCOR,3
DAZARD_RESPONSE_TO_UV_SCC_UP,DAZARD_RESPONSE_TO_UV_SCC_UP,2/77,105/21728,0.05355243673639607,0.23450304195950392,0.19390216630936832,RALB/NAP1L1,2
WP_7Q1123_COPY_NUMBER_VARIATION_SYNDROME,WP_7Q1123_COPY_NUMBER_VARIATION_SYNDROME,2/77,106/21728,0.05446007597042914,0.23450304195950392,0.19390216630936832,DDX21/MYC,2
BIOCARTA_CDMAC_PATHWAY,BIOCARTA_CDMAC_PATHWAY,1/77,16/21728,0.05523720042233893,0.23450304195950392,0.19390216630936832,MYC,1
BIOCARTA_EIF_PATHWAY,BIOCARTA_EIF_PATHWAY,1/77,16/21728,0.05523720042233893,0.23450304195950392,0.19390216630936832,EIF3A,1
FINETTI_BREAST_CANCER_KINOME_RED,FINETTI_BREAST_CANCER_KINOME_RED,1/77,16/21728,0.05523720042233893,0.23450304195950392,0.19390216630936832,SRPK1,1
GALE_APL_WITH_FLT3_MUTATED_DN,GALE_APL_WITH_FLT3_MUTATED_DN,1/77,16/21728,0.05523720042233893,0.23450304195950392,0.19390216630936832,ARF1,1
HOLLEMAN_VINCRISTINE_RESISTANCE_B_ALL_DN,HOLLEMAN_VINCRISTINE_RESISTANCE_B_ALL_DN,1/77,16/21728,0.05523720042233893,0.23450304195950392,0.19390216630936832,RPL12,1
KANG_FLUOROURACIL_RESISTANCE_DN,KANG_FLUOROURACIL_RESISTANCE_DN,1/77,16/21728,0.05523720042233893,0.23450304195950392,0.19390216630936832,NFYA,1
PID_SMAD2_3PATHWAY,PID_SMAD2_3PATHWAY,1/77,16/21728,0.05523720042233893,0.23450304195950392,0.19390216630936832,SMAD2,1
REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_CELL_DEATH_GENES,REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_CELL_DEATH_GENES,1/77,16/21728,0.05523720042233893,0.23450304195950392,0.19390216630936832,NFYA,1
REACTOME_MRNA_DECAY_BY_3_TO_5_EXORIBONUCLEASE,REACTOME_MRNA_DECAY_BY_3_TO_5_EXORIBONUCLEASE,1/77,16/21728,0.05523720042233893,0.23450304195950392,0.19390216630936832,EXOSC7,1
REACTOME_PROCESSING_OF_SMDT1,REACTOME_PROCESSING_OF_SMDT1,1/77,16/21728,0.05523720042233893,0.23450304195950392,0.19390216630936832,YME1L1,1
VETTER_TARGETS_OF_PRKCA_AND_ETS1_UP,VETTER_TARGETS_OF_PRKCA_AND_ETS1_UP,1/77,16/21728,0.05523720042233893,0.23450304195950392,0.19390216630936832,DIAPH1,1
WP_MAPK_PATHWAY_IN_CONGENITAL_THYROID_CANCER,WP_MAPK_PATHWAY_IN_CONGENITAL_THYROID_CANCER,1/77,16/21728,0.05523720042233893,0.23450304195950392,0.19390216630936832,MYC,1
WP_REGULATION_OF_SISTER_CHROMATID_SEPARATION_AT_THE_METAPHASEANAPHASE_TRANSITION,WP_REGULATION_OF_SISTER_CHROMATID_SEPARATION_AT_THE_METAPHASEANAPHASE_TRANSITION,1/77,16/21728,0.05523720042233893,0.23450304195950392,0.19390216630936832,BUB3,1
SENESE_HDAC1_AND_HDAC2_TARGETS_UP,SENESE_HDAC1_AND_HDAC2_TARGETS_UP,3/77,243/21728,0.0552885581320104,0.23450304195950392,0.19390216630936832,NUS1/TFAM/NAP1L1,3
ZHU_CMV_ALL_UP,ZHU_CMV_ALL_UP,2/77,107/21728,0.05537318108516026,0.23450304195950392,0.19390216630936832,SAR1A/DNAJA1,2
BOUDOUKHA_BOUND_BY_IGF2BP2,BOUDOUKHA_BOUND_BY_IGF2BP2,2/77,108/21728,0.056291703093294364,0.2365919876622515,0.1956294406921687,NACA/VPS26A,2
BLUM_RESPONSE_TO_SALIRASIB_UP,BLUM_RESPONSE_TO_SALIRASIB_UP,3/77,245/21728,0.05639191658780629,0.2365919876622515,0.1956294406921687,RPL12/EIF3H/ANXA7,3
REN_ALVEOLAR_RHABDOMYOSARCOMA_DN,REN_ALVEOLAR_RHABDOMYOSARCOMA_DN,4/77,407/21728,0.05654384216675854,0.2365919876622515,0.1956294406921687,ARF1/ANXA7/RAI14/EXT1,4
VANTVEER_BREAST_CANCER_METASTASIS_DN,VANTVEER_BREAST_CANCER_METASTASIS_DN,2/77,109/21728,0.05721559327798259,0.2365919876622515,0.1956294406921687,UCHL5/EXT1,2
BIOCARTA_ARAP_PATHWAY,BIOCARTA_ARAP_PATHWAY,1/77,17/21728,0.05858773172150478,0.2365919876622515,0.1956294406921687,ARF1,1
BIOCARTA_ARF_PATHWAY,BIOCARTA_ARF_PATHWAY,1/77,17/21728,0.05858773172150478,0.2365919876622515,0.1956294406921687,MYC,1
BIOCARTA_TEL_PATHWAY,BIOCARTA_TEL_PATHWAY,1/77,17/21728,0.05858773172150478,0.2365919876622515,0.1956294406921687,MYC,1
LI_CYTIDINE_ANALOG_PATHWAY,LI_CYTIDINE_ANALOG_PATHWAY,1/77,17/21728,0.05858773172150478,0.2365919876622515,0.1956294406921687,NT5C2,1
NELSON_RESPONSE_TO_ANDROGEN_DN,NELSON_RESPONSE_TO_ANDROGEN_DN,1/77,17/21728,0.05858773172150478,0.2365919876622515,0.1956294406921687,MYC,1
PIONTEK_PKD1_TARGETS_DN,PIONTEK_PKD1_TARGETS_DN,1/77,17/21728,0.05858773172150478,0.2365919876622515,0.1956294406921687,RPS6,1
REACTOME_BUTYRATE_RESPONSE_FACTOR_1_BRF1_BINDS_AND_DESTABILIZES_MRNA,REACTOME_BUTYRATE_RESPONSE_FACTOR_1_BRF1_BINDS_AND_DESTABILIZES_MRNA,1/77,17/21728,0.05858773172150478,0.2365919876622515,0.1956294406921687,EXOSC7,1
REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_CELL_CYCLE_GENES,REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_CELL_CYCLE_GENES,1/77,17/21728,0.05858773172150478,0.2365919876622515,0.1956294406921687,SMAD2,1
REACTOME_KSRP_KHSRP_BINDS_AND_DESTABILIZES_MRNA,REACTOME_KSRP_KHSRP_BINDS_AND_DESTABILIZES_MRNA,1/77,17/21728,0.05858773172150478,0.2365919876622515,0.1956294406921687,EXOSC7,1
REACTOME_PURINE_CATABOLISM,REACTOME_PURINE_CATABOLISM,1/77,17/21728,0.05858773172150478,0.2365919876622515,0.1956294406921687,NT5C2,1
REACTOME_TRISTETRAPROLIN_TTP_ZFP36_BINDS_AND_DESTABILIZES_MRNA,REACTOME_TRISTETRAPROLIN_TTP_ZFP36_BINDS_AND_DESTABILIZES_MRNA,1/77,17/21728,0.05858773172150478,0.2365919876622515,0.1956294406921687,EXOSC7,1
WIKMAN_ASBESTOS_LUNG_CANCER_UP,WIKMAN_ASBESTOS_LUNG_CANCER_UP,1/77,17/21728,0.05858773172150478,0.2365919876622515,0.1956294406921687,CTBP2,1
WP_CANONICAL_AND_NONCANONICAL_TGFB_SIGNALING,WP_CANONICAL_AND_NONCANONICAL_TGFB_SIGNALING,1/77,17/21728,0.05858773172150478,0.2365919876622515,0.1956294406921687,SMAD2,1
REACTOME_MITOTIC_SPINDLE_CHECKPOINT,REACTOME_MITOTIC_SPINDLE_CHECKPOINT,2/77,111/21728,0.05907928465430436,0.23710581922033624,0.1960543096038818,BUB3/UBE2D1,2
REACTOME_TRNA_PROCESSING,REACTOME_TRNA_PROCESSING,2/77,111/21728,0.05907928465430436,0.23710581922033624,0.1960543096038818,RPP30/RPP38,2
MITSIADES_RESPONSE_TO_APLIDIN_DN,MITSIADES_RESPONSE_TO_APLIDIN_DN,3/77,250/21728,0.05919624309357516,0.23710581922033624,0.1960543096038818,EIF3A/MYC/DERL1,3
FOSTER_TOLERANT_MACROPHAGE_DN,FOSTER_TOLERANT_MACROPHAGE_DN,4/77,414/21728,0.05946223513655953,0.23752752305901348,0.1964030014041127,MINPP1/RAI14/EXT1/MARCHF5,4
DITTMER_PTHLH_TARGETS_UP,DITTMER_PTHLH_TARGETS_UP,2/77,113/21728,0.060963870840513745,0.23872498298531875,0.19739313812830642,ANXA7/VDAC2,2
BROWNE_HCMV_INFECTION_4HR_DN,BROWNE_HCMV_INFECTION_4HR_DN,3/77,254/21728,0.061486525675356285,0.23872498298531875,0.19739313812830642,NFYA/DYRK2/ALDH1B1,3
SMIRNOV_RESPONSE_TO_IR_6HR_DN,SMIRNOV_RESPONSE_TO_IR_6HR_DN,2/77,114/21728,0.061913880532958085,0.23872498298531875,0.19739313812830642,MYC/GGA2,2
WP_GASTRIN_SIGNALING_PATHWAY,WP_GASTRIN_SIGNALING_PATHWAY,2/77,114/21728,0.061913880532958085,0.23872498298531875,0.19739313812830642,RPS6/MYC,2
BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_48HR_UP,BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_48HR_UP,1/77,18/21728,0.061926534386395615,0.23872498298531875,0.19739313812830642,GDI2,1
BIOCARTA_CARDIACEGF_PATHWAY,BIOCARTA_CARDIACEGF_PATHWAY,1/77,18/21728,0.061926534386395615,0.23872498298531875,0.19739313812830642,MYC,1
GRANDVAUX_IRF3_TARGETS_DN,GRANDVAUX_IRF3_TARGETS_DN,1/77,18/21728,0.061926534386395615,0.23872498298531875,0.19739313812830642,PPP2R3A,1
REACTOME_DISEASES_ASSOCIATED_WITH_GLYCOSYLATION_PRECURSOR_BIOSYNTHESIS,REACTOME_DISEASES_ASSOCIATED_WITH_GLYCOSYLATION_PRECURSOR_BIOSYNTHESIS,1/77,18/21728,0.061926534386395615,0.23872498298531875,0.19739313812830642,NUS1,1
REACTOME_SYNTHESIS_OF_PIPS_AT_THE_GOLGI_MEMBRANE,REACTOME_SYNTHESIS_OF_PIPS_AT_THE_GOLGI_MEMBRANE,1/77,18/21728,0.061926534386395615,0.23872498298531875,0.19739313812830642,ARF1,1
WP_MAMMARY_GLAND_DEVELOPMENT_PATHWAY_EMBRYONIC_DEVELOPMENT_STAGE_1_OF_4,WP_MAMMARY_GLAND_DEVELOPMENT_PATHWAY_EMBRYONIC_DEVELOPMENT_STAGE_1_OF_4,1/77,18/21728,0.061926534386395615,0.23872498298531875,0.19739313812830642,MYC,1
WP_TGFBETA_SIGNALING_IN_THYROID_CELLS_FOR_EPITHELIALMESENCHYMAL_TRANSITION,WP_TGFBETA_SIGNALING_IN_THYROID_CELLS_FOR_EPITHELIALMESENCHYMAL_TRANSITION,1/77,18/21728,0.061926534386395615,0.23872498298531875,0.19739313812830642,SMAD2,1
WU_HBX_TARGETS_3_UP,WU_HBX_TARGETS_3_UP,1/77,18/21728,0.061926534386395615,0.23872498298531875,0.19739313812830642,MYC,1
KAAB_HEART_ATRIUM_VS_VENTRICLE_UP,KAAB_HEART_ATRIUM_VS_VENTRICLE_UP,3/77,256/21728,0.06264712998090927,0.23872498298531875,0.19739313812830642,DYRK2/CDC123/NAP1L1,3
HAHTOLA_MYCOSIS_FUNGOIDES_CD4_DN,HAHTOLA_MYCOSIS_FUNGOIDES_CD4_DN,2/77,115/21728,0.06286897171004409,0.23872498298531875,0.19739313812830642,NACA/NAP1L1,2
HOSHIDA_LIVER_CANCER_SUBCLASS_S2,HOSHIDA_LIVER_CANCER_SUBCLASS_S2,2/77,115/21728,0.06286897171004409,0.23872498298531875,0.19739313812830642,TIAL1/RPS24,2
LAIHO_COLORECTAL_CANCER_SERRATED_UP,LAIHO_COLORECTAL_CANCER_SERRATED_UP,2/77,115/21728,0.06286897171004409,0.23872498298531875,0.19739313812830642,YME1L1/GDI2,2
ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_DN,ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_DN,2/77,116/21728,0.06382909751306107,0.23872498298531875,0.19739313812830642,MINPP1/MYC,2
BOYAULT_LIVER_CANCER_SUBCLASS_G1_UP,BOYAULT_LIVER_CANCER_SUBCLASS_G1_UP,2/77,116/21728,0.06382909751306107,0.23872498298531875,0.19739313812830642,MPZL1/NAP1L1,2
SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM1,SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM1,3/77,259/21728,0.06440721392651202,0.23872498298531875,0.19739313812830642,RPL12/RAI14/NAP1L1,3
DIAZ_CHRONIC_MYELOGENOUS_LEUKEMIA_DN,DIAZ_CHRONIC_MYELOGENOUS_LEUKEMIA_DN,2/77,117/21728,0.06479421134381164,0.23872498298531875,0.19739313812830642,RPL30/RPS24,2
WP_WNT_SIGNALING,WP_WNT_SIGNALING,2/77,117/21728,0.06479421134381164,0.23872498298531875,0.19739313812830642,CTBP2/MYC,2
BIOCARTA_ECM_PATHWAY,BIOCARTA_ECM_PATHWAY,1/77,19/21728,0.06525364893509389,0.23872498298531875,0.19739313812830642,DIAPH1,1
BIOCARTA_MAL_PATHWAY,BIOCARTA_MAL_PATHWAY,1/77,19/21728,0.06525364893509389,0.23872498298531875,0.19739313812830642,DIAPH1,1
BIOCARTA_TGFB_PATHWAY,BIOCARTA_TGFB_PATHWAY,1/77,19/21728,0.06525364893509389,0.23872498298531875,0.19739313812830642,SMAD2,1
CEBALLOS_TARGETS_OF_TP53_AND_MYC_UP,CEBALLOS_TARGETS_OF_TP53_AND_MYC_UP,1/77,19/21728,0.06525364893509389,0.23872498298531875,0.19739313812830642,MYC,1
CHIARETTI_T_ALL_RELAPSE_PROGNOSIS,CHIARETTI_T_ALL_RELAPSE_PROGNOSIS,1/77,19/21728,0.06525364893509389,0.23872498298531875,0.19739313812830642,MYC,1
HEDENFALK_BREAST_CANCER_BRACX_UP,HEDENFALK_BREAST_CANCER_BRACX_UP,1/77,19/21728,0.06525364893509389,0.23872498298531875,0.19739313812830642,RPP30,1
MANN_RESPONSE_TO_AMIFOSTINE_UP,MANN_RESPONSE_TO_AMIFOSTINE_UP,1/77,19/21728,0.06525364893509389,0.23872498298531875,0.19739313812830642,MYC,1
MARSON_FOXP3_CORE_DIRECT_TARGETS,MARSON_FOXP3_CORE_DIRECT_TARGETS,1/77,19/21728,0.06525364893509389,0.23872498298531875,0.19739313812830642,MYC,1
MATZUK_EMBRYONIC_GERM_CELL,MATZUK_EMBRYONIC_GERM_CELL,1/77,19/21728,0.06525364893509389,0.23872498298531875,0.19739313812830642,TIAL1,1
PID_ARF_3PATHWAY,PID_ARF_3PATHWAY,1/77,19/21728,0.06525364893509389,0.23872498298531875,0.19739313812830642,ARF1,1
REACTOME_TICAM1_RIP1_MEDIATED_IKK_COMPLEX_RECRUITMENT,REACTOME_TICAM1_RIP1_MEDIATED_IKK_COMPLEX_RECRUITMENT,1/77,19/21728,0.06525364893509389,0.23872498298531875,0.19739313812830642,UBE2D1,1
REACTOME_TRANSCRIPTION_OF_E2F_TARGETS_UNDER_NEGATIVE_CONTROL_BY_DREAM_COMPLEX,REACTOME_TRANSCRIPTION_OF_E2F_TARGETS_UNDER_NEGATIVE_CONTROL_BY_DREAM_COMPLEX,1/77,19/21728,0.06525364893509389,0.23872498298531875,0.19739313812830642,MYC,1
WP_PROTEOGLYCAN_BIOSYNTHESIS,WP_PROTEOGLYCAN_BIOSYNTHESIS,1/77,19/21728,0.06525364893509389,0.23872498298531875,0.19739313812830642,EXT1,1
FIGUEROA_AML_METHYLATION_CLUSTER_7_UP,FIGUEROA_AML_METHYLATION_CLUSTER_7_UP,2/77,118/21728,0.06576426686339386,0.2389269560388232,0.19756014241227388,MPZL1/BTAF1,2
KAAB_HEART_ATRIUM_VS_VENTRICLE_DN,KAAB_HEART_ATRIUM_VS_VENTRICLE_DN,3/77,262/21728,0.06619014608273825,0.2389269560388232,0.19756014241227388,METAP1/PPP2R3A/UBE2D1,3
LINDGREN_BLADDER_CANCER_CLUSTER_1_UP,LINDGREN_BLADDER_CANCER_CLUSTER_1_UP,2/77,120/21728,0.06771901890265054,0.2389269560388232,0.19756014241227388,RPL6/PPP6C,2
MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_UP,MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_UP,3/77,265/21728,0.06799573770082049,0.2389269560388232,0.19756014241227388,CTBP2/IDE/EXOSC7,3
ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN,ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN,1/77,20/21728,0.06856911574756808,0.2389269560388232,0.19756014241227388,MYC,1
DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_DN,DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_DN,1/77,20/21728,0.06856911574756808,0.2389269560388232,0.19756014241227388,NAP1L1,1
HEDENFALK_BREAST_CANCER_BRACX_DN,HEDENFALK_BREAST_CANCER_BRACX_DN,1/77,20/21728,0.06856911574756808,0.2389269560388232,0.19756014241227388,NAP1L1,1
HOFMANN_MYELODYSPLASTIC_SYNDROM_HIGH_RISK_DN,HOFMANN_MYELODYSPLASTIC_SYNDROM_HIGH_RISK_DN,1/77,20/21728,0.06856911574756808,0.2389269560388232,0.19756014241227388,DYRK2,1
MCGOWAN_RSP6_TARGETS_UP,MCGOWAN_RSP6_TARGETS_UP,1/77,20/21728,0.06856911574756808,0.2389269560388232,0.19756014241227388,GLRX3,1
REACTOME_ABERRANT_REGULATION_OF_MITOTIC_EXIT_IN_CANCER_DUE_TO_RB1_DEFECTS,REACTOME_ABERRANT_REGULATION_OF_MITOTIC_EXIT_IN_CANCER_DUE_TO_RB1_DEFECTS,1/77,20/21728,0.06856911574756808,0.2389269560388232,0.19756014241227388,UBE2D1,1
REACTOME_CONVERSION_FROM_APC_C_CDC20_TO_APC_C_CDH1_IN_LATE_ANAPHASE,REACTOME_CONVERSION_FROM_APC_C_CDC20_TO_APC_C_CDH1_IN_LATE_ANAPHASE,1/77,20/21728,0.06856911574756808,0.2389269560388232,0.19756014241227388,UBE2D1,1
REACTOME_PHOSPHORYLATION_OF_THE_APC_C,REACTOME_PHOSPHORYLATION_OF_THE_APC_C,1/77,20/21728,0.06856911574756808,0.2389269560388232,0.19756014241227388,UBE2D1,1
REACTOME_SIGNALLING_TO_RAS,REACTOME_SIGNALLING_TO_RAS,1/77,20/21728,0.06856911574756808,0.2389269560388232,0.19756014241227388,RALB,1
SEIDEN_MET_SIGNALING,SEIDEN_MET_SIGNALING,1/77,20/21728,0.06856911574756808,0.2389269560388232,0.19756014241227388,CCT8,1
TOMLINS_METASTASIS_DN,TOMLINS_METASTASIS_DN,1/77,20/21728,0.06856911574756808,0.2389269560388232,0.19756014241227388,CTBP2,1
WALLACE_PROSTATE_CANCER_UP,WALLACE_PROSTATE_CANCER_UP,1/77,20/21728,0.06856911574756808,0.2389269560388232,0.19756014241227388,MYC,1
WP_HEREDITARY_LEIOMYOMATOSIS_AND_RENAL_CELL_CARCINOMA_PATHWAY,WP_HEREDITARY_LEIOMYOMATOSIS_AND_RENAL_CELL_CARCINOMA_PATHWAY,1/77,20/21728,0.06856911574756808,0.2389269560388232,0.19756014241227388,RPS6,1
WP_MITOCHONDRIAL_GENE_EXPRESSION,WP_MITOCHONDRIAL_GENE_EXPRESSION,1/77,20/21728,0.06856911574756808,0.2389269560388232,0.19756014241227388,TFAM,1
WP_TP53_NETWORK,WP_TP53_NETWORK,1/77,20/21728,0.06856911574756808,0.2389269560388232,0.19756014241227388,MYC,1
WP_ALZHEIMERS_DISEASE,WP_ALZHEIMERS_DISEASE,3/77,266/21728,0.06860260387228576,0.2389269560388232,0.19756014241227388,KIF5B/VDAC2/IDE,3
WP_DNA_REPAIR_PATHWAYS_FULL_NETWORK,WP_DNA_REPAIR_PATHWAYS_FULL_NETWORK,2/77,121/21728,0.06870362403010816,0.2389269560388232,0.19756014241227388,DCLRE1C/NHEJ1,2
REACTOME_RAB_REGULATION_OF_TRAFFICKING,REACTOME_RAB_REGULATION_OF_TRAFFICKING,2/77,122/21728,0.06969298805956414,0.24179867688271317,0.1999346655229898,GDI2/GGA2,2
WAMUNYOKOLI_OVARIAN_CANCER_LMP_UP,WAMUNYOKOLI_OVARIAN_CANCER_LMP_UP,3/77,270/21728,0.07105488758697567,0.24364279162327301,0.2014594979521544,DYRK2/CTBP2/SRPK1,3
KAYO_AGING_MUSCLE_DN,KAYO_AGING_MUSCLE_DN,2/77,124/21728,0.07168581283450827,0.24364279162327301,0.2014594979521544,VDAC2/EXOSC7,2
REACTOME_GLYCOSAMINOGLYCAN_METABOLISM,REACTOME_GLYCOSAMINOGLYCAN_METABOLISM,2/77,124/21728,0.07168581283450827,0.24364279162327301,0.2014594979521544,B3GNT2/EXT1,2
AMIT_EGF_RESPONSE_240_MCF10A,AMIT_EGF_RESPONSE_240_MCF10A,1/77,21/21728,0.07187297506613466,0.24364279162327301,0.2014594979521544,B3GNT2,1
BIOCARTA_RHO_PATHWAY,BIOCARTA_RHO_PATHWAY,1/77,21/21728,0.07187297506613466,0.24364279162327301,0.2014594979521544,DIAPH1,1
MALTA_CURATED_STEMNESS_MARKERS,MALTA_CURATED_STEMNESS_MARKERS,1/77,21/21728,0.07187297506613466,0.24364279162327301,0.2014594979521544,MYC,1
NUMATA_CSF3_SIGNALING_VIA_STAT3,NUMATA_CSF3_SIGNALING_VIA_STAT3,1/77,21/21728,0.07187297506613466,0.24364279162327301,0.2014594979521544,SRPK1,1
REACTOME_NEF_MEDIATES_DOWN_MODULATION_OF_CELL_SURFACE_RECEPTORS_BY_RECRUITING_THEM_TO_CLATHRIN_ADAPTERS,REACTOME_NEF_MEDIATES_DOWN_MODULATION_OF_CELL_SURFACE_RECEPTORS_BY_RECRUITING_THEM_TO_CLATHRIN_ADAPTERS,1/77,21/21728,0.07187297506613466,0.24364279162327301,0.2014594979521544,ARF1,1
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_MONOCYTE_UP,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_MONOCYTE_UP,1/77,21/21728,0.07187297506613466,0.24364279162327301,0.2014594979521544,NAP1L1,1
WP_IMATINIB_AND_CHRONIC_MYELOID_LEUKEMIA,WP_IMATINIB_AND_CHRONIC_MYELOID_LEUKEMIA,1/77,21/21728,0.07187297506613466,0.24364279162327301,0.2014594979521544,MYC,1
MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_DN,MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_DN,2/77,125/21728,0.07268918421407163,0.24584579924118505,0.20328108604730138,XPNPEP1/GDI2,2
STEARMAN_LUNG_CANCER_EARLY_VS_LATE_UP,STEARMAN_LUNG_CANCER_EARLY_VS_LATE_UP,2/77,127/21728,0.07470962341736075,0.24632874638574945,0.20368041774364726,KIF5B/EXT1,2
DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN,DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN,3/77,276/21728,0.07480696075475186,0.24632874638574945,0.20368041774364726,MYC/ALDH1B1/GGA2,3
BIOCARTA_MTOR_PATHWAY,BIOCARTA_MTOR_PATHWAY,1/77,22/21728,0.07516526699592219,0.24632874638574945,0.20368041774364726,EIF3A,1
HOLLEMAN_PREDNISOLONE_RESISTANCE_B_ALL_UP,HOLLEMAN_PREDNISOLONE_RESISTANCE_B_ALL_UP,1/77,22/21728,0.07516526699592219,0.24632874638574945,0.20368041774364726,PRPF18,1
KEGG_BETA_ALANINE_METABOLISM,KEGG_BETA_ALANINE_METABOLISM,1/77,22/21728,0.07516526699592219,0.24632874638574945,0.20368041774364726,ALDH1B1,1
MULLIGAN_NTF3_SIGNALING_VIA_INSR_AND_IGF1R_UP,MULLIGAN_NTF3_SIGNALING_VIA_INSR_AND_IGF1R_UP,1/77,22/21728,0.07516526699592219,0.24632874638574945,0.20368041774364726,DDX21,1
PEPPER_CHRONIC_LYMPHOCYTIC_LEUKEMIA_DN,PEPPER_CHRONIC_LYMPHOCYTIC_LEUKEMIA_DN,1/77,22/21728,0.07516526699592219,0.24632874638574945,0.20368041774364726,EXT1,1
SCIAN_CELL_CYCLE_TARGETS_OF_TP53_AND_TP73_DN,SCIAN_CELL_CYCLE_TARGETS_OF_TP53_AND_TP73_DN,1/77,22/21728,0.07516526699592219,0.24632874638574945,0.20368041774364726,MYC,1
TIAN_TNF_SIGNALING_NOT_VIA_NFKB,TIAN_TNF_SIGNALING_NOT_VIA_NFKB,1/77,22/21728,0.07516526699592219,0.24632874638574945,0.20368041774364726,EXT1,1
WP_PI3KAKTMTOR_VITD3_SIGNALING,WP_PI3KAKTMTOR_VITD3_SIGNALING,1/77,22/21728,0.07516526699592219,0.24632874638574945,0.20368041774364726,MYC,1
WP_REGULATION_OF_APOPTOSIS_BY_PARATHYROID_HORMONERELATED_PROTEIN,WP_REGULATION_OF_APOPTOSIS_BY_PARATHYROID_HORMONERELATED_PROTEIN,1/77,22/21728,0.07516526699592219,0.24632874638574945,0.20368041774364726,MYC,1
YANG_BREAST_CANCER_ESR1_BULK_DN,YANG_BREAST_CANCER_ESR1_BULK_DN,1/77,22/21728,0.07516526699592219,0.24632874638574945,0.20368041774364726,GTPBP4,1
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_3,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_3,1/77,22/21728,0.07516526699592219,0.24632874638574945,0.20368041774364726,MINPP1,1
YUAN_ZNF143_PARTNERS,YUAN_ZNF143_PARTNERS,1/77,22/21728,0.07516526699592219,0.24632874638574945,0.20368041774364726,GTPBP4,1
SENESE_HDAC1_TARGETS_UP,SENESE_HDAC1_TARGETS_UP,4/77,451/21728,0.07619719483253594,0.24880522438816663,0.20572812870497936,NFYA/TFAM/MYC/NAP1L1,4
BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_D,BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_D,3/77,279/21728,0.07671570036413589,0.24880522438816663,0.20572812870497936,DDX21/GTPBP4/ALDH1B1,3
FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN,FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN,4/77,453/21728,0.07716348503451044,0.24880522438816663,0.20572812870497936,CLIP4/B3GNT2/DCLRE1C/GGA2,4
BIOCARTA_GLEEVEC_PATHWAY,BIOCARTA_GLEEVEC_PATHWAY,1/77,23/21728,0.07844603150533536,0.24880522438816663,0.20572812870497936,MYC,1
BIOCARTA_PTDINS_PATHWAY,BIOCARTA_PTDINS_PATHWAY,1/77,23/21728,0.07844603150533536,0.24880522438816663,0.20572812870497936,ARF1,1
HASLINGER_B_CLL_WITH_CHROMOSOME_12_TRISOMY,HASLINGER_B_CLL_WITH_CHROMOSOME_12_TRISOMY,1/77,23/21728,0.07844603150533536,0.24880522438816663,0.20572812870497936,DYRK2,1
HOFMANN_MYELODYSPLASTIC_SYNDROM_RISK_DN,HOFMANN_MYELODYSPLASTIC_SYNDROM_RISK_DN,1/77,23/21728,0.07844603150533536,0.24880522438816663,0.20572812870497936,DYRK2,1
HOLLEMAN_ASPARAGINASE_RESISTANCE_ALL_UP,HOLLEMAN_ASPARAGINASE_RESISTANCE_ALL_UP,1/77,23/21728,0.07844603150533536,0.24880522438816663,0.20572812870497936,RPL6,1
MARIADASON_RESPONSE_TO_CURCUMIN_SULINDAC_5,MARIADASON_RESPONSE_TO_CURCUMIN_SULINDAC_5,1/77,23/21728,0.07844603150533536,0.24880522438816663,0.20572812870497936,BTF3,1
REACTOME_BBSOME_MEDIATED_CARGO_TARGETING_TO_CILIUM,REACTOME_BBSOME_MEDIATED_CARGO_TARGETING_TO_CILIUM,1/77,23/21728,0.07844603150533536,0.24880522438816663,0.20572812870497936,CCT8,1
REACTOME_IKK_COMPLEX_RECRUITMENT_MEDIATED_BY_RIP1,REACTOME_IKK_COMPLEX_RECRUITMENT_MEDIATED_BY_RIP1,1/77,23/21728,0.07844603150533536,0.24880522438816663,0.20572812870497936,UBE2D1,1
REACTOME_SIGNALING_BY_NODAL,REACTOME_SIGNALING_BY_NODAL,1/77,23/21728,0.07844603150533536,0.24880522438816663,0.20572812870497936,SMAD2,1
REACTOME_TELOMERE_EXTENSION_BY_TELOMERASE,REACTOME_TELOMERE_EXTENSION_BY_TELOMERASE,1/77,23/21728,0.07844603150533536,0.24880522438816663,0.20572812870497936,PPP6C,1
VERNELL_RETINOBLASTOMA_PATHWAY_DN,VERNELL_RETINOBLASTOMA_PATHWAY_DN,1/77,23/21728,0.07844603150533536,0.24880522438816663,0.20572812870497936,CLIP4,1
WP_PROGERIAASSOCIATED_LIPODYSTROPHY,WP_PROGERIAASSOCIATED_LIPODYSTROPHY,1/77,23/21728,0.07844603150533536,0.24880522438816663,0.20572812870497936,SMAD2,1
BROWN_MYELOID_CELL_DEVELOPMENT_DN,BROWN_MYELOID_CELL_DEVELOPMENT_DN,2/77,131/21728,0.07880406257736021,0.2494055770649644,0.20622453883086941,IDE/GTPBP4,2
WP_MRNA_PROCESSING,WP_MRNA_PROCESSING,2/77,133/21728,0.08087737134374409,0.25426363337764407,0.21024149159706915,SRPK1/PRPF18,2
BIOCARTA_CTCF_PATHWAY,BIOCARTA_CTCF_PATHWAY,1/77,24/21728,0.08171530842650943,0.25426363337764407,0.21024149159706915,MYC,1
BIOCARTA_WNT_PATHWAY,BIOCARTA_WNT_PATHWAY,1/77,24/21728,0.08171530842650943,0.25426363337764407,0.21024149159706915,MYC,1
KEGG_NICOTINATE_AND_NICOTINAMIDE_METABOLISM,KEGG_NICOTINATE_AND_NICOTINAMIDE_METABOLISM,1/77,24/21728,0.08171530842650943,0.25426363337764407,0.21024149159706915,NT5C2,1
KORKOLA_EMBRYONIC_CARCINOMA_VS_SEMINOMA_UP,KORKOLA_EMBRYONIC_CARCINOMA_VS_SEMINOMA_UP,1/77,24/21728,0.08171530842650943,0.25426363337764407,0.21024149159706915,NAP1L1,1
MAGRANGEAS_MULTIPLE_MYELOMA_IGLL_VS_IGLK_DN,MAGRANGEAS_MULTIPLE_MYELOMA_IGLL_VS_IGLK_DN,1/77,24/21728,0.08171530842650943,0.25426363337764407,0.21024149159706915,RPL4,1
REACTOME_APC_C_CDC20_MEDIATED_DEGRADATION_OF_CYCLIN_B,REACTOME_APC_C_CDC20_MEDIATED_DEGRADATION_OF_CYCLIN_B,1/77,24/21728,0.08171530842650943,0.25426363337764407,0.21024149159706915,UBE2D1,1
REACTOME_MTORC1_MEDIATED_SIGNALLING,REACTOME_MTORC1_MEDIATED_SIGNALLING,1/77,24/21728,0.08171530842650943,0.25426363337764407,0.21024149159706915,RPS6,1
REACTOME_GOLGI_TO_ER_RETROGRADE_TRANSPORT,REACTOME_GOLGI_TO_ER_RETROGRADE_TRANSPORT,2/77,134/21728,0.08192039873755905,0.25436628011368123,0.21032636650664763,ARF1/KIF5B,2
GABRIELY_MIR21_TARGETS,GABRIELY_MIR21_TARGETS,3/77,289/21728,0.08323245471253335,0.2563067288972124,0.21193085410559334,CLIP4/YME1L1/RAI14,3
DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN,DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN,4/77,466/21728,0.08359512582450998,0.2563067288972124,0.21193085410559334,PPP2R3A/CTBP2/EXT1/MYC,4
GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN,GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN,4/77,467/21728,0.08410060276736672,0.2563067288972124,0.21193085410559334,NFYA/DCLRE1C/RANBP17/RMND1,4
BROWNE_HCMV_INFECTION_14HR_DN,BROWNE_HCMV_INFECTION_14HR_DN,3/77,291/21728,0.0845638171871387,0.2563067288972124,0.21193085410559334,TIAL1/EIF3A/EXT1,3
DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_UP,DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_UP,1/77,25/21728,0.08497313745577406,0.2563067288972124,0.21193085410559334,ALDH1B1,1
DELACROIX_RAR_TARGETS_DN,DELACROIX_RAR_TARGETS_DN,1/77,25/21728,0.08497313745577406,0.2563067288972124,0.21193085410559334,CTBP2,1
FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN,FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN,1/77,25/21728,0.08497313745577406,0.2563067288972124,0.21193085410559334,MYC,1
HEIDENBLAD_AMPLICON_12P11_12_DN,HEIDENBLAD_AMPLICON_12P11_12_DN,1/77,25/21728,0.08497313745577406,0.2563067288972124,0.21193085410559334,SAR1A,1
KEGG_ASCORBATE_AND_ALDARATE_METABOLISM,KEGG_ASCORBATE_AND_ALDARATE_METABOLISM,1/77,25/21728,0.08497313745577406,0.2563067288972124,0.21193085410559334,ALDH1B1,1
PID_MYC_PATHWAY,PID_MYC_PATHWAY,1/77,25/21728,0.08497313745577406,0.2563067288972124,0.21193085410559334,MYC,1
REACTOME_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC,REACTOME_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC,1/77,25/21728,0.08497313745577406,0.2563067288972124,0.21193085410559334,SEC24C,1
REACTOME_INACTIVATION_OF_CSF3_G_CSF_SIGNALING,REACTOME_INACTIVATION_OF_CSF3_G_CSF_SIGNALING,1/77,25/21728,0.08497313745577406,0.2563067288972124,0.21193085410559334,UBE2D1,1
WP_HYPOTHESIZED_PATHWAYS_IN_PATHOGENESIS_OF_CARDIOVASCULAR_DISEASE,WP_HYPOTHESIZED_PATHWAYS_IN_PATHOGENESIS_OF_CARDIOVASCULAR_DISEASE,1/77,25/21728,0.08497313745577406,0.2563067288972124,0.21193085410559334,SMAD2,1
WP_IL7_SIGNALING_PATHWAY,WP_IL7_SIGNALING_PATHWAY,1/77,25/21728,0.08497313745577406,0.2563067288972124,0.21193085410559334,MYC,1
NOUZOVA_TRETINOIN_AND_H4_ACETYLATION,NOUZOVA_TRETINOIN_AND_H4_ACETYLATION,2/77,138/21728,0.08613401519910512,0.2592791740616647,0.21438866254938588,EIF3H/CDC123,2
ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_UP,ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_UP,2/77,139/21728,0.08719758843912698,0.2603909928805808,0.21530798570924745,B3GNT2/PPP2R3A,2
BIOCARTA_VIP_PATHWAY,BIOCARTA_VIP_PATHWAY,1/77,26/21728,0.08821955815410654,0.2603909928805808,0.21530798570924745,MYC,1
DEN_INTERACT_WITH_LCA5,DEN_INTERACT_WITH_LCA5,1/77,26/21728,0.08821955815410654,0.2603909928805808,0.21530798570924745,NAP1L1,1
KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_HEPARAN_SULFATE,KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_HEPARAN_SULFATE,1/77,26/21728,0.08821955815410654,0.2603909928805808,0.21530798570924745,EXT1,1
KEGG_GLYCOSPHINGOLIPID_BIOSYNTHESIS_LACTO_AND_NEOLACTO_SERIES,KEGG_GLYCOSPHINGOLIPID_BIOSYNTHESIS_LACTO_AND_NEOLACTO_SERIES,1/77,26/21728,0.08821955815410654,0.2603909928805808,0.21530798570924745,B3GNT2,1
REACTOME_FORMATION_OF_TUBULIN_FOLDING_INTERMEDIATES_BY_CCT_TRIC,REACTOME_FORMATION_OF_TUBULIN_FOLDING_INTERMEDIATES_BY_CCT_TRIC,1/77,26/21728,0.08821955815410654,0.2603909928805808,0.21530798570924745,CCT8,1
REACTOME_WNT_LIGAND_BIOGENESIS_AND_TRAFFICKING,REACTOME_WNT_LIGAND_BIOGENESIS_AND_TRAFFICKING,1/77,26/21728,0.08821955815410654,0.2603909928805808,0.21530798570924745,VPS26A,1
WP_PPARALPHA_PATHWAY,WP_PPARALPHA_PATHWAY,1/77,26/21728,0.08821955815410654,0.2603909928805808,0.21530798570924745,MYC,1
WP_WNTBETACATENIN_SIGNALING_PATHWAY_IN_LEUKEMIA,WP_WNTBETACATENIN_SIGNALING_PATHWAY_IN_LEUKEMIA,1/77,26/21728,0.08821955815410654,0.2603909928805808,0.21530798570924745,MYC,1
REACTOME_RHO_GTPASES_ACTIVATE_FORMINS,REACTOME_RHO_GTPASES_ACTIVATE_FORMINS,2/77,140/21728,0.08826514711310622,0.2603909928805808,0.21530798570924745,DIAPH1/BUB3,2
WEST_ADRENOCORTICAL_TUMOR_UP,WEST_ADRENOCORTICAL_TUMOR_UP,3/77,298/21728,0.08929551178523071,0.2622534698419288,0.21684800120111059,KIF5B/BUB3/CDC123,3
BOYLAN_MULTIPLE_MYELOMA_C_D_UP,BOYLAN_MULTIPLE_MYELOMA_C_D_UP,2/77,141/21728,0.08933665052142939,0.2622534698419288,0.21684800120111059,DYRK2/NAP1L1,2
DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP,DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP,3/77,300/21728,0.09066770451568601,0.2622534698419288,0.21684800120111059,TIAL1/BUB3/UBE2D1,3
BIOCARTA_ERK_PATHWAY,BIOCARTA_ERK_PATHWAY,1/77,27/21728,0.0914546099475878,0.2622534698419288,0.21684800120111059,MYC,1
GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_UP,GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_UP,1/77,27/21728,0.0914546099475878,0.2622534698419288,0.21684800120111059,NUS1,1
LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_UP,LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_UP,1/77,27/21728,0.0914546099475878,0.2622534698419288,0.21684800120111059,NAP1L1,1
PID_GLYPICAN_1PATHWAY,PID_GLYPICAN_1PATHWAY,1/77,27/21728,0.0914546099475878,0.2622534698419288,0.21684800120111059,SMAD2,1
REACTOME_FGFR2_ALTERNATIVE_SPLICING,REACTOME_FGFR2_ALTERNATIVE_SPLICING,1/77,27/21728,0.0914546099475878,0.2622534698419288,0.21684800120111059,TIAL1,1
REACTOME_G0_AND_EARLY_G1,REACTOME_G0_AND_EARLY_G1,1/77,27/21728,0.0914546099475878,0.2622534698419288,0.21684800120111059,MYC,1
REACTOME_INSULIN_PROCESSING,REACTOME_INSULIN_PROCESSING,1/77,27/21728,0.0914546099475878,0.2622534698419288,0.21684800120111059,KIF5B,1
REACTOME_SIGNALING_BY_ALK,REACTOME_SIGNALING_BY_ALK,1/77,27/21728,0.0914546099475878,0.2622534698419288,0.21684800120111059,MYC,1
WP_FOLLICLE_STIMULATING_HORMONE_FSH_SIGNALING_PATHWAY,WP_FOLLICLE_STIMULATING_HORMONE_FSH_SIGNALING_PATHWAY,1/77,27/21728,0.0914546099475878,0.2622534698419288,0.21684800120111059,RPS6,1
GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_UP,GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_UP,2/77,143/21728,0.0914913298994168,0.2622534698419288,0.21684800120111059,XPNPEP1/NAP1L1,2
REACTOME_DISEASES_OF_GLYCOSYLATION,REACTOME_DISEASES_OF_GLYCOSYLATION,2/77,143/21728,0.0914913298994168,0.2622534698419288,0.21684800120111059,NUS1/EXT1,2
SWEET_LUNG_CANCER_KRAS_UP,SWEET_LUNG_CANCER_KRAS_UP,4/77,482/21728,0.09186387129486422,0.2622534698419288,0.21684800120111059,CLIP4/RPL37/RPL6/MARCHF5,4
PECE_MAMMARY_STEM_CELL_DN,PECE_MAMMARY_STEM_CELL_DN,2/77,144/21728,0.09257442562333944,0.2622534698419288,0.21684800120111059,GDI2/DERL1,2
WP_ECTODERM_DIFFERENTIATION,WP_ECTODERM_DIFFERENTIATION,2/77,144/21728,0.09257442562333944,0.2622534698419288,0.21684800120111059,MYC/BCOR,2
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_14,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_14,2/77,144/21728,0.09257442562333944,0.2622534698419288,0.21684800120111059,METAP1/CCT8,2
BROWNE_HCMV_INFECTION_48HR_DN,BROWNE_HCMV_INFECTION_48HR_DN,4/77,485/21728,0.09345681840618131,0.2622534698419288,0.21684800120111059,DYRK2/RAI14/PPP2R3A/NAP1L1,4
SMITH_TERT_TARGETS_UP,SMITH_TERT_TARGETS_UP,2/77,145/21728,0.09366130558794762,0.2622534698419288,0.21684800120111059,EXOSC7/RPP30,2
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_MAGENTA_UP,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_MAGENTA_UP,1/77,28/21728,0.0946783321278577,0.2622534698419288,0.21684800120111059,DNAJA1,1
MATZUK_MALE_REPRODUCTION_SERTOLI,MATZUK_MALE_REPRODUCTION_SERTOLI,1/77,28/21728,0.0946783321278577,0.2622534698419288,0.21684800120111059,DNAJA1,1
MOREIRA_RESPONSE_TO_TSA_UP,MOREIRA_RESPONSE_TO_TSA_UP,1/77,28/21728,0.0946783321278577,0.2622534698419288,0.21684800120111059,MYC,1
REACTOME_KERATAN_SULFATE_BIOSYNTHESIS,REACTOME_KERATAN_SULFATE_BIOSYNTHESIS,1/77,28/21728,0.0946783321278577,0.2622534698419288,0.21684800120111059,B3GNT2,1
REACTOME_SIGNALING_BY_BMP,REACTOME_SIGNALING_BY_BMP,1/77,28/21728,0.0946783321278577,0.2622534698419288,0.21684800120111059,UBE2D1,1
REACTOME_THE_ROLE_OF_NEF_IN_HIV_1_REPLICATION_AND_DISEASE_PATHOGENESIS,REACTOME_THE_ROLE_OF_NEF_IN_HIV_1_REPLICATION_AND_DISEASE_PATHOGENESIS,1/77,28/21728,0.0946783321278577,0.2622534698419288,0.21684800120111059,ARF1,1
RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_UP,RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_UP,1/77,28/21728,0.0946783321278577,0.2622534698419288,0.21684800120111059,MYC,1
WP_INTERACTIONS_OF_NATURAL_KILLER_CELLS_IN_PANCREATIC_CANCER,WP_INTERACTIONS_OF_NATURAL_KILLER_CELLS_IN_PANCREATIC_CANCER,1/77,28/21728,0.0946783321278577,0.2622534698419288,0.21684800120111059,MYC,1
WP_METASTATIC_BRAIN_TUMOR,WP_METASTATIC_BRAIN_TUMOR,1/77,28/21728,0.0946783321278577,0.2622534698419288,0.21684800120111059,MYC,1
WP_SPHINGOLIPID_METABOLISM_IN_SENESCENCE,WP_SPHINGOLIPID_METABOLISM_IN_SENESCENCE,1/77,28/21728,0.0946783321278577,0.2622534698419288,0.21684800120111059,RPP38,1
ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_UP,ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_UP,1/77,28/21728,0.0946783321278577,0.2622534698419288,0.21684800120111059,TIAL1,1
BASSO_B_LYMPHOCYTE_NETWORK,BASSO_B_LYMPHOCYTE_NETWORK,2/77,146/21728,0.09475193024058863,0.2622534698419288,0.21684800120111059,OGA/SAR1A,2
VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_DN,VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_DN,2/77,146/21728,0.09475193024058863,0.2622534698419288,0.21684800120111059,EIF3H/DERL1,2
ELVIDGE_HYPOXIA_DN,ELVIDGE_HYPOXIA_DN,2/77,147/21728,0.09584626025475593,0.26478649094678364,0.2189424656286702,IDE/DNAJA1,2
KEGG_HISTIDINE_METABOLISM,KEGG_HISTIDINE_METABOLISM,1/77,29/21728,0.09789076385256523,0.2679306462483174,0.2215422550347529,ALDH1B1,1
KEGG_THYROID_CANCER,KEGG_THYROID_CANCER,1/77,29/21728,0.09789076385256523,0.2679306462483174,0.2215422550347529,MYC,1
NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_UP,NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_UP,1/77,29/21728,0.09789076385256523,0.2679306462483174,0.2215422550347529,MYC,1
VALK_AML_CLUSTER_16,VALK_AML_CLUSTER_16,1/77,29/21728,0.09789076385256523,0.2679306462483174,0.2215422550347529,GGA2,1
WP_T_CELL_RECEPTOR_AND_COSTIMULATORY_SIGNALING,WP_T_CELL_RECEPTOR_AND_COSTIMULATORY_SIGNALING,1/77,29/21728,0.09789076385256523,0.2679306462483174,0.2215422550347529,DYRK2,1
BERENJENO_TRANSFORMED_BY_RHOA_REVERSIBLY_DN,BERENJENO_TRANSFORMED_BY_RHOA_REVERSIBLY_DN,1/77,30/21728,0.10109194414582079,0.2726530902327064,0.22544707482385315,MYC,1
PID_IL2_STAT5_PATHWAY,PID_IL2_STAT5_PATHWAY,1/77,30/21728,0.10109194414582079,0.2726530902327064,0.22544707482385315,MYC,1
PID_P38_ALPHA_BETA_PATHWAY,PID_P38_ALPHA_BETA_PATHWAY,1/77,30/21728,0.10109194414582079,0.2726530902327064,0.22544707482385315,RALB,1
REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_OXIDATIVE_STRESS_METABOLIC_AND_NEURONAL_GENES,REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_OXIDATIVE_STRESS_METABOLIC_AND_NEURONAL_GENES,1/77,30/21728,0.10109194414582079,0.2726530902327064,0.22544707482385315,SMAD2,1
REACTOME_SIGNALING_BY_CSF3_G_CSF,REACTOME_SIGNALING_BY_CSF3_G_CSF,1/77,30/21728,0.10109194414582079,0.2726530902327064,0.22544707482385315,UBE2D1,1
REACTOME_SYNTHESIS_OF_ACTIVE_UBIQUITIN_ROLES_OF_E1_AND_E2_ENZYMES,REACTOME_SYNTHESIS_OF_ACTIVE_UBIQUITIN_ROLES_OF_E1_AND_E2_ENZYMES,1/77,30/21728,0.10109194414582079,0.2726530902327064,0.22544707482385315,UBE2D1,1
SARTIPY_NORMAL_AT_INSULIN_RESISTANCE_UP,SARTIPY_NORMAL_AT_INSULIN_RESISTANCE_UP,1/77,30/21728,0.10109194414582079,0.2726530902327064,0.22544707482385315,B3GNT2,1
WP_EXTRACELLULAR_VESICLEMEDIATED_SIGNALING_IN_RECIPIENT_CELLS,WP_EXTRACELLULAR_VESICLEMEDIATED_SIGNALING_IN_RECIPIENT_CELLS,1/77,30/21728,0.10109194414582079,0.2726530902327064,0.22544707482385315,SMAD2,1
REACTOME_METABOLISM_OF_STEROIDS,REACTOME_METABOLISM_OF_STEROIDS,2/77,153/21728,0.10248787887289257,0.27473915469910337,0.22717196681551102,NFYA/SEC24C,2
DACOSTA_UV_RESPONSE_VIA_ERCC3_UP,DACOSTA_UV_RESPONSE_VIA_ERCC3_UP,3/77,317/21728,0.10268355140780462,0.27473915469910337,0.22717196681551102,TFAM/GDI2/ALDH1B1,3
HORIUCHI_WTAP_TARGETS_DN,HORIUCHI_WTAP_TARGETS_DN,3/77,318/21728,0.10340948300863254,0.27473915469910337,0.22717196681551102,SMAD2/BUB3/NAP1L1,3
WP_HEPATITIS_B_INFECTION,WP_HEPATITIS_B_INFECTION,2/77,154/21728,0.10360706404804733,0.27473915469910337,0.22717196681551102,SMAD2/MYC,2
BILANGES_SERUM_SENSITIVE_VIA_TSC2,BILANGES_SERUM_SENSITIVE_VIA_TSC2,1/77,31/21728,0.10428191189864477,0.27473915469910337,0.22717196681551102,EIF3A,1
DANG_MYC_TARGETS_DN,DANG_MYC_TARGETS_DN,1/77,31/21728,0.10428191189864477,0.27473915469910337,0.22717196681551102,MYC,1
PID_CD40_PATHWAY,PID_CD40_PATHWAY,1/77,31/21728,0.10428191189864477,0.27473915469910337,0.22717196681551102,MYC,1
REACTOME_HS_GAG_BIOSYNTHESIS,REACTOME_HS_GAG_BIOSYNTHESIS,1/77,31/21728,0.10428191189864477,0.27473915469910337,0.22717196681551102,EXT1,1
REACTOME_TRANSCRIPTIONAL_REGULATION_OF_PLURIPOTENT_STEM_CELLS,REACTOME_TRANSCRIPTIONAL_REGULATION_OF_PLURIPOTENT_STEM_CELLS,1/77,31/21728,0.10428191189864477,0.27473915469910337,0.22717196681551102,SMAD2,1
SHIN_B_CELL_LYMPHOMA_CLUSTER_2,SHIN_B_CELL_LYMPHOMA_CLUSTER_2,1/77,31/21728,0.10428191189864477,0.27473915469910337,0.22717196681551102,MYC,1
WP_CELL_MIGRATION_AND_INVASION_THROUGH_P75NTR,WP_CELL_MIGRATION_AND_INVASION_THROUGH_P75NTR,1/77,31/21728,0.10428191189864477,0.27473915469910337,0.22717196681551102,ARF1,1
YIH_RESPONSE_TO_ARSENITE_C3,YIH_RESPONSE_TO_ARSENITE_C3,1/77,31/21728,0.10428191189864477,0.27473915469910337,0.22717196681551102,TFAM,1
ZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_DN,ZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_DN,1/77,31/21728,0.10428191189864477,0.27473915469910337,0.22717196681551102,NAP1L1,1
REACTOME_RHO_GTPASE_EFFECTORS,REACTOME_RHO_GTPASE_EFFECTORS,3/77,322/21728,0.10633381795625103,0.2786437250438513,0.23040051618539378,DIAPH1/KIF5B/BUB3,3
BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_TRANS,BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_TRANS,2/77,157/21728,0.10698486301269586,0.2786437250438513,0.23040051618539378,VDAC2/GDI2,2
CAFFAREL_RESPONSE_TO_THC_DN,CAFFAREL_RESPONSE_TO_THC_DN,1/77,32/21728,0.10746070586941492,0.2786437250438513,0.23040051618539378,DNAJA1,1
CAFFAREL_RESPONSE_TO_THC_UP,CAFFAREL_RESPONSE_TO_THC_UP,1/77,32/21728,0.10746070586941492,0.2786437250438513,0.23040051618539378,MYC,1
DORSAM_HOXA9_TARGETS_DN,DORSAM_HOXA9_TARGETS_DN,1/77,32/21728,0.10746070586941492,0.2786437250438513,0.23040051618539378,MYC,1
JIANG_AGING_CEREBRAL_CORTEX_UP,JIANG_AGING_CEREBRAL_CORTEX_UP,1/77,32/21728,0.10746070586941492,0.2786437250438513,0.23040051618539378,RPS24,1
MODY_HIPPOCAMPUS_NEONATAL,MODY_HIPPOCAMPUS_NEONATAL,1/77,32/21728,0.10746070586941492,0.2786437250438513,0.23040051618539378,CCT8,1
TAVOR_CEBPA_TARGETS_DN,TAVOR_CEBPA_TARGETS_DN,1/77,32/21728,0.10746070586941492,0.2786437250438513,0.23040051618539378,MYC,1
VALK_AML_CLUSTER_5,VALK_AML_CLUSTER_5,1/77,32/21728,0.10746070586941492,0.2786437250438513,0.23040051618539378,UBE2D1,1
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP,2/77,159/21728,0.10925322782265127,0.2799806900743433,0.23150600468364974,EXT1/NAP1L1,2
BARRIER_CANCER_RELAPSE_NORMAL_SAMPLE_UP,BARRIER_CANCER_RELAPSE_NORMAL_SAMPLE_UP,1/77,33/21728,0.11062836468431425,0.2799806900743433,0.23150600468364974,TFAM,1
DOANE_BREAST_CANCER_CLASSES_DN,DOANE_BREAST_CANCER_CLASSES_DN,1/77,33/21728,0.11062836468431425,0.2799806900743433,0.23150600468364974,CLIP4,1
DORN_ADENOVIRUS_INFECTION_12HR_DN,DORN_ADENOVIRUS_INFECTION_12HR_DN,1/77,33/21728,0.11062836468431425,0.2799806900743433,0.23150600468364974,MYC,1
KEGG_PROPANOATE_METABOLISM,KEGG_PROPANOATE_METABOLISM,1/77,33/21728,0.11062836468431425,0.2799806900743433,0.23150600468364974,ALDH1B1,1
LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_SMALL_VS_HUGE_DN,LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_SMALL_VS_HUGE_DN,1/77,33/21728,0.11062836468431425,0.2799806900743433,0.23150600468364974,DNAJA1,1
PID_NCADHERIN_PATHWAY,PID_NCADHERIN_PATHWAY,1/77,33/21728,0.11062836468431425,0.2799806900743433,0.23150600468364974,KIF5B,1
REACTOME_CARGO_CONCENTRATION_IN_THE_ER,REACTOME_CARGO_CONCENTRATION_IN_THE_ER,1/77,33/21728,0.11062836468431425,0.2799806900743433,0.23150600468364974,SEC24C,1
REACTOME_COOPERATION_OF_PREFOLDIN_AND_TRIC_CCT_IN_ACTIN_AND_TUBULIN_FOLDING,REACTOME_COOPERATION_OF_PREFOLDIN_AND_TRIC_CCT_IN_ACTIN_AND_TUBULIN_FOLDING,1/77,33/21728,0.11062836468431425,0.2799806900743433,0.23150600468364974,CCT8,1
SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX4_DN,SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX4_DN,1/77,33/21728,0.11062836468431425,0.2799806900743433,0.23150600468364974,EIF3A,1
SIMBULAN_UV_RESPONSE_NORMAL_DN,SIMBULAN_UV_RESPONSE_NORMAL_DN,1/77,33/21728,0.11062836468431425,0.2799806900743433,0.23150600468364974,MYC,1
WP_GASTRIC_CANCER_NETWORK_2,WP_GASTRIC_CANCER_NETWORK_2,1/77,33/21728,0.11062836468431425,0.2799806900743433,0.23150600468364974,MYC,1
WP_MAMMARY_GLAND_DEVELOPMENT_PATHWAY_PREGNANCY_AND_LACTATION_STAGE_3_OF_4,WP_MAMMARY_GLAND_DEVELOPMENT_PATHWAY_PREGNANCY_AND_LACTATION_STAGE_3_OF_4,1/77,33/21728,0.11062836468431425,0.2799806900743433,0.23150600468364974,MYC,1
WP_REGUCALCIN_IN_PROXIMAL_TUBULE_EPITHELIAL_KIDNEY_CELLS,WP_REGUCALCIN_IN_PROXIMAL_TUBULE_EPITHELIAL_KIDNEY_CELLS,1/77,33/21728,0.11062836468431425,0.2799806900743433,0.23150600468364974,SMAD2,1
REACTOME_SIGNALING_BY_WNT,REACTOME_SIGNALING_BY_WNT,3/77,329/21728,0.11152939960694645,0.2807581333326039,0.23214884466858005,CTBP2/VPS26A/MYC,3
WP_INSULIN_SIGNALING,WP_INSULIN_SIGNALING,2/77,161/21728,0.11153444970446115,0.2807581333326039,0.23214884466858005,ARF1/KIF5B,2
REACTOME_DNA_REPAIR,REACTOME_DNA_REPAIR,3/77,330/21728,0.11227958823888304,0.2807581333326039,0.23214884466858005,DCLRE1C/DCLRE1A/NHEJ1,3
REACTOME_S_PHASE,REACTOME_S_PHASE,2/77,162/21728,0.11267979150135785,0.2807581333326039,0.23214884466858005,MYC/UBE2D1,2
WINNEPENNINCKX_MELANOMA_METASTASIS_UP,WINNEPENNINCKX_MELANOMA_METASTASIS_UP,2/77,162/21728,0.11267979150135785,0.2807581333326039,0.23214884466858005,MRPS16/DNAJA1,2
DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_DN,DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_DN,1/77,34/21728,0.11378492683777386,0.2807581333326039,0.23214884466858005,PPP2R3A,1
KEGG_BUTANOATE_METABOLISM,KEGG_BUTANOATE_METABOLISM,1/77,34/21728,0.11378492683777386,0.2807581333326039,0.23214884466858005,ALDH1B1,1
LUI_TARGETS_OF_PAX8_PPARG_FUSION,LUI_TARGETS_OF_PAX8_PPARG_FUSION,1/77,34/21728,0.11378492683777386,0.2807581333326039,0.23214884466858005,DNAJA1,1
PID_ATM_PATHWAY,PID_ATM_PATHWAY,1/77,34/21728,0.11378492683777386,0.2807581333326039,0.23214884466858005,DCLRE1C,1
PID_HDAC_CLASSII_PATHWAY,PID_HDAC_CLASSII_PATHWAY,1/77,34/21728,0.11378492683777386,0.2807581333326039,0.23214884466858005,BCOR,1
REACTOME_KERATAN_SULFATE_KERATIN_METABOLISM,REACTOME_KERATAN_SULFATE_KERATIN_METABOLISM,1/77,34/21728,0.11378492683777386,0.2807581333326039,0.23214884466858005,B3GNT2,1
REACTOME_SIGNALING_BY_WNT_IN_CANCER,REACTOME_SIGNALING_BY_WNT_IN_CANCER,1/77,34/21728,0.11378492683777386,0.2807581333326039,0.23214884466858005,CTBP2,1
REACTOME_SIGNALLING_TO_ERKS,REACTOME_SIGNALLING_TO_ERKS,1/77,34/21728,0.11378492683777386,0.2807581333326039,0.23214884466858005,RALB,1
REACTOME_THE_PHOTOTRANSDUCTION_CASCADE,REACTOME_THE_PHOTOTRANSDUCTION_CASCADE,1/77,34/21728,0.11378492683777386,0.2807581333326039,0.23214884466858005,METAP1,1
WP_P38_MAPK_SIGNALING_PATHWAY,WP_P38_MAPK_SIGNALING_PATHWAY,1/77,34/21728,0.11378492683777386,0.2807581333326039,0.23214884466858005,MYC,1
DARWICHE_PAPILLOMA_RISK_LOW_UP,DARWICHE_PAPILLOMA_RISK_LOW_UP,2/77,164/21728,0.11497975755229843,0.28101329522623186,0.23235982889940546,SAR1A/IDE,2
REACTOME_PROTEIN_LOCALIZATION,REACTOME_PROTEIN_LOCALIZATION,2/77,164/21728,0.11497975755229843,0.28101329522623186,0.23235982889940546,IDE/UBE2D1,2
WP_ALZHEIMERS_DISEASE_AND_MIRNA_EFFECTS,WP_ALZHEIMERS_DISEASE_AND_MIRNA_EFFECTS,3/77,336/21728,0.11682165625013033,0.28101329522623186,0.23235982889940546,KIF5B/VDAC2/IDE,3
ANDERSEN_LIVER_CANCER_KRT19_UP,ANDERSEN_LIVER_CANCER_KRT19_UP,1/77,35/21728,0.11693043069291786,0.28101329522623186,0.23235982889940546,NAP1L1,1
GENTILE_UV_RESPONSE_CLUSTER_D6,GENTILE_UV_RESPONSE_CLUSTER_D6,1/77,35/21728,0.11693043069291786,0.28101329522623186,0.23235982889940546,NFYA,1
HOWLIN_CITED1_TARGETS_1_UP,HOWLIN_CITED1_TARGETS_1_UP,1/77,35/21728,0.11693043069291786,0.28101329522623186,0.23235982889940546,KIF5B,1
JIANG_AGING_HYPOTHALAMUS_DN,JIANG_AGING_HYPOTHALAMUS_DN,1/77,35/21728,0.11693043069291786,0.28101329522623186,0.23235982889940546,KIF5B,1
KEGG_PRIMARY_IMMUNODEFICIENCY,KEGG_PRIMARY_IMMUNODEFICIENCY,1/77,35/21728,0.11693043069291786,0.28101329522623186,0.23235982889940546,DCLRE1C,1
NAKAMURA_ADIPOGENESIS_EARLY_DN,NAKAMURA_ADIPOGENESIS_EARLY_DN,1/77,35/21728,0.11693043069291786,0.28101329522623186,0.23235982889940546,RAI14,1
NAKAMURA_ADIPOGENESIS_LATE_DN,NAKAMURA_ADIPOGENESIS_LATE_DN,1/77,35/21728,0.11693043069291786,0.28101329522623186,0.23235982889940546,RAI14,1
REACTOME_LYSOSOME_VESICLE_BIOGENESIS,REACTOME_LYSOSOME_VESICLE_BIOGENESIS,1/77,35/21728,0.11693043069291786,0.28101329522623186,0.23235982889940546,ARF1,1
REACTOME_N_GLYCAN_TRIMMING_IN_THE_ER_AND_CALNEXIN_CALRETICULIN_CYCLE,REACTOME_N_GLYCAN_TRIMMING_IN_THE_ER_AND_CALNEXIN_CALRETICULIN_CYCLE,1/77,35/21728,0.11693043069291786,0.28101329522623186,0.23235982889940546,DERL1,1
REACTOME_NEGATIVE_REGULATORS_OF_DDX58_IFIH1_SIGNALING,REACTOME_NEGATIVE_REGULATORS_OF_DDX58_IFIH1_SIGNALING,1/77,35/21728,0.11693043069291786,0.28101329522623186,0.23235982889940546,UBE2D1,1
REACTOME_NUCLEOTIDE_CATABOLISM,REACTOME_NUCLEOTIDE_CATABOLISM,1/77,35/21728,0.11693043069291786,0.28101329522623186,0.23235982889940546,NT5C2,1
SIG_REGULATION_OF_THE_ACTIN_CYTOSKELETON_BY_RHO_GTPASES,SIG_REGULATION_OF_THE_ACTIN_CYTOSKELETON_BY_RHO_GTPASES,1/77,35/21728,0.11693043069291786,0.28101329522623186,0.23235982889940546,GDI2,1
YAGI_AML_RELAPSE_PROGNOSIS,YAGI_AML_RELAPSE_PROGNOSIS,1/77,35/21728,0.11693043069291786,0.28101329522623186,0.23235982889940546,TIAL1,1
BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_DN,BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_DN,2/77,166/21728,0.1172918636347519,0.2814243091755898,0.23269968161303306,RPL6/DNAJA1,2
KIM_WT1_TARGETS_12HR_UP,KIM_WT1_TARGETS_12HR_UP,2/77,167/21728,0.11845238124565095,0.2821239167001619,0.23327816201758278,OGA/KIF5B,2
REACTOME_DNA_DOUBLE_STRAND_BREAK_REPAIR,REACTOME_DNA_DOUBLE_STRAND_BREAK_REPAIR,2/77,167/21728,0.11845238124565095,0.2821239167001619,0.23327816201758278,DCLRE1C/NHEJ1,2
YAMAZAKI_TCEB3_TARGETS_UP,YAMAZAKI_TCEB3_TARGETS_UP,2/77,167/21728,0.11845238124565095,0.2821239167001619,0.23327816201758278,DYRK2/EXT1,2
WHITFIELD_CELL_CYCLE_G2,WHITFIELD_CELL_CYCLE_G2,2/77,168/21728,0.11961582874421853,0.2821239167001619,0.23327816201758278,KIF5B/BUB3,2
BIOCARTA_P38MAPK_PATHWAY,BIOCARTA_P38MAPK_PATHWAY,1/77,36/21728,0.12006491448200396,0.2821239167001619,0.23327816201758278,MYC,1
BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_UP,BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_UP,1/77,36/21728,0.12006491448200396,0.2821239167001619,0.23327816201758278,NFYA,1
HEIDENBLAD_AMPLICON_12P11_12_UP,HEIDENBLAD_AMPLICON_12P11_12_UP,1/77,36/21728,0.12006491448200396,0.2821239167001619,0.23327816201758278,SAR1A,1
HU_GENOTOXIC_DAMAGE_24HR,HU_GENOTOXIC_DAMAGE_24HR,1/77,36/21728,0.12006491448200396,0.2821239167001619,0.23327816201758278,DNAJA1,1
SHAFFER_IRF4_MULTIPLE_MYELOMA_PROGRAM,SHAFFER_IRF4_MULTIPLE_MYELOMA_PROGRAM,1/77,36/21728,0.12006491448200396,0.2821239167001619,0.23327816201758278,MYC,1
SUBTIL_PROGESTIN_TARGETS,SUBTIL_PROGESTIN_TARGETS,1/77,36/21728,0.12006491448200396,0.2821239167001619,0.23327816201758278,UCHL5,1
VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_DN,VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_DN,1/77,36/21728,0.12006491448200396,0.2821239167001619,0.23327816201758278,ALDH1B1,1
WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2,WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2,1/77,36/21728,0.12006491448200396,0.2821239167001619,0.23327816201758278,MYC,1
WP_TYPE_2_PAPILLARY_RENAL_CELL_CARCINOMA,WP_TYPE_2_PAPILLARY_RENAL_CELL_CARCINOMA,1/77,36/21728,0.12006491448200396,0.2821239167001619,0.23327816201758278,DIAPH1,1
PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_DN,PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_DN,2/77,170/21728,0.1219513751497081,0.2861017975734422,0.23656732923777965,UBE2D1/NAP1L1,2
UEDA_PERIFERAL_CLOCK,UEDA_PERIFERAL_CLOCK,2/77,171/21728,0.12312340543493266,0.28630803646925707,0.23673786079396583,OGA/DNAJA1,2
BIOCARTA_IL2RB_PATHWAY,BIOCARTA_IL2RB_PATHWAY,1/77,37/21728,0.12318841630686539,0.28630803646925707,0.23673786079396583,MYC,1
HU_ANGIOGENESIS_DN,HU_ANGIOGENESIS_DN,1/77,37/21728,0.12318841630686539,0.28630803646925707,0.23673786079396583,ANXA7,1
WP_FACTORS_AND_PATHWAYS_AFFECTING_INSULINLIKE_GROWTH_FACTOR_IGF1AKT_SIGNALING,WP_FACTORS_AND_PATHWAYS_AFFECTING_INSULINLIKE_GROWTH_FACTOR_IGF1AKT_SIGNALING,1/77,37/21728,0.12318841630686539,0.28630803646925707,0.23673786079396583,SMAD2,1
WP_NEOVASCULARISATION_PROCESSES,WP_NEOVASCULARISATION_PROCESSES,1/77,37/21728,0.12318841630686539,0.28630803646925707,0.23673786079396583,SMAD2,1
WP_PI3KAKT_SIGNALING_PATHWAY,WP_PI3KAKT_SIGNALING_PATHWAY,3/77,345/21728,0.12376312772077071,0.28630803646925707,0.23673786079396583,RPS6/PPP2R3A/MYC,3
ELVIDGE_HYPOXIA_UP,ELVIDGE_HYPOXIA_UP,2/77,172/21728,0.12429822836249545,0.28630803646925707,0.23673786079396583,NAP1L1/BCOR,2
ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_UP,ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_UP,2/77,173/21728,0.12547581012282816,0.28630803646925707,0.23673786079396583,EIF3A/SAR1A,2
BROWNE_HCMV_INFECTION_18HR_UP,BROWNE_HCMV_INFECTION_18HR_UP,2/77,173/21728,0.12547581012282816,0.28630803646925707,0.23673786079396583,SAR1A/RPP30,2
CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP,CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP,2/77,173/21728,0.12547581012282816,0.28630803646925707,0.23673786079396583,NFYA/NACA,2
GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_UP,GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_UP,2/77,173/21728,0.12547581012282816,0.28630803646925707,0.23673786079396583,BUB3/RMND1,2
HOLLERN_SQUAMOUS_BREAST_TUMOR,HOLLERN_SQUAMOUS_BREAST_TUMOR,2/77,173/21728,0.12547581012282816,0.28630803646925707,0.23673786079396583,CLIP4/IDE,2
BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_DN,BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_DN,1/77,38/21728,0.1263009741393475,0.28630803646925707,0.23673786079396583,DYRK2,1
GRADE_COLON_VS_RECTAL_CANCER_UP,GRADE_COLON_VS_RECTAL_CANCER_UP,1/77,38/21728,0.1263009741393475,0.28630803646925707,0.23673786079396583,DDX50,1
LEE_AGING_MUSCLE_UP,LEE_AGING_MUSCLE_UP,1/77,38/21728,0.1263009741393475,0.28630803646925707,0.23673786079396583,BUB3,1
MA_MYELOID_DIFFERENTIATION_UP,MA_MYELOID_DIFFERENTIATION_UP,1/77,38/21728,0.1263009741393475,0.28630803646925707,0.23673786079396583,TIAL1,1
REACTOME_COOPERATION_OF_PDCL_PHLP1_AND_TRIC_CCT_IN_G_PROTEIN_BETA_FOLDING,REACTOME_COOPERATION_OF_PDCL_PHLP1_AND_TRIC_CCT_IN_G_PROTEIN_BETA_FOLDING,1/77,38/21728,0.1263009741393475,0.28630803646925707,0.23673786079396583,CCT8,1
REACTOME_DISEASES_OF_MITOTIC_CELL_CYCLE,REACTOME_DISEASES_OF_MITOTIC_CELL_CYCLE,1/77,38/21728,0.1263009741393475,0.28630803646925707,0.23673786079396583,UBE2D1,1
REACTOME_GENE_AND_PROTEIN_EXPRESSION_BY_JAK_STAT_SIGNALING_AFTER_INTERLEUKIN_12_STIMULATION,REACTOME_GENE_AND_PROTEIN_EXPRESSION_BY_JAK_STAT_SIGNALING_AFTER_INTERLEUKIN_12_STIMULATION,1/77,38/21728,0.1263009741393475,0.28630803646925707,0.23673786079396583,ARF1,1
REACTOME_TRANSCRIPTIONAL_REGULATION_BY_THE_AP_2_TFAP2_FAMILY_OF_TRANSCRIPTION_FACTORS,REACTOME_TRANSCRIPTIONAL_REGULATION_BY_THE_AP_2_TFAP2_FAMILY_OF_TRANSCRIPTION_FACTORS,1/77,38/21728,0.1263009741393475,0.28630803646925707,0.23673786079396583,MYC,1
WP_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS,WP_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS,1/77,38/21728,0.1263009741393475,0.28630803646925707,0.23673786079396583,DERL1,1
WP_FBXL10_ENHANCEMENT_OF_MAPERK_SIGNALING_IN_DIFFUSE_LARGE_BCELL_LYMPHOMA,WP_FBXL10_ENHANCEMENT_OF_MAPERK_SIGNALING_IN_DIFFUSE_LARGE_BCELL_LYMPHOMA,1/77,38/21728,0.1263009741393475,0.28630803646925707,0.23673786079396583,BCOR,1
BLANCO_MELO_COVID19_SARS_COV_2_POS_PATIENT_LUNG_TISSUE_DN,BLANCO_MELO_COVID19_SARS_COV_2_POS_PATIENT_LUNG_TISSUE_DN,2/77,175/21728,0.12783911589649816,0.28715096874151885,0.23743485129898398,EXOSC7/BCOR,2
VILLANUEVA_LIVER_CANCER_KRT19_UP,VILLANUEVA_LIVER_CANCER_KRT19_UP,2/77,175/21728,0.12783911589649816,0.28715096874151885,0.23743485129898398,DCLRE1C/NAP1L1,2
MOREAUX_MULTIPLE_MYELOMA_BY_TACI_DN,MOREAUX_MULTIPLE_MYELOMA_BY_TACI_DN,2/77,176/21728,0.12902477328081108,0.28715096874151885,0.23743485129898398,MINPP1/BUB3,2
CONRAD_STEM_CELL,CONRAD_STEM_CELL,1/77,39/21728,0.12940262582174822,0.28715096874151885,0.23743485129898398,MYC,1
GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_DN,GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_DN,1/77,39/21728,0.12940262582174822,0.28715096874151885,0.23743485129898398,DCLRE1C,1
GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_UP,GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_UP,1/77,39/21728,0.12940262582174822,0.28715096874151885,0.23743485129898398,CHMP1B,1
HEIDENBLAD_AMPLICON_8Q24_DN,HEIDENBLAD_AMPLICON_8Q24_DN,1/77,39/21728,0.12940262582174822,0.28715096874151885,0.23743485129898398,NT5C2,1
LANDIS_ERBB2_BREAST_TUMORS_65_DN,LANDIS_ERBB2_BREAST_TUMORS_65_DN,1/77,39/21728,0.12940262582174822,0.28715096874151885,0.23743485129898398,DERL1,1
LEE_CALORIE_RESTRICTION_MUSCLE_UP,LEE_CALORIE_RESTRICTION_MUSCLE_UP,1/77,39/21728,0.12940262582174822,0.28715096874151885,0.23743485129898398,EEF1G,1
REACTOME_ASSOCIATION_OF_TRIC_CCT_WITH_TARGET_PROTEINS_DURING_BIOSYNTHESIS,REACTOME_ASSOCIATION_OF_TRIC_CCT_WITH_TARGET_PROTEINS_DURING_BIOSYNTHESIS,1/77,39/21728,0.12940262582174822,0.28715096874151885,0.23743485129898398,CCT8,1
REACTOME_FANCONI_ANEMIA_PATHWAY,REACTOME_FANCONI_ANEMIA_PATHWAY,1/77,39/21728,0.12940262582174822,0.28715096874151885,0.23743485129898398,DCLRE1A,1
REACTOME_OVARIAN_TUMOR_DOMAIN_PROTEASES,REACTOME_OVARIAN_TUMOR_DOMAIN_PROTEASES,1/77,39/21728,0.12940262582174822,0.28715096874151885,0.23743485129898398,UBE2D1,1
HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_UP,HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_UP,2/77,177/21728,0.13021305623795087,0.28715096874151885,0.23743485129898398,EIF3A/CUTC,2
REACTOME_DISORDERS_OF_TRANSMEMBRANE_TRANSPORTERS,REACTOME_DISORDERS_OF_TRANSMEMBRANE_TRANSPORTERS,2/77,177/21728,0.13021305623795087,0.28715096874151885,0.23743485129898398,ERLIN1/DERL1,2
MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_UP,MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_UP,2/77,178/21728,0.1314039319427783,0.28715096874151885,0.23743485129898398,MYC/MARCHF5,2
BOYAULT_LIVER_CANCER_SUBCLASS_G12_UP,BOYAULT_LIVER_CANCER_SUBCLASS_G12_UP,1/77,40/21728,0.1324934090672516,0.28715096874151885,0.23743485129898398,ARF1,1
BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_DN,BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_DN,1/77,40/21728,0.1324934090672516,0.28715096874151885,0.23743485129898398,KIF5B,1
DELPUECH_FOXO3_TARGETS_DN,DELPUECH_FOXO3_TARGETS_DN,1/77,40/21728,0.1324934090672516,0.28715096874151885,0.23743485129898398,TIAL1,1
FIGUEROA_AML_METHYLATION_CLUSTER_3_DN,FIGUEROA_AML_METHYLATION_CLUSTER_3_DN,1/77,40/21728,0.1324934090672516,0.28715096874151885,0.23743485129898398,EIF3A,1
KEGG_PYRUVATE_METABOLISM,KEGG_PYRUVATE_METABOLISM,1/77,40/21728,0.1324934090672516,0.28715096874151885,0.23743485129898398,ALDH1B1,1
KEGG_TRYPTOPHAN_METABOLISM,KEGG_TRYPTOPHAN_METABOLISM,1/77,40/21728,0.1324934090672516,0.28715096874151885,0.23743485129898398,ALDH1B1,1
PID_FOXM1_PATHWAY,PID_FOXM1_PATHWAY,1/77,40/21728,0.1324934090672516,0.28715096874151885,0.23743485129898398,MYC,1
TOMLINS_PROSTATE_CANCER_UP,TOMLINS_PROSTATE_CANCER_UP,1/77,40/21728,0.1324934090672516,0.28715096874151885,0.23743485129898398,NACA,1
WP_G13_SIGNALING_PATHWAY,WP_G13_SIGNALING_PATHWAY,1/77,40/21728,0.1324934090672516,0.28715096874151885,0.23743485129898398,DIAPH1,1
WP_GLYCOGEN_SYNTHESIS_AND_DEGRADATION,WP_GLYCOGEN_SYNTHESIS_AND_DEGRADATION,1/77,40/21728,0.1324934090672516,0.28715096874151885,0.23743485129898398,PPP2R3A,1
FERNANDEZ_BOUND_BY_MYC,FERNANDEZ_BOUND_BY_MYC,2/77,181/21728,0.1349917901972781,0.28715096874151885,0.23743485129898398,ARF1/RPS6,2
AMIT_EGF_RESPONSE_120_MCF10A,AMIT_EGF_RESPONSE_120_MCF10A,1/77,41/21728,0.1355733614603638,0.28715096874151885,0.23743485129898398,NAP1L1,1
BURTON_ADIPOGENESIS_PEAK_AT_16HR,BURTON_ADIPOGENESIS_PEAK_AT_16HR,1/77,41/21728,0.1355733614603638,0.28715096874151885,0.23743485129898398,DDX21,1
CHANGOLKAR_H2AFY_TARGETS_DN,CHANGOLKAR_H2AFY_TARGETS_DN,1/77,41/21728,0.1355733614603638,0.28715096874151885,0.23743485129898398,GTPBP4,1
GALLUZZI_PERMEABILIZE_MITOCHONDRIA,GALLUZZI_PERMEABILIZE_MITOCHONDRIA,1/77,41/21728,0.1355733614603638,0.28715096874151885,0.23743485129898398,VDAC2,1
KAMMINGA_EZH2_TARGETS,KAMMINGA_EZH2_TARGETS,1/77,41/21728,0.1355733614603638,0.28715096874151885,0.23743485129898398,NAP1L1,1
LEE_AGING_MUSCLE_DN,LEE_AGING_MUSCLE_DN,1/77,41/21728,0.1355733614603638,0.28715096874151885,0.23743485129898398,EEF1G,1
LI_LUNG_CANCER,LI_LUNG_CANCER,1/77,41/21728,0.1355733614603638,0.28715096874151885,0.23743485129898398,EEF1G,1
MAGRANGEAS_MULTIPLE_MYELOMA_IGLL_VS_IGLK_UP,MAGRANGEAS_MULTIPLE_MYELOMA_IGLL_VS_IGLK_UP,1/77,41/21728,0.1355733614603638,0.28715096874151885,0.23743485129898398,EXT1,1
MARTIN_INTERACT_WITH_HDAC,MARTIN_INTERACT_WITH_HDAC,1/77,41/21728,0.1355733614603638,0.28715096874151885,0.23743485129898398,BCOR,1
PID_ECADHERIN_STABILIZATION_PATHWAY,PID_ECADHERIN_STABILIZATION_PATHWAY,1/77,41/21728,0.1355733614603638,0.28715096874151885,0.23743485129898398,DIAPH1,1
PID_ERBB1_INTERNALIZATION_PATHWAY,PID_ERBB1_INTERNALIZATION_PATHWAY,1/77,41/21728,0.1355733614603638,0.28715096874151885,0.23743485129898398,UBE2D1,1
REACTOME_DISEASES_ASSOCIATED_WITH_GLYCOSAMINOGLYCAN_METABOLISM,REACTOME_DISEASES_ASSOCIATED_WITH_GLYCOSAMINOGLYCAN_METABOLISM,1/77,41/21728,0.1355733614603638,0.28715096874151885,0.23743485129898398,EXT1,1
REACTOME_MTOR_SIGNALLING,REACTOME_MTOR_SIGNALLING,1/77,41/21728,0.1355733614603638,0.28715096874151885,0.23743485129898398,RPS6,1
REACTOME_TRANSCRIPTIONAL_REGULATION_BY_VENTX,REACTOME_TRANSCRIPTIONAL_REGULATION_BY_VENTX,1/77,41/21728,0.1355733614603638,0.28715096874151885,0.23743485129898398,UBE2D1,1
STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_DN,STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_DN,1/77,41/21728,0.1355733614603638,0.28715096874151885,0.23743485129898398,RAI14,1
WP_BLADDER_CANCER,WP_BLADDER_CANCER,1/77,41/21728,0.1355733614603638,0.28715096874151885,0.23743485129898398,MYC,1
WP_NEURAL_CREST_CELL_MIGRATION_DURING_DEVELOPMENT,WP_NEURAL_CREST_CELL_MIGRATION_DURING_DEVELOPMENT,1/77,41/21728,0.1355733614603638,0.28715096874151885,0.23743485129898398,ARF1,1
XU_CREBBP_TARGETS_DN,XU_CREBBP_TARGETS_DN,1/77,41/21728,0.1355733614603638,0.28715096874151885,0.23743485129898398,DIAPH1,1
ZHU_CMV_8_HR_UP,ZHU_CMV_8_HR_UP,1/77,41/21728,0.1355733614603638,0.28715096874151885,0.23743485129898398,DNAJA1,1
BROWNE_HCMV_INFECTION_18HR_DN,BROWNE_HCMV_INFECTION_18HR_DN,2/77,182/21728,0.13619271250866355,0.28715096874151885,0.23743485129898398,EXT1/MYC,2
KEGG_HUNTINGTONS_DISEASE,KEGG_HUNTINGTONS_DISEASE,2/77,182/21728,0.13619271250866355,0.28715096874151885,0.23743485129898398,TFAM/VDAC2,2
KYNG_DNA_DAMAGE_DN,KYNG_DNA_DAMAGE_DN,2/77,182/21728,0.13619271250866355,0.28715096874151885,0.23743485129898398,ARF1/DNAJA1,2
WANG_CLIM2_TARGETS_DN,WANG_CLIM2_TARGETS_DN,2/77,182/21728,0.13619271250866355,0.28715096874151885,0.23743485129898398,GTPBP4/RPP30,2
WANG_LMO4_TARGETS_DN,WANG_LMO4_TARGETS_DN,3/77,361/21728,0.1364652986095945,0.2873158281267531,0.23757116761994188,CHMP1B/EIF3A/SAR1A,3
ELLWOOD_MYC_TARGETS_DN,ELLWOOD_MYC_TARGETS_DN,1/77,42/21728,0.13864252045734604,0.28861076793796825,0.23864190696957566,IDE,1
FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN,FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN,1/77,42/21728,0.13864252045734604,0.28861076793796825,0.23864190696957566,NFYA,1
KEGG_BLADDER_CANCER,KEGG_BLADDER_CANCER,1/77,42/21728,0.13864252045734604,0.28861076793796825,0.23864190696957566,MYC,1
KEGG_FATTY_ACID_METABOLISM,KEGG_FATTY_ACID_METABOLISM,1/77,42/21728,0.13864252045734604,0.28861076793796825,0.23864190696957566,ALDH1B1,1
REACTOME_ACTIVATION_OF_GENE_EXPRESSION_BY_SREBF_SREBP,REACTOME_ACTIVATION_OF_GENE_EXPRESSION_BY_SREBF_SREBP,1/77,42/21728,0.13864252045734604,0.28861076793796825,0.23864190696957566,NFYA,1
REACTOME_RHOF_GTPASE_CYCLE,REACTOME_RHOF_GTPASE_CYCLE,1/77,42/21728,0.13864252045734604,0.28861076793796825,0.23864190696957566,DIAPH1,1
WIERENGA_PML_INTERACTOME,WIERENGA_PML_INTERACTOME,1/77,42/21728,0.13864252045734604,0.28861076793796825,0.23864190696957566,EEF1G,1
ZHAN_EARLY_DIFFERENTIATION_GENES_DN,ZHAN_EARLY_DIFFERENTIATION_GENES_DN,1/77,42/21728,0.13864252045734604,0.28861076793796825,0.23864190696957566,MYC,1
GOBERT_CORE_OLIGODENDROCYTE_DIFFERENTIATION,GOBERT_CORE_OLIGODENDROCYTE_DIFFERENTIATION,1/77,43/21728,0.1417009233866452,0.29373627596838936,0.2428800059819814,EXT1,1
LASTOWSKA_COAMPLIFIED_WITH_MYCN,LASTOWSKA_COAMPLIFIED_WITH_MYCN,1/77,43/21728,0.1417009233866452,0.29373627596838936,0.2428800059819814,CLIP4,1
YU_MYC_TARGETS_UP,YU_MYC_TARGETS_UP,1/77,43/21728,0.1417009233866452,0.29373627596838936,0.2428800059819814,UCHL5,1
WANG_LMO4_TARGETS_UP,WANG_LMO4_TARGETS_UP,3/77,369/21728,0.14298048269641736,0.2938714860028895,0.24299180631675435,CDC123/NAP1L1/BCOR,3
CHOI_ATL_STAGE_PREDICTOR,CHOI_ATL_STAGE_PREDICTOR,1/77,44/21728,0.14474860744932583,0.2938714860028895,0.24299180631675435,NAP1L1,1
GROSS_HYPOXIA_VIA_ELK3_ONLY_DN,GROSS_HYPOXIA_VIA_ELK3_ONLY_DN,1/77,44/21728,0.14474860744932583,0.2938714860028895,0.24299180631675435,MINPP1,1
IKEDA_MIR133_TARGETS_UP,IKEDA_MIR133_TARGETS_UP,1/77,44/21728,0.14474860744932583,0.2938714860028895,0.24299180631675435,CTBP2,1
KEGG_LYSINE_DEGRADATION,KEGG_LYSINE_DEGRADATION,1/77,44/21728,0.14474860744932583,0.2938714860028895,0.24299180631675435,ALDH1B1,1
KEGG_VALINE_LEUCINE_AND_ISOLEUCINE_DEGRADATION,KEGG_VALINE_LEUCINE_AND_ISOLEUCINE_DEGRADATION,1/77,44/21728,0.14474860744932583,0.2938714860028895,0.24299180631675435,ALDH1B1,1
MARTIN_NFKB_TARGETS_UP,MARTIN_NFKB_TARGETS_UP,1/77,44/21728,0.14474860744932583,0.2938714860028895,0.24299180631675435,MYC,1
PARENT_MTOR_SIGNALING_DN,PARENT_MTOR_SIGNALING_DN,1/77,44/21728,0.14474860744932583,0.2938714860028895,0.24299180631675435,RPL12,1
PID_CERAMIDE_PATHWAY,PID_CERAMIDE_PATHWAY,1/77,44/21728,0.14474860744932583,0.2938714860028895,0.24299180631675435,MYC,1
REACTOME_INTRA_GOLGI_TRAFFIC,REACTOME_INTRA_GOLGI_TRAFFIC,1/77,44/21728,0.14474860744932583,0.2938714860028895,0.24299180631675435,ARF1,1
REACTOME_TBC_RABGAPS,REACTOME_TBC_RABGAPS,1/77,44/21728,0.14474860744932583,0.2938714860028895,0.24299180631675435,GGA2,1
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINDED_IN_ERYTHROCYTE_UP,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINDED_IN_ERYTHROCYTE_UP,1/77,44/21728,0.14474860744932583,0.2938714860028895,0.24299180631675435,NAP1L1,1
VARELA_ZMPSTE24_TARGETS_UP,VARELA_ZMPSTE24_TARGETS_UP,1/77,44/21728,0.14474860744932583,0.2938714860028895,0.24299180631675435,MYC,1
WP_INTERLEUKIN11_SIGNALING_PATHWAY,WP_INTERLEUKIN11_SIGNALING_PATHWAY,1/77,44/21728,0.14474860744932583,0.2938714860028895,0.24299180631675435,RPS6,1
WP_NEURAL_CREST_CELL_MIGRATION_IN_CANCER,WP_NEURAL_CREST_CELL_MIGRATION_IN_CANCER,1/77,44/21728,0.14474860744932583,0.2938714860028895,0.24299180631675435,ARF1,1
BOYAULT_LIVER_CANCER_SUBCLASS_G3_UP,BOYAULT_LIVER_CANCER_SUBCLASS_G3_UP,2/77,190/21728,0.14588498847795595,0.29557121943899456,0.2443972550165036,EIF3H/SMAD2,2
IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_UP,IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_UP,2/77,191/21728,0.14710666985023169,0.29557121943899456,0.2443972550165036,NT5C2/OGA,2
REACTOME_SEPARATION_OF_SISTER_CHROMATIDS,REACTOME_SEPARATION_OF_SISTER_CHROMATIDS,2/77,191/21728,0.14710666985023169,0.29557121943899456,0.2443972550165036,BUB3/UBE2D1,2
BURTON_ADIPOGENESIS_4,BURTON_ADIPOGENESIS_4,1/77,45/21728,0.14778560971949728,0.29557121943899456,0.2443972550165036,UCHL5,1
HALMOS_CEBPA_TARGETS_DN,HALMOS_CEBPA_TARGETS_DN,1/77,45/21728,0.14778560971949728,0.29557121943899456,0.2443972550165036,DYRK2,1
KYNG_RESPONSE_TO_H2O2_VIA_ERCC6_DN,KYNG_RESPONSE_TO_H2O2_VIA_ERCC6_DN,1/77,45/21728,0.14778560971949728,0.29557121943899456,0.2443972550165036,NAP1L1,1
NAKAMURA_METASTASIS_MODEL_UP,NAKAMURA_METASTASIS_MODEL_UP,1/77,45/21728,0.14778560971949728,0.29557121943899456,0.2443972550165036,GGA2,1
PID_RHOA_PATHWAY,PID_RHOA_PATHWAY,1/77,45/21728,0.14778560971949728,0.29557121943899456,0.2443972550165036,DIAPH1,1
SCHAEFFER_SOX9_TARGETS_IN_PROSTATE_DEVELOPMENT_DN,SCHAEFFER_SOX9_TARGETS_IN_PROSTATE_DEVELOPMENT_DN,1/77,45/21728,0.14778560971949728,0.29557121943899456,0.2443972550165036,EIF3A,1
SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_UP,SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_UP,1/77,45/21728,0.14778560971949728,0.29557121943899456,0.2443972550165036,EXOSC7,1
SIG_CHEMOTAXIS,SIG_CHEMOTAXIS,1/77,45/21728,0.14778560971949728,0.29557121943899456,0.2443972550165036,GDI2,1
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN,2/77,193/21728,0.14955646204292652,0.2968043774166848,0.245416909180807,DYRK2/BCOR,2
WIERENGA_STAT5A_TARGETS_DN,WIERENGA_STAT5A_TARGETS_DN,2/77,193/21728,0.14955646204292652,0.2968043774166848,0.245416909180807,DCLRE1A/MARCHF5,2
BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN,BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN,1/77,46/21728,0.1508119671447431,0.2968043774166848,0.245416909180807,MYC,1
BURTON_ADIPOGENESIS_PEAK_AT_2HR,BURTON_ADIPOGENESIS_PEAK_AT_2HR,1/77,46/21728,0.1508119671447431,0.2968043774166848,0.245416909180807,MYC,1
FIGUEROA_AML_METHYLATION_CLUSTER_1_DN,FIGUEROA_AML_METHYLATION_CLUSTER_1_DN,1/77,46/21728,0.1508119671447431,0.2968043774166848,0.245416909180807,CDC123,1
JIANG_TIP30_TARGETS_UP,JIANG_TIP30_TARGETS_UP,1/77,46/21728,0.1508119671447431,0.2968043774166848,0.245416909180807,OGA,1
KHETCHOUMIAN_TRIM24_TARGETS_UP,KHETCHOUMIAN_TRIM24_TARGETS_UP,1/77,46/21728,0.1508119671447431,0.2968043774166848,0.245416909180807,RAI14,1
LUI_THYROID_CANCER_PAX8_PPARG_DN,LUI_THYROID_CANCER_PAX8_PPARG_DN,1/77,46/21728,0.1508119671447431,0.2968043774166848,0.245416909180807,DNAJA1,1
LUI_THYROID_CANCER_PAX8_PPARG_UP,LUI_THYROID_CANCER_PAX8_PPARG_UP,1/77,46/21728,0.1508119671447431,0.2968043774166848,0.245416909180807,CTBP2,1
NIKOLSKY_BREAST_CANCER_12Q13_Q21_AMPLICON,NIKOLSKY_BREAST_CANCER_12Q13_Q21_AMPLICON,1/77,46/21728,0.1508119671447431,0.2968043774166848,0.245416909180807,DYRK2,1
PID_PS1_PATHWAY,PID_PS1_PATHWAY,1/77,46/21728,0.1508119671447431,0.2968043774166848,0.245416909180807,MYC,1
WP_ATM_SIGNALING_IN_DEVELOPMENT_AND_DISEASE,WP_ATM_SIGNALING_IN_DEVELOPMENT_AND_DISEASE,1/77,46/21728,0.1508119671447431,0.2968043774166848,0.245416909180807,DCLRE1C,1
HUANG_FOXA2_TARGETS_UP,HUANG_FOXA2_TARGETS_UP,1/77,47/21728,0.15382771654654404,0.29702905395334006,0.24560268616183167,CLIP4,1
KEGG_NOTCH_SIGNALING_PATHWAY,KEGG_NOTCH_SIGNALING_PATHWAY,1/77,47/21728,0.15382771654654404,0.29702905395334006,0.24560268616183167,CTBP2,1
KUNINGER_IGF1_VS_PDGFB_TARGETS_DN,KUNINGER_IGF1_VS_PDGFB_TARGETS_DN,1/77,47/21728,0.15382771654654404,0.29702905395334006,0.24560268616183167,B3GNT2,1
MARIADASON_RESPONSE_TO_BUTYRATE_SULINDAC_6,MARIADASON_RESPONSE_TO_BUTYRATE_SULINDAC_6,1/77,47/21728,0.15382771654654404,0.29702905395334006,0.24560268616183167,NAP1L1,1
MCDOWELL_ACUTE_LUNG_INJURY_UP,MCDOWELL_ACUTE_LUNG_INJURY_UP,1/77,47/21728,0.15382771654654404,0.29702905395334006,0.24560268616183167,MYC,1
NAKAMURA_METASTASIS,NAKAMURA_METASTASIS,1/77,47/21728,0.15382771654654404,0.29702905395334006,0.24560268616183167,GGA2,1
PID_IL6_7_PATHWAY,PID_IL6_7_PATHWAY,1/77,47/21728,0.15382771654654404,0.29702905395334006,0.24560268616183167,MYC,1
PID_LKB1_PATHWAY,PID_LKB1_PATHWAY,1/77,47/21728,0.15382771654654404,0.29702905395334006,0.24560268616183167,MYC,1
REACTOME_INTERLEUKIN_12_SIGNALING,REACTOME_INTERLEUKIN_12_SIGNALING,1/77,47/21728,0.15382771654654404,0.29702905395334006,0.24560268616183167,ARF1,1
SMITH_LIVER_CANCER,SMITH_LIVER_CANCER,1/77,47/21728,0.15382771654654404,0.29702905395334006,0.24560268616183167,ANXA7,1
TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_UP,TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_UP,1/77,47/21728,0.15382771654654404,0.29702905395334006,0.24560268616183167,UBE2D1,1
WP_NOTCH_SIGNALING,WP_NOTCH_SIGNALING,1/77,47/21728,0.15382771654654404,0.29702905395334006,0.24560268616183167,CTBP2,1
RAMALHO_STEMNESS_UP,RAMALHO_STEMNESS_UP,2/77,197/21728,0.15448093022800652,0.29702905395334006,0.24560268616183167,SMAD2/CTBP2,2
SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4,SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4,2/77,197/21728,0.15448093022800652,0.29702905395334006,0.24560268616183167,PPP2R3A/RANBP17,2
WHITFIELD_CELL_CYCLE_G2_M,WHITFIELD_CELL_CYCLE_G2_M,2/77,198/21728,0.15571705973801114,0.29702905395334006,0.24560268616183167,KIF5B/DNAJA1,2
CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_UP,CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_UP,3/77,385/21728,0.15631579733931644,0.29702905395334006,0.24560268616183167,NACA/ONECUT2/BCOR,3
BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_DN,BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_DN,1/77,48/21728,0.15683289462070693,0.29702905395334006,0.24560268616183167,EXT1,1
BROWNE_HCMV_INFECTION_8HR_DN,BROWNE_HCMV_INFECTION_8HR_DN,1/77,48/21728,0.15683289462070693,0.29702905395334006,0.24560268616183167,MYC,1
HOFMANN_CELL_LYMPHOMA_UP,HOFMANN_CELL_LYMPHOMA_UP,1/77,48/21728,0.15683289462070693,0.29702905395334006,0.24560268616183167,MYC,1
LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_DN,LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_DN,1/77,48/21728,0.15683289462070693,0.29702905395334006,0.24560268616183167,MYC,1
PARK_APL_PATHOGENESIS_DN,PARK_APL_PATHOGENESIS_DN,1/77,48/21728,0.15683289462070693,0.29702905395334006,0.24560268616183167,SRPK1,1
PID_PI3KCI_PATHWAY,PID_PI3KCI_PATHWAY,1/77,48/21728,0.15683289462070693,0.29702905395334006,0.24560268616183167,ARF1,1
REACTOME_INOSITOL_PHOSPHATE_METABOLISM,REACTOME_INOSITOL_PHOSPHATE_METABOLISM,1/77,48/21728,0.15683289462070693,0.29702905395334006,0.24560268616183167,MINPP1,1
REACTOME_NOTCH1_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION,REACTOME_NOTCH1_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION,1/77,48/21728,0.15683289462070693,0.29702905395334006,0.24560268616183167,MYC,1
WOOD_EBV_EBNA1_TARGETS_DN,WOOD_EBV_EBNA1_TARGETS_DN,1/77,48/21728,0.15683289462070693,0.29702905395334006,0.24560268616183167,KIF5B,1
WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2586,WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2586,1/77,48/21728,0.15683289462070693,0.29702905395334006,0.24560268616183167,MYC,1
WP_ENERGY_METABOLISM,WP_ENERGY_METABOLISM,1/77,48/21728,0.15683289462070693,0.29702905395334006,0.24560268616183167,TFAM,1
WP_TRANSLATION_INHIBITORS_IN_CHRONICALLY_ACTIVATED_PDGFRA_CELLS,WP_TRANSLATION_INHIBITORS_IN_CHRONICALLY_ACTIVATED_PDGFRA_CELLS,1/77,48/21728,0.15683289462070693,0.29702905395334006,0.24560268616183167,RPS6,1
ZHAN_MULTIPLE_MYELOMA_CD2_UP,ZHAN_MULTIPLE_MYELOMA_CD2_UP,1/77,48/21728,0.15683289462070693,0.29702905395334006,0.24560268616183167,DYRK2,1
YAMAZAKI_TCEB3_TARGETS_DN,YAMAZAKI_TCEB3_TARGETS_DN,2/77,199/21728,0.15695513608765804,0.29702905395334006,0.24560268616183167,DIAPH1/CTBP2,2
FAELT_B_CLL_WITH_VH3_21_DN,FAELT_B_CLL_WITH_VH3_21_DN,1/77,49/21728,0.15982753793778293,0.297512721753203,0.24600261374223253,SMAD2,1
FRASOR_RESPONSE_TO_SERM_OR_FULVESTRANT_DN,FRASOR_RESPONSE_TO_SERM_OR_FULVESTRANT_DN,1/77,49/21728,0.15982753793778293,0.297512721753203,0.24600261374223253,MYC,1
GUILLAUMOND_KLF10_TARGETS_UP,GUILLAUMOND_KLF10_TARGETS_UP,1/77,49/21728,0.15982753793778293,0.297512721753203,0.24600261374223253,DERL1,1
HENDRICKS_SMARCA4_TARGETS_DN,HENDRICKS_SMARCA4_TARGETS_DN,1/77,49/21728,0.15982753793778293,0.297512721753203,0.24600261374223253,MYC,1
JIANG_AGING_CEREBRAL_CORTEX_DN,JIANG_AGING_CEREBRAL_CORTEX_DN,1/77,49/21728,0.15982753793778293,0.297512721753203,0.24600261374223253,EEF1G,1
KEGG_GLYCEROLIPID_METABOLISM,KEGG_GLYCEROLIPID_METABOLISM,1/77,49/21728,0.15982753793778293,0.297512721753203,0.24600261374223253,ALDH1B1,1
MILI_PSEUDOPODIA,MILI_PSEUDOPODIA,1/77,49/21728,0.15982753793778293,0.297512721753203,0.24600261374223253,KIF5B,1
PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_DN,PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_DN,1/77,49/21728,0.15982753793778293,0.297512721753203,0.24600261374223253,DERL1,1
PID_FOXO_PATHWAY,PID_FOXO_PATHWAY,1/77,49/21728,0.15982753793778293,0.297512721753203,0.24600261374223253,RALB,1
REACTOME_TRANSLATION_OF_SARS_COV_2_STRUCTURAL_PROTEINS,REACTOME_TRANSLATION_OF_SARS_COV_2_STRUCTURAL_PROTEINS,1/77,49/21728,0.15982753793778293,0.297512721753203,0.24600261374223253,SRPK1,1
WP_EXERCISEINDUCED_CIRCADIAN_REGULATION,WP_EXERCISEINDUCED_CIRCADIAN_REGULATION,1/77,49/21728,0.15982753793778293,0.297512721753203,0.24600261374223253,DNAJA1,1
WP_MICROTUBULE_CYTOSKELETON_REGULATION,WP_MICROTUBULE_CYTOSKELETON_REGULATION,1/77,49/21728,0.15982753793778293,0.297512721753203,0.24600261374223253,DIAPH1,1
ZHANG_PROLIFERATING_VS_QUIESCENT,ZHANG_PROLIFERATING_VS_QUIESCENT,1/77,49/21728,0.15982753793778293,0.297512721753203,0.24600261374223253,RPL6,1
REACTOME_INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC,REACTOME_INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC,2/77,203/21728,0.1619263371889383,0.29929809376925587,0.24747887391646328,ARF1/KIF5B,2
CHANGOLKAR_H2AFY_TARGETS_UP,CHANGOLKAR_H2AFY_TARGETS_UP,1/77,50/21728,0.16281168294349235,0.29929809376925587,0.24747887391646328,CCT8,1
MARTINEZ_RESPONSE_TO_TRABECTEDIN,MARTINEZ_RESPONSE_TO_TRABECTEDIN,1/77,50/21728,0.16281168294349235,0.29929809376925587,0.24747887391646328,EXT1,1
REACTOME_SIGNALING_BY_ERBB2,REACTOME_SIGNALING_BY_ERBB2,1/77,50/21728,0.16281168294349235,0.29929809376925587,0.24747887391646328,DIAPH1,1
WP_HEPATITIS_C_AND_HEPATOCELLULAR_CARCINOMA,WP_HEPATITIS_C_AND_HEPATOCELLULAR_CARCINOMA,1/77,50/21728,0.16281168294349235,0.29929809376925587,0.24747887391646328,MYC,1
WP_INTERLEUKIN1_IL1_STRUCTURAL_PATHWAY,WP_INTERLEUKIN1_IL1_STRUCTURAL_PATHWAY,1/77,50/21728,0.16281168294349235,0.29929809376925587,0.24747887391646328,MYC,1
WP_MIRNAS_INVOLVED_IN_DNA_DAMAGE_RESPONSE,WP_MIRNAS_INVOLVED_IN_DNA_DAMAGE_RESPONSE,1/77,50/21728,0.16281168294349235,0.29929809376925587,0.24747887391646328,MYC,1
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_8,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_8,1/77,50/21728,0.16281168294349235,0.29929809376925587,0.24747887391646328,MYC,1
ZHAN_MULTIPLE_MYELOMA_HP_UP,ZHAN_MULTIPLE_MYELOMA_HP_UP,1/77,50/21728,0.16281168294349235,0.29929809376925587,0.24747887391646328,RPL37,1
ZHOU_TNF_SIGNALING_4HR,ZHOU_TNF_SIGNALING_4HR,1/77,50/21728,0.16281168294349235,0.29929809376925587,0.24747887391646328,GDI2,1
MANALO_HYPOXIA_UP,MANALO_HYPOXIA_UP,2/77,205/21728,0.16442287912680922,0.3018844911172969,0.24961747324776137,RAI14/NAP1L1,2
BURTON_ADIPOGENESIS_11,BURTON_ADIPOGENESIS_11,1/77,51/21728,0.16578536595914706,0.3021341194668549,0.2498238819891878,KIF5B,1
DAIRKEE_CANCER_PRONE_RESPONSE_BPA,DAIRKEE_CANCER_PRONE_RESPONSE_BPA,1/77,51/21728,0.16578536595914706,0.3021341194668549,0.2498238819891878,MYC,1
MORI_IMMATURE_B_LYMPHOCYTE_UP,MORI_IMMATURE_B_LYMPHOCYTE_UP,1/77,51/21728,0.16578536595914706,0.3021341194668549,0.2498238819891878,GGA2,1
REACTOME_CARGO_TRAFFICKING_TO_THE_PERICILIARY_MEMBRANE,REACTOME_CARGO_TRAFFICKING_TO_THE_PERICILIARY_MEMBRANE,1/77,51/21728,0.16578536595914706,0.3021341194668549,0.2498238819891878,CCT8,1
REACTOME_EXTENSION_OF_TELOMERES,REACTOME_EXTENSION_OF_TELOMERES,1/77,51/21728,0.16578536595914706,0.3021341194668549,0.2498238819891878,PPP6C,1
ZHOU_TNF_SIGNALING_30MIN,ZHOU_TNF_SIGNALING_30MIN,1/77,51/21728,0.16578536595914706,0.3021341194668549,0.2498238819891878,CDC123,1
PEREZ_TP53_AND_TP63_TARGETS,PEREZ_TP53_AND_TP63_TARGETS,2/77,207/21728,0.1669264177002026,0.3038389721193343,0.2512335635856044,OGA/BCOR,2
PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_7,PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_7,3/77,399/21728,0.16829359248119982,0.30415910373547367,0.2514982689529841,PPP2R3A/RMND1/NAP1L1,3
BIOCARTA_PPARA_PATHWAY,BIOCARTA_PPARA_PATHWAY,1/77,52/21728,0.16874862318206252,0.30415910373547367,0.2514982689529841,MYC,1
CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_DN,CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_DN,1/77,52/21728,0.16874862318206252,0.30415910373547367,0.2514982689529841,ONECUT2,1
KEGG_ENDOMETRIAL_CANCER,KEGG_ENDOMETRIAL_CANCER,1/77,52/21728,0.16874862318206252,0.30415910373547367,0.2514982689529841,MYC,1
KEGG_MTOR_SIGNALING_PATHWAY,KEGG_MTOR_SIGNALING_PATHWAY,1/77,52/21728,0.16874862318206252,0.30415910373547367,0.2514982689529841,RPS6,1
LUI_THYROID_CANCER_CLUSTER_1,LUI_THYROID_CANCER_CLUSTER_1,1/77,52/21728,0.16874862318206252,0.30415910373547367,0.2514982689529841,CTBP2,1
PRAMOONJAGO_SOX4_TARGETS_UP,PRAMOONJAGO_SOX4_TARGETS_UP,1/77,52/21728,0.16874862318206252,0.30415910373547367,0.2514982689529841,NAP1L1,1
WANG_BARRETTS_ESOPHAGUS_UP,WANG_BARRETTS_ESOPHAGUS_UP,1/77,52/21728,0.16874862318206252,0.30415910373547367,0.2514982689529841,RALB,1
BILD_MYC_ONCOGENIC_SIGNATURE,BILD_MYC_ONCOGENIC_SIGNATURE,2/77,209/21728,0.16943673308703106,0.3046563156966325,0.25190939571525556,MYC/ALDH1B1,2
GROSS_HYPOXIA_VIA_ELK3_UP,GROSS_HYPOXIA_VIA_ELK3_UP,2/77,209/21728,0.16943673308703106,0.3046563156966325,0.25190939571525556,MINPP1/NAP1L1,2
KEGG_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS,KEGG_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS,1/77,53/21728,0.17170149068598306,0.30686191443033006,0.25373312631124084,DERL1,1
PID_AR_TF_PATHWAY,PID_AR_TF_PATHWAY,1/77,53/21728,0.17170149068598306,0.30686191443033006,0.25373312631124084,DNAJA1,1
REACTOME_RHOD_GTPASE_CYCLE,REACTOME_RHOD_GTPASE_CYCLE,1/77,53/21728,0.17170149068598306,0.30686191443033006,0.25373312631124084,DIAPH1,1
REACTOME_SYNTHESIS_OF_PIPS_AT_THE_PLASMA_MEMBRANE,REACTOME_SYNTHESIS_OF_PIPS_AT_THE_PLASMA_MEMBRANE,1/77,53/21728,0.17170149068598306,0.30686191443033006,0.25373312631124084,ARF1,1
WP_WNT_SIGNALING_PATHWAY,WP_WNT_SIGNALING_PATHWAY,1/77,53/21728,0.17170149068598306,0.30686191443033006,0.25373312631124084,MYC,1
DEMAGALHAES_AGING_UP,DEMAGALHAES_AGING_UP,1/77,54/21728,0.17464400442149297,0.3087605724102472,0.25530305859147995,DERL1,1
KEGG_ARGININE_AND_PROLINE_METABOLISM,KEGG_ARGININE_AND_PROLINE_METABOLISM,1/77,54/21728,0.17464400442149297,0.3087605724102472,0.25530305859147995,ALDH1B1,1
KEGG_INOSITOL_PHOSPHATE_METABOLISM,KEGG_INOSITOL_PHOSPHATE_METABOLISM,1/77,54/21728,0.17464400442149297,0.3087605724102472,0.25530305859147995,MINPP1,1
KEGG_VIBRIO_CHOLERAE_INFECTION,KEGG_VIBRIO_CHOLERAE_INFECTION,1/77,54/21728,0.17464400442149297,0.3087605724102472,0.25530305859147995,ARF1,1
MARSON_FOXP3_TARGETS_DN,MARSON_FOXP3_TARGETS_DN,1/77,54/21728,0.17464400442149297,0.3087605724102472,0.25530305859147995,MYC,1
MORI_PLASMA_CELL_UP,MORI_PLASMA_CELL_UP,1/77,54/21728,0.17464400442149297,0.3087605724102472,0.25530305859147995,DERL1,1
PID_TGFBR_PATHWAY,PID_TGFBR_PATHWAY,1/77,54/21728,0.17464400442149297,0.3087605724102472,0.25530305859147995,SMAD2,1
ROVERSI_GLIOMA_COPY_NUMBER_DN,ROVERSI_GLIOMA_COPY_NUMBER_DN,1/77,54/21728,0.17464400442149297,0.3087605724102472,0.25530305859147995,CTBP2,1
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_UP,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_UP,1/77,54/21728,0.17464400442149297,0.3087605724102472,0.25530305859147995,TFAM,1
LAU_APOPTOSIS_CDKN2A_UP,LAU_APOPTOSIS_CDKN2A_UP,1/77,55/21728,0.17757620021643417,0.31023359801405404,0.25652105070459136,MYC,1
NAGASHIMA_NRG1_SIGNALING_DN,NAGASHIMA_NRG1_SIGNALING_DN,1/77,55/21728,0.17757620021643417,0.31023359801405404,0.25652105070459136,B3GNT2,1
PID_IL2_1PATHWAY,PID_IL2_1PATHWAY,1/77,55/21728,0.17757620021643417,0.31023359801405404,0.25652105070459136,MYC,1
REACTOME_HEPARAN_SULFATE_HEPARIN_HS_GAG_METABOLISM,REACTOME_HEPARAN_SULFATE_HEPARIN_HS_GAG_METABOLISM,1/77,55/21728,0.17757620021643417,0.31023359801405404,0.25652105070459136,EXT1,1
REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES,REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES,1/77,55/21728,0.17757620021643417,0.31023359801405404,0.25652105070459136,CUTC,1
REACTOME_TRANSCRIPTIONAL_ACTIVATION_OF_MITOCHONDRIAL_BIOGENESIS,REACTOME_TRANSCRIPTIONAL_ACTIVATION_OF_MITOCHONDRIAL_BIOGENESIS,1/77,55/21728,0.17757620021643417,0.31023359801405404,0.25652105070459136,TFAM,1
SONG_TARGETS_OF_IE86_CMV_PROTEIN,SONG_TARGETS_OF_IE86_CMV_PROTEIN,1/77,55/21728,0.17757620021643417,0.31023359801405404,0.25652105070459136,TFAM,1
WP_DNA_IRDOUBLE_STRAND_BREAKS_AND_CELLULAR_RESPONSE_VIA_ATM,WP_DNA_IRDOUBLE_STRAND_BREAKS_AND_CELLULAR_RESPONSE_VIA_ATM,1/77,55/21728,0.17757620021643417,0.31023359801405404,0.25652105070459136,DCLRE1C,1
WP_INTERFERON_TYPE_I_SIGNALING_PATHWAYS,WP_INTERFERON_TYPE_I_SIGNALING_PATHWAYS,1/77,55/21728,0.17757620021643417,0.31023359801405404,0.25652105070459136,RPS6,1
WP_NRP1TRIGGERED_SIGNALING_PATHWAYS_IN_PANCREATIC_CANCER,WP_NRP1TRIGGERED_SIGNALING_PATHWAYS_IN_PANCREATIC_CANCER,1/77,55/21728,0.17757620021643417,0.31023359801405404,0.25652105070459136,SMAD2,1
MAYBURD_RESPONSE_TO_L663536_DN,MAYBURD_RESPONSE_TO_L663536_DN,1/77,56/21728,0.18049811377631675,0.3123843233740002,0.25829940847319577,BUB3,1
OUILLETTE_CLL_13Q14_DELETION_DN,OUILLETTE_CLL_13Q14_DELETION_DN,1/77,56/21728,0.18049811377631675,0.3123843233740002,0.25829940847319577,ALDH1B1,1
REACTOME_DEADENYLATION_DEPENDENT_MRNA_DECAY,REACTOME_DEADENYLATION_DEPENDENT_MRNA_DECAY,1/77,56/21728,0.18049811377631675,0.3123843233740002,0.25829940847319577,EXOSC7,1
REACTOME_GOLGI_ASSOCIATED_VESICLE_BIOGENESIS,REACTOME_GOLGI_ASSOCIATED_VESICLE_BIOGENESIS,1/77,56/21728,0.18049811377631675,0.3123843233740002,0.25829940847319577,ARF1,1
TANG_SENESCENCE_TP53_TARGETS_DN,TANG_SENESCENCE_TP53_TARGETS_DN,1/77,56/21728,0.18049811377631675,0.3123843233740002,0.25829940847319577,TFAM,1
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_DN,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_DN,1/77,56/21728,0.18049811377631675,0.3123843233740002,0.25829940847319577,GGA2,1
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_2,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_2,1/77,56/21728,0.18049811377631675,0.3123843233740002,0.25829940847319577,RPP30,1
ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_DN,ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_DN,1/77,56/21728,0.18049811377631675,0.3123843233740002,0.25829940847319577,MYC,1
LIM_MAMMARY_STEM_CELL_DN,LIM_MAMMARY_STEM_CELL_DN,3/77,416/21728,0.18318903044545226,0.3144775589930822,0.26003023003416315,ANXA7/DCLRE1C/IDE,3
BIDUS_METASTASIS_UP,BIDUS_METASTASIS_UP,2/77,220/21728,0.18335503262835046,0.3144775589930822,0.26003023003416315,DDX21/NAP1L1,2
AMIT_SERUM_RESPONSE_240_MCF10A,AMIT_SERUM_RESPONSE_240_MCF10A,1/77,57/21728,0.18340978068473401,0.3144775589930822,0.26003023003416315,B3GNT2,1
KEGG_ACUTE_MYELOID_LEUKEMIA,KEGG_ACUTE_MYELOID_LEUKEMIA,1/77,57/21728,0.18340978068473401,0.3144775589930822,0.26003023003416315,MYC,1
REACTOME_HSP90_CHAPERONE_CYCLE_FOR_STEROID_HORMONE_RECEPTORS_SHR_IN_THE_PRESENCE_OF_LIGAND,REACTOME_HSP90_CHAPERONE_CYCLE_FOR_STEROID_HORMONE_RECEPTORS_SHR_IN_THE_PRESENCE_OF_LIGAND,1/77,57/21728,0.18340978068473401,0.3144775589930822,0.26003023003416315,DNAJA1,1
REACTOME_INTERLEUKIN_12_FAMILY_SIGNALING,REACTOME_INTERLEUKIN_12_FAMILY_SIGNALING,1/77,57/21728,0.18340978068473401,0.3144775589930822,0.26003023003416315,ARF1,1
TONG_INTERACT_WITH_PTTG1,TONG_INTERACT_WITH_PTTG1,1/77,57/21728,0.18340978068473401,0.3144775589930822,0.26003023003416315,RPL30,1
ZAMORA_NOS2_TARGETS_UP,ZAMORA_NOS2_TARGETS_UP,1/77,57/21728,0.18340978068473401,0.3144775589930822,0.26003023003416315,SMAD2,1
REACTOME_IRON_UPTAKE_AND_TRANSPORT,REACTOME_IRON_UPTAKE_AND_TRANSPORT,1/77,58/21728,0.18631123640377234,0.31834451723095436,0.26322767930000573,GLRX3,1
REACTOME_SIGNALING_BY_NOTCH1_PEST_DOMAIN_MUTANTS_IN_CANCER,REACTOME_SIGNALING_BY_NOTCH1_PEST_DOMAIN_MUTANTS_IN_CANCER,1/77,58/21728,0.18631123640377234,0.31834451723095436,0.26322767930000573,MYC,1
WP_TGFBETA_RECEPTOR_SIGNALING,WP_TGFBETA_RECEPTOR_SIGNALING,1/77,58/21728,0.18631123640377234,0.31834451723095436,0.26322767930000573,SMAD2,1
CAIRO_LIVER_DEVELOPMENT_DN,CAIRO_LIVER_DEVELOPMENT_DN,2/77,224/21728,0.18845862340509914,0.3210577715885081,0.2654711721488911,ALDH1B1/MARCHF5,2
DAZARD_RESPONSE_TO_UV_NHEK_UP,DAZARD_RESPONSE_TO_UV_NHEK_UP,2/77,224/21728,0.18845862340509914,0.3210577715885081,0.2654711721488911,RPL37/RPL30,2
ELVIDGE_HYPOXIA_BY_DMOG_DN,ELVIDGE_HYPOXIA_BY_DMOG_DN,1/77,59/21728,0.18920251627441853,0.3210577715885081,0.2654711721488911,IDE,1
KEGG_RNA_DEGRADATION,KEGG_RNA_DEGRADATION,1/77,59/21728,0.18920251627441853,0.3210577715885081,0.2654711721488911,EXOSC7,1
MORI_LARGE_PRE_BII_LYMPHOCYTE_DN,MORI_LARGE_PRE_BII_LYMPHOCYTE_DN,1/77,59/21728,0.18920251627441853,0.3210577715885081,0.2654711721488911,GGA2,1
PID_NOTCH_PATHWAY,PID_NOTCH_PATHWAY,1/77,59/21728,0.18920251627441853,0.3210577715885081,0.2654711721488911,MYC,1
SANSOM_APC_TARGETS_REQUIRE_MYC,SANSOM_APC_TARGETS_REQUIRE_MYC,2/77,225/21728,0.1897377166347056,0.3215967261308428,0.26591681435646214,RAI14/MYC,2
REACTOME_RRNA_MODIFICATION_IN_THE_NUCLEUS_AND_CYTOSOL,REACTOME_RRNA_MODIFICATION_IN_THE_NUCLEUS_AND_CYTOSOL,1/77,60/21728,0.19208365551697149,0.3248214378720605,0.2685832129972668,RPS6,1
WP_KIT_RECEPTOR_SIGNALING_PATHWAY,WP_KIT_RECEPTOR_SIGNALING_PATHWAY,1/77,60/21728,0.19208365551697149,0.3248214378720605,0.2685832129972668,RPS6,1
THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN,THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN,2/77,227/21728,0.19229956572263396,0.3248214378720605,0.2685832129972668,TIAL1/GDI2,2
DUTERTRE_ESTRADIOL_RESPONSE_6HR_UP,DUTERTRE_ESTRADIOL_RESPONSE_6HR_UP,2/77,228/21728,0.19358227304901648,0.32661483968772415,0.27006611272519604,DDX21/MYC,2
BOQUEST_STEM_CELL_CULTURED_VS_FRESH_UP,BOQUEST_STEM_CELL_CULTURED_VS_FRESH_UP,3/77,428/21728,0.19391296334844105,0.3267997261448071,0.2702189887145653,RAI14/MYC/NAP1L1,3
KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN,KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN,1/77,61/21728,0.19495468923144388,0.3274352621409932,0.2707444906671129,MYC,1
REACTOME_KINESINS,REACTOME_KINESINS,1/77,61/21728,0.19495468923144388,0.3274352621409932,0.2707444906671129,KIF5B,1
YU_MYC_TARGETS_DN,YU_MYC_TARGETS_DN,1/77,61/21728,0.19495468923144388,0.3274352621409932,0.2707444906671129,GGA2,1
BENPORATH_MYC_TARGETS_WITH_EBOX,BENPORATH_MYC_TARGETS_WITH_EBOX,2/77,230/21728,0.1961511330782871,0.3277707783006764,0.27102191696252786,ARF1/RPS6,2
KAUFFMANN_DNA_REPAIR_GENES,KAUFFMANN_DNA_REPAIR_GENES,2/77,230/21728,0.1961511330782871,0.3277707783006764,0.27102191696252786,DCLRE1C/DCLRE1A,2
MOOTHA_HUMAN_MITODB_6_2002,MOOTHA_HUMAN_MITODB_6_2002,3/77,431/21728,0.1966189209976266,0.3277707783006764,0.27102191696252786,TFAM/VDAC2/MRPS16,3
ZHANG_BREAST_CANCER_PROGENITORS_UP,ZHANG_BREAST_CANCER_PROGENITORS_UP,3/77,432/21728,0.19752303367529833,0.3277707783006764,0.27102191696252786,MPZL1/UCHL5/DNAJA1,3
GEORGES_CELL_CYCLE_MIR192_TARGETS,GEORGES_CELL_CYCLE_MIR192_TARGETS,1/77,62/21728,0.1978156523979725,0.3277707783006764,0.27102191696252786,NFYA,1
HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_UP,HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_UP,1/77,62/21728,0.1978156523979725,0.3277707783006764,0.27102191696252786,MPZL1,1
KEGG_GLYCOLYSIS_GLUCONEOGENESIS,KEGG_GLYCOLYSIS_GLUCONEOGENESIS,1/77,62/21728,0.1978156523979725,0.3277707783006764,0.27102191696252786,ALDH1B1,1
REACTOME_CA2_PATHWAY,REACTOME_CA2_PATHWAY,1/77,62/21728,0.1978156523979725,0.3277707783006764,0.27102191696252786,MYC,1
REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS,REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS,1/77,62/21728,0.1978156523979725,0.3277707783006764,0.27102191696252786,B3GNT2,1
REN_BOUND_BY_E2F,REN_BOUND_BY_E2F,1/77,62/21728,0.1978156523979725,0.3277707783006764,0.27102191696252786,BUB3,1
TENEDINI_MEGAKARYOCYTE_MARKERS,TENEDINI_MEGAKARYOCYTE_MARKERS,1/77,62/21728,0.1978156523979725,0.3277707783006764,0.27102191696252786,MYC,1
WP_TGFBETA_RECEPTOR_SIGNALING_IN_SKELETAL_DYSPLASIAS,WP_TGFBETA_RECEPTOR_SIGNALING_IN_SKELETAL_DYSPLASIAS,1/77,62/21728,0.1978156523979725,0.3277707783006764,0.27102191696252786,SMAD2,1
JOHNSTONE_PARVB_TARGETS_3_UP,JOHNSTONE_PARVB_TARGETS_3_UP,3/77,433/21728,0.19842819527722388,0.3284175505260212,0.2715567097505239,CLIP4/OGA/NAP1L1,3
ZWANG_CLASS_3_TRANSIENTLY_INDUCED_BY_EGF,ZWANG_CLASS_3_TRANSIENTLY_INDUCED_BY_EGF,2/77,232/21728,0.19872442845349872,0.3285399387631668,0.2716579082002967,CHMP1B/NAP1L1,2
DELYS_THYROID_CANCER_DN,DELYS_THYROID_CANCER_DN,2/77,233/21728,0.20001268052410381,0.32880843132874715,0.2718799150863011,UCHL5/ALDH1B1,2
POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_UP,POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_UP,1/77,63/21728,0.20066657987721914,0.32880843132874715,0.2718799150863011,SMAD2,1
REACTOME_SYNTHESIS_OF_SUBSTRATES_IN_N_GLYCAN_BIOSYTHESIS,REACTOME_SYNTHESIS_OF_SUBSTRATES_IN_N_GLYCAN_BIOSYTHESIS,1/77,63/21728,0.20066657987721914,0.32880843132874715,0.2718799150863011,NUS1,1
RIZKI_TUMOR_INVASIVENESS_2D_DN,RIZKI_TUMOR_INVASIVENESS_2D_DN,1/77,63/21728,0.20066657987721914,0.32880843132874715,0.2718799150863011,RPL12,1
SANSOM_WNT_PATHWAY_REQUIRE_MYC,SANSOM_WNT_PATHWAY_REQUIRE_MYC,1/77,63/21728,0.20066657987721914,0.32880843132874715,0.2718799150863011,MYC,1
VILLANUEVA_LIVER_CANCER_KRT19_DN,VILLANUEVA_LIVER_CANCER_KRT19_DN,1/77,63/21728,0.20066657987721914,0.32880843132874715,0.2718799150863011,ALDH1B1,1
WP_ENDOMETRIAL_CANCER,WP_ENDOMETRIAL_CANCER,1/77,63/21728,0.20066657987721914,0.32880843132874715,0.2718799150863011,MYC,1
WP_NOTCH_SIGNALING_PATHWAY,WP_NOTCH_SIGNALING_PATHWAY,1/77,63/21728,0.20066657987721914,0.32880843132874715,0.2718799150863011,MYC,1
VECCHI_GASTRIC_CANCER_EARLY_UP,VECCHI_GASTRIC_CANCER_EARLY_UP,3/77,436/21728,0.201149887034151,0.3292353632740589,0.2722329298206555,BUB3/GTPBP4/MRPS16,3
HOSHIDA_LIVER_CANCER_SUBCLASS_S1,HOSHIDA_LIVER_CANCER_SUBCLASS_S1,2/77,235/21728,0.20259227698836837,0.3308634092694016,0.2735791027432343,SMAD2/RALB,2
MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_DN,MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_DN,2/77,235/21728,0.20259227698836837,0.3308634092694016,0.2735791027432343,PPP2R3A/NAP1L1,2
PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_UP,PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_UP,1/77,64/21728,0.20350750641077342,0.33089559348198366,0.27360571471589135,SAR1A,1
PID_ERA_GENOMIC_PATHWAY,PID_ERA_GENOMIC_PATHWAY,1/77,64/21728,0.20350750641077342,0.33089559348198366,0.27360571471589135,MYC,1
WP_G1_TO_S_CELL_CYCLE_CONTROL,WP_G1_TO_S_CELL_CYCLE_CONTROL,1/77,64/21728,0.20350750641077342,0.33089559348198366,0.27360571471589135,MYC,1
WP_PROTEASOME_DEGRADATION,WP_PROTEASOME_DEGRADATION,1/77,64/21728,0.20350750641077342,0.33089559348198366,0.27360571471589135,UBE2D1,1
REACTOME_MITOTIC_METAPHASE_AND_ANAPHASE,REACTOME_MITOTIC_METAPHASE_AND_ANAPHASE,2/77,236/21728,0.20388357524721662,0.33114277386306173,0.2738100993198595,BUB3/UBE2D1,2
AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_DN,AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_DN,2/77,237/21728,0.2051758430113924,0.3327821887688189,0.275165672787265,RPS6/DYRK2,2
FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP,FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP,1/77,65/21728,0.20633846662155508,0.3327821887688189,0.275165672787265,NFYA,1
LEE_LIVER_CANCER_ACOX1_UP,LEE_LIVER_CANCER_ACOX1_UP,1/77,65/21728,0.20633846662155508,0.3327821887688189,0.275165672787265,RPL12,1
SHAFFER_IRF4_TARGETS_IN_ACTIVATED_DENDRITIC_CELL,SHAFFER_IRF4_TARGETS_IN_ACTIVATED_DENDRITIC_CELL,1/77,65/21728,0.20633846662155508,0.3327821887688189,0.275165672787265,B3GNT2,1
WP_FERROPTOSIS,WP_FERROPTOSIS,1/77,65/21728,0.20633846662155508,0.3327821887688189,0.275165672787265,VDAC2,1
CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP,CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP,2/77,238/21728,0.20646905757848913,0.3327821887688189,0.275165672787265,GLRX3/IDE,2
ZWANG_EGF_INTERVAL_DN,ZWANG_EGF_INTERVAL_DN,2/77,238/21728,0.20646905757848913,0.3327821887688189,0.275165672787265,RPL12/EIF3A,2
DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_DN,DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_DN,1/77,66/21728,0.2091594950142125,0.3348994584403448,0.2769163672453816,NAP1L1,1
GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_DN,GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_DN,1/77,66/21728,0.2091594950142125,0.3348994584403448,0.2769163672453816,NAP1L1,1
HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_UP,HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_UP,1/77,66/21728,0.2091594950142125,0.3348994584403448,0.2769163672453816,GGA2,1
KYNG_RESPONSE_TO_H2O2,KYNG_RESPONSE_TO_H2O2,1/77,66/21728,0.2091594950142125,0.3348994584403448,0.2769163672453816,DNAJA1,1
WP_ONCOSTATIN_M_SIGNALING_PATHWAY,WP_ONCOSTATIN_M_SIGNALING_PATHWAY,1/77,66/21728,0.2091594950142125,0.3348994584403448,0.2769163672453816,RPS6,1
MITSIADES_RESPONSE_TO_APLIDIN_UP,MITSIADES_RESPONSE_TO_APLIDIN_UP,3/77,445/21728,0.20936880893022908,0.3348994584403448,0.2769163672453816,DDX50/EXT1/NAP1L1,3
RATTENBACHER_BOUND_BY_CELF1,RATTENBACHER_BOUND_BY_CELF1,3/77,445/21728,0.20936880893022908,0.3348994584403448,0.2769163672453816,OGA/MARCHF5/UBE2D1,3
WP_MALIGNANT_PLEURAL_MESOTHELIOMA,WP_MALIGNANT_PLEURAL_MESOTHELIOMA,3/77,446/21728,0.21028682260305798,0.33600424195385914,0.2778298731631867,RPS6/CTBP2/MYC,3
RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_UP,RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_UP,2/77,242/21728,0.2116509348773771,0.336511906758134,0.2782496430070462,NFYA/NAP1L1,2
BEIER_GLIOMA_STEM_CELL_DN,BEIER_GLIOMA_STEM_CELL_DN,1/77,67/21728,0.21197062597552285,0.336511906758134,0.2782496430070462,ECD,1
PID_TELOMERASE_PATHWAY,PID_TELOMERASE_PATHWAY,1/77,67/21728,0.21197062597552285,0.336511906758134,0.2782496430070462,MYC,1
SETLUR_PROSTATE_CANCER_TMPRSS2_ERG_FUSION_UP,SETLUR_PROSTATE_CANCER_TMPRSS2_ERG_FUSION_UP,1/77,67/21728,0.21197062597552285,0.336511906758134,0.2782496430070462,RPP38,1
SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE,SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE,1/77,67/21728,0.21197062597552285,0.336511906758134,0.2782496430070462,B3GNT2,1
SIG_PIP3_SIGNALING_IN_CARDIAC_MYOCTES,SIG_PIP3_SIGNALING_IN_CARDIAC_MYOCTES,1/77,67/21728,0.21197062597552285,0.336511906758134,0.2782496430070462,MYC,1
AMIT_EGF_RESPONSE_120_HELA,AMIT_EGF_RESPONSE_120_HELA,1/77,68/21728,0.21477189377478811,0.3391376698708727,0.2804207924792274,NAP1L1,1
DANG_REGULATED_BY_MYC_UP,DANG_REGULATED_BY_MYC_UP,1/77,68/21728,0.21477189377478811,0.3391376698708727,0.2804207924792274,SRPK1,1
JI_RESPONSE_TO_FSH_UP,JI_RESPONSE_TO_FSH_UP,1/77,68/21728,0.21477189377478811,0.3391376698708727,0.2804207924792274,NT5C2,1
LINDVALL_IMMORTALIZED_BY_TERT_UP,LINDVALL_IMMORTALIZED_BY_TERT_UP,1/77,68/21728,0.21477189377478811,0.3391376698708727,0.2804207924792274,EXT1,1
WP_PHYSICOCHEMICAL_FEATURES_AND_TOXICITYASSOCIATED_PATHWAYS,WP_PHYSICOCHEMICAL_FEATURES_AND_TOXICITYASSOCIATED_PATHWAYS,1/77,68/21728,0.21477189377478811,0.3391376698708727,0.2804207924792274,MYC,1
MIKKELSEN_NPC_ICP_WITH_H3K4ME3,MIKKELSEN_NPC_ICP_WITH_H3K4ME3,3/77,452/21728,0.21581411263527042,0.34041969954634976,0.28148085690001573,RAI14/DCLRE1C/DCLRE1A,3
REACTOME_DISEASES_OF_METABOLISM,REACTOME_DISEASES_OF_METABOLISM,2/77,246/21728,0.21684618215228377,0.34063411602747234,0.28165815020860013,NUS1/EXT1,2
HESS_TARGETS_OF_HOXA9_AND_MEIS1_UP,HESS_TARGETS_OF_HOXA9_AND_MEIS1_UP,1/77,69/21728,0.21756333256423133,0.34063411602747234,0.28165815020860013,IDE,1
LEE_AGING_NEOCORTEX_DN,LEE_AGING_NEOCORTEX_DN,1/77,69/21728,0.21756333256423133,0.34063411602747234,0.28165815020860013,EEF1G,1
PID_VEGFR1_2_PATHWAY,PID_VEGFR1_2_PATHWAY,1/77,69/21728,0.21756333256423133,0.34063411602747234,0.28165815020860013,ARF1,1
SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A5,SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A5,1/77,69/21728,0.21756333256423133,0.34063411602747234,0.28165815020860013,GGA2,1
WP_DNA_DAMAGE_RESPONSE,WP_DNA_DAMAGE_RESPONSE,1/77,69/21728,0.21756333256423133,0.34063411602747234,0.28165815020860013,MYC,1
WP_RAC1PAK1P38MMP2_PATHWAY,WP_RAC1PAK1P38MMP2_PATHWAY,1/77,69/21728,0.21756333256423133,0.34063411602747234,0.28165815020860013,MYC,1
BILD_E2F3_ONCOGENIC_SIGNATURE,BILD_E2F3_ONCOGENIC_SIGNATURE,2/77,248/21728,0.21944838542244458,0.3413730346842149,0.28226913558035294,RPS6/BCOR,2
FONTAINE_FOLLICULAR_THYROID_ADENOMA_DN,FONTAINE_FOLLICULAR_THYROID_ADENOMA_DN,1/77,70/21728,0.22034497637939177,0.3413730346842149,0.28226913558035294,MYC,1
HUANG_DASATINIB_RESISTANCE_DN,HUANG_DASATINIB_RESISTANCE_DN,1/77,70/21728,0.22034497637939177,0.3413730346842149,0.28226913558035294,YME1L1,1
NATSUME_RESPONSE_TO_INTERFERON_BETA_UP,NATSUME_RESPONSE_TO_INTERFERON_BETA_UP,1/77,70/21728,0.22034497637939177,0.3413730346842149,0.28226913558035294,DNAJA1,1
PID_AP1_PATHWAY,PID_AP1_PATHWAY,1/77,70/21728,0.22034497637939177,0.3413730346842149,0.28226913558035294,MYC,1
REACTOME_RHOB_GTPASE_CYCLE,REACTOME_RHOB_GTPASE_CYCLE,1/77,70/21728,0.22034497637939177,0.3413730346842149,0.28226913558035294,DIAPH1,1
ROSS_AML_OF_FAB_M7_TYPE,ROSS_AML_OF_FAB_M7_TYPE,1/77,70/21728,0.22034497637939177,0.3413730346842149,0.28226913558035294,MINPP1,1
SESTO_RESPONSE_TO_UV_C7,SESTO_RESPONSE_TO_UV_C7,1/77,70/21728,0.22034497637939177,0.3413730346842149,0.28226913558035294,EXOSC7,1
WP_3Q29_COPY_NUMBER_VARIATION_SYNDROME,WP_3Q29_COPY_NUMBER_VARIATION_SYNDROME,1/77,70/21728,0.22034497637939177,0.3413730346842149,0.28226913558035294,MYC,1
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_10,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_10,1/77,70/21728,0.22034497637939177,0.3413730346842149,0.28226913558035294,VDAC2,1
DER_IFN_GAMMA_RESPONSE_UP,DER_IFN_GAMMA_RESPONSE_UP,1/77,71/21728,0.22311685913951673,0.3427928459544758,0.2834431266670083,NAP1L1,1
GU_PDEF_TARGETS_UP,GU_PDEF_TARGETS_UP,1/77,71/21728,0.22311685913951673,0.3427928459544758,0.2834431266670083,SMAD2,1
HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_UP,HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_UP,1/77,71/21728,0.22311685913951673,0.3427928459544758,0.2834431266670083,PPP2R3A,1
PEART_HDAC_PROLIFERATION_CLUSTER_DN,PEART_HDAC_PROLIFERATION_CLUSTER_DN,1/77,71/21728,0.22311685913951673,0.3427928459544758,0.2834431266670083,MYC,1
RAGHAVACHARI_PLATELET_SPECIFIC_GENES,RAGHAVACHARI_PLATELET_SPECIFIC_GENES,1/77,71/21728,0.22311685913951673,0.3427928459544758,0.2834431266670083,NAP1L1,1
REACTOME_SARS_COV_2_INFECTION,REACTOME_SARS_COV_2_INFECTION,1/77,71/21728,0.22311685913951673,0.3427928459544758,0.2834431266670083,SRPK1,1
SATOH_COLORECTAL_CANCER_MYC_DN,SATOH_COLORECTAL_CANCER_MYC_DN,1/77,71/21728,0.22311685913951673,0.3427928459544758,0.2834431266670083,B3GNT2,1
SESTO_RESPONSE_TO_UV_C8,SESTO_RESPONSE_TO_UV_C8,1/77,71/21728,0.22311685913951673,0.3427928459544758,0.2834431266670083,MYC,1
DANG_REGULATED_BY_MYC_DN,DANG_REGULATED_BY_MYC_DN,2/77,251/21728,0.22335693666486428,0.3428053503537585,0.2834534661069109,YME1L1/MYC,2
CROMER_METASTASIS_UP,CROMER_METASTASIS_UP,1/77,72/21728,0.22587901464795512,0.34440185641232196,0.2847735597854183,BUB3,1
KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN,KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN,1/77,72/21728,0.22587901464795512,0.34440185641232196,0.2847735597854183,MYC,1
LANDIS_BREAST_CANCER_PROGRESSION_DN,LANDIS_BREAST_CANCER_PROGRESSION_DN,1/77,72/21728,0.22587901464795512,0.34440185641232196,0.2847735597854183,DERL1,1
LIU_NASOPHARYNGEAL_CARCINOMA,LIU_NASOPHARYNGEAL_CARCINOMA,1/77,72/21728,0.22587901464795512,0.34440185641232196,0.2847735597854183,BTF3,1
REACTOME_TRANS_GOLGI_NETWORK_VESICLE_BUDDING,REACTOME_TRANS_GOLGI_NETWORK_VESICLE_BUDDING,1/77,72/21728,0.22587901464795512,0.34440185641232196,0.2847735597854183,ARF1,1
WP_MECP2_AND_ASSOCIATED_RETT_SYNDROME,WP_MECP2_AND_ASSOCIATED_RETT_SYNDROME,1/77,72/21728,0.22587901464795512,0.34440185641232196,0.2847735597854183,RPS6,1
SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN,SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN,3/77,463/21728,0.2260282819485469,0.34440185641232196,0.2847735597854183,NFYA/DERL1/ECD,3
FURUKAWA_DUSP6_TARGETS_PCI35_UP,FURUKAWA_DUSP6_TARGETS_PCI35_UP,1/77,73/21728,0.22863147659254823,0.34546694535943223,0.2856542436879858,ALDH1B1,1
KEGG_ADHERENS_JUNCTION,KEGG_ADHERENS_JUNCTION,1/77,73/21728,0.22863147659254823,0.34546694535943223,0.2856542436879858,SMAD2,1
LEE_AGING_CEREBELLUM_DN,LEE_AGING_CEREBELLUM_DN,1/77,73/21728,0.22863147659254823,0.34546694535943223,0.2856542436879858,ANXA7,1
MCCLUNG_COCAIN_REWARD_4WK,MCCLUNG_COCAIN_REWARD_4WK,1/77,73/21728,0.22863147659254823,0.34546694535943223,0.2856542436879858,DCLRE1A,1
PID_E2F_PATHWAY,PID_E2F_PATHWAY,1/77,73/21728,0.22863147659254823,0.34546694535943223,0.2856542436879858,MYC,1
REACTOME_SIGNALING_BY_FGFR2,REACTOME_SIGNALING_BY_FGFR2,1/77,73/21728,0.22863147659254823,0.34546694535943223,0.2856542436879858,TIAL1,1
WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_DN,WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_DN,1/77,73/21728,0.22863147659254823,0.34546694535943223,0.2856542436879858,CLIP4,1
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_7,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_7,1/77,73/21728,0.22863147659254823,0.34546694535943223,0.2856542436879858,KIF5B,1
CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN,CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN,3/77,466/21728,0.22883094689234382,0.34546694535943223,0.2856542436879858,RAI14/EXT1/NAP1L1,3
ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN,ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN,1/77,74/21728,0.23137427854601766,0.3468267583073165,0.2867786243108002,NFYA,1
CAMPS_COLON_CANCER_COPY_NUMBER_DN,CAMPS_COLON_CANCER_COPY_NUMBER_DN,1/77,74/21728,0.23137427854601766,0.3468267583073165,0.2867786243108002,EEF1G,1
REACTOME_APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1,REACTOME_APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1,1/77,74/21728,0.23137427854601766,0.3468267583073165,0.2867786243108002,UBE2D1,1
REACTOME_RHOC_GTPASE_CYCLE,REACTOME_RHOC_GTPASE_CYCLE,1/77,74/21728,0.23137427854601766,0.3468267583073165,0.2867786243108002,DIAPH1,1
REACTOME_SIGNALING_BY_NOTCH1,REACTOME_SIGNALING_BY_NOTCH1,1/77,74/21728,0.23137427854601766,0.3468267583073165,0.2867786243108002,MYC,1
SESTO_RESPONSE_TO_UV_C1,SESTO_RESPONSE_TO_UV_C1,1/77,74/21728,0.23137427854601766,0.3468267583073165,0.2867786243108002,VDAC2,1
TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN,TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN,1/77,74/21728,0.23137427854601766,0.3468267583073165,0.2867786243108002,NACA,1
DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_UP,DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_UP,1/77,75/21728,0.23410745396635324,0.34985926892039443,0.28928609872272487,TFAM,1
OUILLETTE_CLL_13Q14_DELETION_UP,OUILLETTE_CLL_13Q14_DELETION_UP,1/77,75/21728,0.23410745396635324,0.34985926892039443,0.28928609872272487,GTPBP4,1
REACTOME_CELLULAR_RESPONSE_TO_HYPOXIA,REACTOME_CELLULAR_RESPONSE_TO_HYPOXIA,1/77,75/21728,0.23410745396635324,0.34985926892039443,0.28928609872272487,UBE2D1,1
MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_DN,MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_DN,1/77,76/21728,0.23683103619720314,0.3525037980860687,0.2914727651719435,GDI2,1
WP_16P112_PROXIMAL_DELETION_SYNDROME,WP_16P112_PROXIMAL_DELETION_SYNDROME,1/77,76/21728,0.23683103619720314,0.3525037980860687,0.2914727651719435,CCT8,1
WP_HEAD_AND_NECK_SQUAMOUS_CELL_CARCINOMA,WP_HEAD_AND_NECK_SQUAMOUS_CELL_CARCINOMA,1/77,76/21728,0.23683103619720314,0.3525037980860687,0.2914727651719435,RPS6,1
WP_LEPTIN_SIGNALING_PATHWAY,WP_LEPTIN_SIGNALING_PATHWAY,1/77,76/21728,0.23683103619720314,0.3525037980860687,0.2914727651719435,RPS6,1
RIZKI_TUMOR_INVASIVENESS_3D_DN,RIZKI_TUMOR_INVASIVENESS_3D_DN,2/77,262/21728,0.23773370427434973,0.3529886305245079,0.29187365575026974,SEC24C/RPP38,2
JINESH_BLEBBISHIELD_VS_LIVE_CONTROL_UP,JINESH_BLEBBISHIELD_VS_LIVE_CONTROL_UP,3/77,476/21728,0.23822145755827825,0.3529886305245079,0.29187365575026974,DCLRE1C/RPL4/NAP1L1,3
CARD_MIR302A_TARGETS,CARD_MIR302A_TARGETS,1/77,77/21728,0.23954505846825536,0.3529886305245079,0.29187365575026974,PPP6C,1
KYNG_DNA_DAMAGE_BY_GAMMA_AND_UV_RADIATION,KYNG_DNA_DAMAGE_BY_GAMMA_AND_UV_RADIATION,1/77,77/21728,0.23954505846825536,0.3529886305245079,0.29187365575026974,DNAJA1,1
KYNG_DNA_DAMAGE_BY_GAMMA_RADIATION,KYNG_DNA_DAMAGE_BY_GAMMA_RADIATION,1/77,77/21728,0.23954505846825536,0.3529886305245079,0.29187365575026974,ARF1,1
MAHAJAN_RESPONSE_TO_IL1A_UP,MAHAJAN_RESPONSE_TO_IL1A_UP,1/77,77/21728,0.23954505846825536,0.3529886305245079,0.29187365575026974,MYC,1
MORI_SMALL_PRE_BII_LYMPHOCYTE_UP,MORI_SMALL_PRE_BII_LYMPHOCYTE_UP,1/77,77/21728,0.23954505846825536,0.3529886305245079,0.29187365575026974,XPNPEP1,1
MUNSHI_MULTIPLE_MYELOMA_UP,MUNSHI_MULTIPLE_MYELOMA_UP,1/77,77/21728,0.23954505846825536,0.3529886305245079,0.29187365575026974,NACA,1
PURBEY_TARGETS_OF_CTBP1_AND_SATB1_UP,PURBEY_TARGETS_OF_CTBP1_AND_SATB1_UP,1/77,77/21728,0.23954505846825536,0.3529886305245079,0.29187365575026974,RPS6,1
REACTOME_SENSORY_PROCESSING_OF_SOUND,REACTOME_SENSORY_PROCESSING_OF_SOUND,1/77,77/21728,0.23954505846825536,0.3529886305245079,0.29187365575026974,CTBP2,1
REACTOME_NEUTROPHIL_DEGRANULATION,REACTOME_NEUTROPHIL_DEGRANULATION,3/77,479/21728,0.24105225636911207,0.3544998422353773,0.293123222587617,DIAPH1/GDI2/CCT8,3
LIM_MAMMARY_STEM_CELL_UP,LIM_MAMMARY_STEM_CELL_UP,3/77,480/21728,0.24199718056696828,0.3544998422353773,0.293123222587617,EXT1/MYC/BCOR,3
DUAN_PRDM5_TARGETS,DUAN_PRDM5_TARGETS,1/77,78/21728,0.2422495538956232,0.3544998422353773,0.293123222587617,MYC,1
GUO_HEX_TARGETS_UP,GUO_HEX_TARGETS_UP,1/77,78/21728,0.2422495538956232,0.3544998422353773,0.293123222587617,EXT1,1
REACTOME_BIOSYNTHESIS_OF_THE_N_GLYCAN_PRECURSOR_DOLICHOL_LIPID_LINKED_OLIGOSACCHARIDE_LLO_AND_TRANSFER_TO_A_NASCENT_PROTEIN,REACTOME_BIOSYNTHESIS_OF_THE_N_GLYCAN_PRECURSOR_DOLICHOL_LIPID_LINKED_OLIGOSACCHARIDE_LLO_AND_TRANSFER_TO_A_NASCENT_PROTEIN,1/77,78/21728,0.2422495538956232,0.3544998422353773,0.293123222587617,NUS1,1
TAYLOR_METHYLATED_IN_ACUTE_LYMPHOBLASTIC_LEUKEMIA,TAYLOR_METHYLATED_IN_ACUTE_LYMPHOBLASTIC_LEUKEMIA,1/77,78/21728,0.2422495538956232,0.3544998422353773,0.293123222587617,MYC,1
WOO_LIVER_CANCER_RECURRENCE_DN,WOO_LIVER_CANCER_RECURRENCE_DN,1/77,78/21728,0.2422495538956232,0.3544998422353773,0.293123222587617,NHEJ1,1
BASSO_HAIRY_CELL_LEUKEMIA_UP,BASSO_HAIRY_CELL_LEUKEMIA_UP,1/77,79/21728,0.24494455548222993,0.35738208588621506,0.29550644663050757,CTBP2,1
PID_MYC_ACTIV_PATHWAY,PID_MYC_ACTIV_PATHWAY,1/77,79/21728,0.24494455548222993,0.35738208588621506,0.29550644663050757,MYC,1
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_12,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_12,1/77,79/21728,0.24494455548222993,0.35738208588621506,0.29550644663050757,NAP1L1,1
WANG_CLIM2_TARGETS_UP,WANG_CLIM2_TARGETS_UP,2/77,268/21728,0.2455989082481796,0.3579834185313702,0.2960036670571333,BTF3/GGA2,2
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_DN,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_DN,1/77,80/21728,0.24763009611818843,0.35917299515474244,0.29698728536048424,RPS6,1
PID_BETA_CATENIN_NUC_PATHWAY,PID_BETA_CATENIN_NUC_PATHWAY,1/77,80/21728,0.24763009611818843,0.35917299515474244,0.29698728536048424,MYC,1
SCIBETTA_KDM5B_TARGETS_DN,SCIBETTA_KDM5B_TARGETS_DN,1/77,80/21728,0.24763009611818843,0.35917299515474244,0.29698728536048424,BUB3,1
SU_TESTIS,SU_TESTIS,1/77,80/21728,0.24763009611818843,0.35917299515474244,0.29698728536048424,IDE,1
YAO_HOXA10_TARGETS_VIA_PROGESTERONE_UP,YAO_HOXA10_TARGETS_VIA_PROGESTERONE_UP,1/77,80/21728,0.24763009611818843,0.35917299515474244,0.29698728536048424,DDX50,1
TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_UP,TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_UP,2/77,271/21728,0.2495359665238858,0.3605775597300075,0.2981486695011315,DIAPH1/DERL1,2
BILANGES_SERUM_SENSITIVE_GENES,BILANGES_SERUM_SENSITIVE_GENES,1/77,81/21728,0.25030620858118247,0.3605775597300075,0.2981486695011315,NAP1L1,1
BIOCARTA_MAPK_PATHWAY,BIOCARTA_MAPK_PATHWAY,1/77,81/21728,0.25030620858118247,0.3605775597300075,0.2981486695011315,MYC,1
GRABARCZYK_BCL11B_TARGETS_UP,GRABARCZYK_BCL11B_TARGETS_UP,1/77,81/21728,0.25030620858118247,0.3605775597300075,0.2981486695011315,NUS1,1
MORI_PRE_BI_LYMPHOCYTE_UP,MORI_PRE_BI_LYMPHOCYTE_UP,1/77,81/21728,0.25030620858118247,0.3605775597300075,0.2981486695011315,IDE,1
ROSS_AML_WITH_MLL_FUSIONS,ROSS_AML_WITH_MLL_FUSIONS,1/77,81/21728,0.25030620858118247,0.3605775597300075,0.2981486695011315,GGA2,1
WP_DNA_IRDAMAGE_AND_CELLULAR_RESPONSE_VIA_ATR,WP_DNA_IRDAMAGE_AND_CELLULAR_RESPONSE_VIA_ATR,1/77,81/21728,0.25030620858118247,0.3605775597300075,0.2981486695011315,DCLRE1A,1
REACTOME_DDX58_IFIH1_MEDIATED_INDUCTION_OF_INTERFERON_ALPHA_BETA,REACTOME_DDX58_IFIH1_MEDIATED_INDUCTION_OF_INTERFERON_ALPHA_BETA,1/77,82/21728,0.25297292553684636,0.3633566413444693,0.3004465925510497,UBE2D1,1
SATOH_COLORECTAL_CANCER_MYC_UP,SATOH_COLORECTAL_CANCER_MYC_UP,1/77,82/21728,0.25297292553684636,0.3633566413444693,0.3004465925510497,ALDH1B1,1
ZHU_CMV_24_HR_UP,ZHU_CMV_24_HR_UP,1/77,82/21728,0.25297292553684636,0.3633566413444693,0.3004465925510497,SAR1A,1
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_UP,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_UP,1/77,83/21728,0.25563027953914075,0.36504497889743964,0.301842618403196,MYC,1
KESHELAVA_MULTIPLE_DRUG_RESISTANCE,KESHELAVA_MULTIPLE_DRUG_RESISTANCE,1/77,83/21728,0.25563027953914075,0.36504497889743964,0.301842618403196,GGA2,1
LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP,LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP,1/77,83/21728,0.25563027953914075,0.36504497889743964,0.301842618403196,MYC,1
SANA_TNF_SIGNALING_UP,SANA_TNF_SIGNALING_UP,1/77,83/21728,0.25563027953914075,0.36504497889743964,0.301842618403196,DNAJA1,1
STEIN_ESR1_TARGETS,STEIN_ESR1_TARGETS,1/77,83/21728,0.25563027953914075,0.36504497889743964,0.301842618403196,RAI14,1
SWEET_KRAS_TARGETS_UP,SWEET_KRAS_TARGETS_UP,1/77,83/21728,0.25563027953914075,0.36504497889743964,0.301842618403196,OGA,1
PILON_KLF1_TARGETS_UP,PILON_KLF1_TARGETS_UP,3/77,497/21728,0.2581537663396514,0.36599744187863986,0.3026301759284245,TIAL1/OGA/NAP1L1,3
JACKSON_DNMT1_TARGETS_UP,JACKSON_DNMT1_TARGETS_UP,1/77,84/21728,0.2582783030307316,0.36599744187863986,0.3026301759284245,EIF3A,1
KEGG_SMALL_CELL_LUNG_CANCER,KEGG_SMALL_CELL_LUNG_CANCER,1/77,84/21728,0.2582783030307316,0.36599744187863986,0.3026301759284245,MYC,1
LEE_AGING_CEREBELLUM_UP,LEE_AGING_CEREBELLUM_UP,1/77,84/21728,0.2582783030307316,0.36599744187863986,0.3026301759284245,NFYA,1
PID_CMYB_PATHWAY,PID_CMYB_PATHWAY,1/77,84/21728,0.2582783030307316,0.36599744187863986,0.3026301759284245,MYC,1
REACTOME_PI_METABOLISM,REACTOME_PI_METABOLISM,1/77,84/21728,0.2582783030307316,0.36599744187863986,0.3026301759284245,ARF1,1
STAMBOLSKY_RESPONSE_TO_VITAMIN_D3_UP,STAMBOLSKY_RESPONSE_TO_VITAMIN_D3_UP,1/77,84/21728,0.2582783030307316,0.36599744187863986,0.3026301759284245,CTBP2,1
ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_6HR,ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_6HR,1/77,84/21728,0.2582783030307316,0.36599744187863986,0.3026301759284245,DCLRE1A,1
DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN,DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN,1/77,85/21728,0.2609170283433647,0.3686762599345058,0.30484519463283327,EIF3A,1
REACTOME_CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY,REACTOME_CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY,1/77,85/21728,0.2609170283433647,0.3686762599345058,0.30484519463283327,MYC,1
SASSON_RESPONSE_TO_FORSKOLIN_DN,SASSON_RESPONSE_TO_FORSKOLIN_DN,1/77,85/21728,0.2609170283433647,0.3686762599345058,0.30484519463283327,GDI2,1
OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN,OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN,2/77,281/21728,0.2626734704572233,0.3708036192318777,0.30660423184118657,DDX50/UBE2D1,2
SASSON_RESPONSE_TO_GONADOTROPHINS_UP,SASSON_RESPONSE_TO_GONADOTROPHINS_UP,1/77,86/21728,0.26354648769823996,0.37132670049380234,0.3070367490017125,GDI2,1
WP_APOPTOSIS,WP_APOPTOSIS,1/77,86/21728,0.26354648769823996,0.37132670049380234,0.3070367490017125,MYC,1
KAYO_CALORIE_RESTRICTION_MUSCLE_DN,KAYO_CALORIE_RESTRICTION_MUSCLE_DN,1/77,87/21728,0.2661667132063833,0.37253257776423726,0.3080338457262869,VDAC2,1
KEGG_ERBB_SIGNALING_PATHWAY,KEGG_ERBB_SIGNALING_PATHWAY,1/77,87/21728,0.2661667132063833,0.37253257776423726,0.3080338457262869,MYC,1
MARTIN_VIRAL_GPCR_SIGNALING_UP,MARTIN_VIRAL_GPCR_SIGNALING_UP,1/77,87/21728,0.2661667132063833,0.37253257776423726,0.3080338457262869,MYC,1
REACTOME_REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS,REACTOME_REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS,1/77,87/21728,0.2661667132063833,0.37253257776423726,0.3080338457262869,EXOSC7,1
REACTOME_SIGNALING_BY_FGFR,REACTOME_SIGNALING_BY_FGFR,1/77,87/21728,0.2661667132063833,0.37253257776423726,0.3080338457262869,TIAL1,1
SANA_RESPONSE_TO_IFNG_DN,SANA_RESPONSE_TO_IFNG_DN,1/77,87/21728,0.2661667132063833,0.37253257776423726,0.3080338457262869,RPL6,1
TAKAO_RESPONSE_TO_UVB_RADIATION_UP,TAKAO_RESPONSE_TO_UVB_RADIATION_UP,1/77,87/21728,0.2661667132063833,0.37253257776423726,0.3080338457262869,NAP1L1,1
REACTOME_SENSORY_PERCEPTION,REACTOME_SENSORY_PERCEPTION,2/77,284/21728,0.2666170939119269,0.37280990047476625,0.30826315394288417,METAP1/CTBP2,2
NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_UP,NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_UP,2/77,285/21728,0.2679317196593759,0.37335854801918283,0.30871681094670694,IDE/DERL1,2
BHAT_ESR1_TARGETS_NOT_VIA_AKT1_DN,BHAT_ESR1_TARGETS_NOT_VIA_AKT1_DN,1/77,88/21728,0.2687777368690193,0.37335854801918283,0.30871681094670694,EXT1,1
HOEBEKE_LYMPHOID_STEM_CELL_DN,HOEBEKE_LYMPHOID_STEM_CELL_DN,1/77,88/21728,0.2687777368690193,0.37335854801918283,0.30871681094670694,RPS6,1
KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION,KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION,1/77,88/21728,0.2687777368690193,0.37335854801918283,0.30871681094670694,NFYA,1
MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_UP,MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_UP,1/77,88/21728,0.2687777368690193,0.37335854801918283,0.30871681094670694,NAP1L1,1
REACTOME_TRANSCRIPTIONAL_REGULATION_OF_GRANULOPOIESIS,REACTOME_TRANSCRIPTIONAL_REGULATION_OF_GRANULOPOIESIS,1/77,88/21728,0.2687777368690193,0.37335854801918283,0.30871681094670694,MYC,1
WP_RETINOBLASTOMA_GENE_IN_CANCER,WP_RETINOBLASTOMA_GENE_IN_CANCER,1/77,88/21728,0.2687777368690193,0.37335854801918283,0.30871681094670694,MYC,1
BAELDE_DIABETIC_NEPHROPATHY_UP,BAELDE_DIABETIC_NEPHROPATHY_UP,1/77,89/21728,0.2713795905779417,0.3738108433123931,0.3090907977250114,MYC,1
FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_DN,FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_DN,1/77,89/21728,0.2713795905779417,0.3738108433123931,0.3090907977250114,MYC,1
GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN,GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN,1/77,89/21728,0.2713795905779417,0.3738108433123931,0.3090907977250114,MINPP1,1
IVANOVSKA_MIR106B_TARGETS,IVANOVSKA_MIR106B_TARGETS,1/77,89/21728,0.2713795905779417,0.3738108433123931,0.3090907977250114,CLIP4,1
REACTOME_B_WICH_COMPLEX_POSITIVELY_REGULATES_RRNA_EXPRESSION,REACTOME_B_WICH_COMPLEX_POSITIVELY_REGULATES_RRNA_EXPRESSION,1/77,89/21728,0.2713795905779417,0.3738108433123931,0.3090907977250114,DDX21,1
SAFFORD_T_LYMPHOCYTE_ANERGY,SAFFORD_T_LYMPHOCYTE_ANERGY,1/77,89/21728,0.2713795905779417,0.3738108433123931,0.3090907977250114,GGA2,1
SEIDEN_ONCOGENESIS_BY_MET,SEIDEN_ONCOGENESIS_BY_MET,1/77,89/21728,0.2713795905779417,0.3738108433123931,0.3090907977250114,YME1L1,1
SWEET_KRAS_ONCOGENIC_SIGNATURE,SWEET_KRAS_ONCOGENIC_SIGNATURE,1/77,89/21728,0.2713795905779417,0.3738108433123931,0.3090907977250114,RPL6,1
WP_HAIR_FOLLICLE_DEVELOPMENT_CYTODIFFERENTIATION_PART_3_OF_3,WP_HAIR_FOLLICLE_DEVELOPMENT_CYTODIFFERENTIATION_PART_3_OF_3,1/77,89/21728,0.2713795905779417,0.3738108433123931,0.3090907977250114,GTPBP4,1
HADDAD_B_LYMPHOCYTE_PROGENITOR,HADDAD_B_LYMPHOCYTE_PROGENITOR,2/77,289/21728,0.2731902060035045,0.3759544920606887,0.31086330409690166,DYRK2/CTBP2,2
BOYLAN_MULTIPLE_MYELOMA_D_UP,BOYLAN_MULTIPLE_MYELOMA_D_UP,1/77,90/21728,0.27397230611588264,0.3759805649389736,0.3108848628261152,MYC,1
REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX,REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX,1/77,90/21728,0.27397230611588264,0.3759805649389736,0.3108848628261152,MYC,1
REACTOME_RAB_GEFS_EXCHANGE_GTP_FOR_GDP_ON_RABS,REACTOME_RAB_GEFS_EXCHANGE_GTP_FOR_GDP_ON_RABS,1/77,90/21728,0.27397230611588264,0.3759805649389736,0.3108848628261152,GDI2,1
GRADE_COLON_AND_RECTAL_CANCER_UP,GRADE_COLON_AND_RECTAL_CANCER_UP,2/77,290/21728,0.27450474227131993,0.3763617894962995,0.31120008375842445,CCT8/MYC,2
LU_IL4_SIGNALING,LU_IL4_SIGNALING,1/77,91/21728,0.27655591515687883,0.3777723129407273,0.3123663950745562,PPP6C,1
REACTOME_PEPTIDE_HORMONE_METABOLISM,REACTOME_PEPTIDE_HORMONE_METABOLISM,1/77,91/21728,0.27655591515687883,0.3777723129407273,0.3123663950745562,KIF5B,1
REACTOME_SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE,REACTOME_SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE,1/77,91/21728,0.27655591515687883,0.3777723129407273,0.3123663950745562,UBE2D1,1
WP_ERBB_SIGNALING_PATHWAY,WP_ERBB_SIGNALING_PATHWAY,1/77,91/21728,0.27655591515687883,0.3777723129407273,0.3123663950745562,MYC,1
REACTOME_CELL_CYCLE_CHECKPOINTS,REACTOME_CELL_CYCLE_CHECKPOINTS,2/77,292/21728,0.2771336003718815,0.37821187566910514,0.312729853751037,BUB3/UBE2D1,2
HELLER_HDAC_TARGETS_DN,HELLER_HDAC_TARGETS_DN,2/77,293/21728,0.2784478906328308,0.37930505286204974,0.3136337628180612,CTBP2/MYC,2
REACTOME_METABOLISM_OF_CARBOHYDRATES,REACTOME_METABOLISM_OF_CARBOHYDRATES,2/77,293/21728,0.2784478906328308,0.37930505286204974,0.3136337628180612,B3GNT2/EXT1,2
DURCHDEWALD_SKIN_CARCINOGENESIS_UP,DURCHDEWALD_SKIN_CARCINOGENESIS_UP,1/77,92/21728,0.27913044926664066,0.3795352382852759,0.3138240949000821,RPP38,1
REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION,REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION,1/77,92/21728,0.27913044926664066,0.3795352382852759,0.3138240949000821,DYRK2,1
CAMPS_COLON_CANCER_COPY_NUMBER_UP,CAMPS_COLON_CANCER_COPY_NUMBER_UP,1/77,93/21728,0.2816959399029165,0.38092095075618543,0.3149698909108548,XPNPEP1,1
DE_YY1_TARGETS_DN,DE_YY1_TARGETS_DN,1/77,93/21728,0.2816959399029165,0.38092095075618543,0.3149698909108548,GDI2,1
MORI_MATURE_B_LYMPHOCYTE_UP,MORI_MATURE_B_LYMPHOCYTE_UP,1/77,93/21728,0.2816959399029165,0.38092095075618543,0.3149698909108548,GGA2,1
REACTOME_MAPK6_MAPK4_SIGNALING,REACTOME_MAPK6_MAPK4_SIGNALING,1/77,93/21728,0.2816959399029165,0.38092095075618543,0.3149698909108548,MYC,1
WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_DN,WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_DN,1/77,93/21728,0.2816959399029165,0.38092095075618543,0.3149698909108548,RPP38,1
WP_MIRNA_REGULATION_OF_DNA_DAMAGE_RESPONSE,WP_MIRNA_REGULATION_OF_DNA_DAMAGE_RESPONSE,1/77,93/21728,0.2816959399029165,0.38092095075618543,0.3149698909108548,MYC,1
REACTOME_ORGANELLE_BIOGENESIS_AND_MAINTENANCE,REACTOME_ORGANELLE_BIOGENESIS_AND_MAINTENANCE,2/77,296/21728,0.2823900191293164,0.3815104646006669,0.31545733879451204,TFAM/CCT8,2
GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP,GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP,1/77,94/21728,0.2842524184158579,0.3829763668355861,0.3166694408490247,MINPP1,1
NIKOLSKY_MUTATED_AND_AMPLIFIED_IN_BREAST_CANCER,NIKOLSKY_MUTATED_AND_AMPLIFIED_IN_BREAST_CANCER,1/77,94/21728,0.2842524184158579,0.3829763668355861,0.3166694408490247,DYRK2,1
REACTOME_MITOCHONDRIAL_BIOGENESIS,REACTOME_MITOCHONDRIAL_BIOGENESIS,1/77,94/21728,0.2842524184158579,0.3829763668355861,0.3166694408490247,TFAM,1
CHEN_LIVER_METABOLISM_QTL_CIS,CHEN_LIVER_METABOLISM_QTL_CIS,1/77,95/21728,0.2867999160483795,0.38535479629045905,0.31863607897815177,UCHL5,1
KIM_GASTRIC_CANCER_CHEMOSENSITIVITY,KIM_GASTRIC_CANCER_CHEMOSENSITIVITY,1/77,95/21728,0.2867999160483795,0.38535479629045905,0.31863607897815177,MPZL1,1
WP_THYROID_HORMONES_PRODUCTION_AND_PERIPHERAL_DOWNSTREAM_SIGNALING_EFFECTS,WP_THYROID_HORMONES_PRODUCTION_AND_PERIPHERAL_DOWNSTREAM_SIGNALING_EFFECTS,1/77,95/21728,0.2867999160483795,0.38535479629045905,0.31863607897815177,RPS6,1
GUO_TARGETS_OF_IRS1_AND_IRS2,GUO_TARGETS_OF_IRS1_AND_IRS2,1/77,96/21728,0.2893384639365263,0.3877082952839401,0.32058210300167683,DNAJA1,1
REACTOME_MITOCHONDRIAL_TRANSLATION,REACTOME_MITOCHONDRIAL_TRANSLATION,1/77,96/21728,0.2893384639365263,0.3877082952839401,0.32058210300167683,MRPS16,1
REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX3,REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX3,1/77,96/21728,0.2893384639365263,0.3877082952839401,0.32058210300167683,MYC,1
AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_UP,AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_UP,2/77,303/21728,0.2915820327726887,0.3896847711077935,0.3222163800699012,MYC/DERL1,2
NAKAMURA_ADIPOGENESIS_LATE_UP,NAKAMURA_ADIPOGENESIS_LATE_UP,1/77,97/21728,0.2918680931098291,0.3896847711077935,0.3222163800699012,MYC,1
REACTOME_METABOLISM_OF_NUCLEOTIDES,REACTOME_METABOLISM_OF_NUCLEOTIDES,1/77,97/21728,0.2918680931098291,0.3896847711077935,0.3222163800699012,NT5C2,1
REACTOME_MYD88_INDEPENDENT_TLR4_CASCADE,REACTOME_MYD88_INDEPENDENT_TLR4_CASCADE,1/77,97/21728,0.2918680931098291,0.3896847711077935,0.3222163800699012,UBE2D1,1
SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP,SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP,2/77,304/21728,0.29289424028081534,0.39023022186429085,0.3226673937642915,MINPP1/NAP1L1,2
BROWNE_HCMV_INFECTION_10HR_UP,BROWNE_HCMV_INFECTION_10HR_UP,1/77,98/21728,0.2943888344916673,0.39023022186429085,0.3226673937642915,TIAL1,1
KEGG_PYRIMIDINE_METABOLISM,KEGG_PYRIMIDINE_METABOLISM,1/77,98/21728,0.2943888344916673,0.39023022186429085,0.3226673937642915,NT5C2,1
KONG_E2F3_TARGETS,KONG_E2F3_TARGETS,1/77,98/21728,0.2943888344916673,0.39023022186429085,0.3226673937642915,RPL12,1
REACTOME_PROTEIN_FOLDING,REACTOME_PROTEIN_FOLDING,1/77,98/21728,0.2943888344916673,0.39023022186429085,0.3226673937642915,CCT8,1
TAKAO_RESPONSE_TO_UVB_RADIATION_DN,TAKAO_RESPONSE_TO_UVB_RADIATION_DN,1/77,98/21728,0.2943888344916673,0.39023022186429085,0.3226673937642915,CCT8,1
WP_B_CELL_RECEPTOR_SIGNALING_PATHWAY,WP_B_CELL_RECEPTOR_SIGNALING_PATHWAY,1/77,98/21728,0.2943888344916673,0.39023022186429085,0.3226673937642915,MYC,1
WP_SMALL_CELL_LUNG_CANCER,WP_SMALL_CELL_LUNG_CANCER,1/77,98/21728,0.2943888344916673,0.39023022186429085,0.3226673937642915,MYC,1
TARTE_PLASMA_CELL_VS_PLASMABLAST_DN,TARTE_PLASMA_CELL_VS_PLASMABLAST_DN,2/77,307/21728,0.29682913661656385,0.39285520370066834,0.32483789722703227,EIF3A/CDC123,2
WP_HIPPO_SIGNALING_REGULATION_PATHWAYS,WP_HIPPO_SIGNALING_REGULATION_PATHWAYS,1/77,99/21728,0.29690071889962555,0.39285520370066834,0.32483789722703227,SMAD2,1
BENPORATH_ES_CORE_NINE_CORRELATED,BENPORATH_ES_CORE_NINE_CORRELATED,1/77,100/21728,0.2994037770458524,0.3930624441948338,0.3250092569690208,MYC,1
BROWNE_HCMV_INFECTION_12HR_DN,BROWNE_HCMV_INFECTION_12HR_DN,1/77,100/21728,0.2994037770458524,0.3930624441948338,0.3250092569690208,OGA,1
DING_LUNG_CANCER_EXPRESSION_BY_COPY_NUMBER,DING_LUNG_CANCER_EXPRESSION_BY_COPY_NUMBER,1/77,100/21728,0.2994037770458524,0.3930624441948338,0.3250092569690208,EIF3H,1
PID_CXCR4_PATHWAY,PID_CXCR4_PATHWAY,1/77,100/21728,0.2994037770458524,0.3930624441948338,0.3250092569690208,RALB,1
REACTOME_CLEC7A_DECTIN_1_SIGNALING,REACTOME_CLEC7A_DECTIN_1_SIGNALING,1/77,100/21728,0.2994037770458524,0.3930624441948338,0.3250092569690208,UBE2D1,1
REACTOME_UCH_PROTEINASES,REACTOME_UCH_PROTEINASES,1/77,100/21728,0.2994037770458524,0.3930624441948338,0.3250092569690208,UCHL5,1
REACTOME_VISUAL_PHOTOTRANSDUCTION,REACTOME_VISUAL_PHOTOTRANSDUCTION,1/77,100/21728,0.2994037770458524,0.3930624441948338,0.3250092569690208,METAP1,1
WINZEN_DEGRADED_VIA_KHSRP,WINZEN_DEGRADED_VIA_KHSRP,1/77,100/21728,0.2994037770458524,0.3930624441948338,0.3250092569690208,B3GNT2,1
WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING_PATHWAY,WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING_PATHWAY,2/77,309/21728,0.2994508201376068,0.3930624441948338,0.3250092569690208,RPS6/PPP2R3A,2
MCCLUNG_CREB1_TARGETS_UP,MCCLUNG_CREB1_TARGETS_UP,1/77,101/21728,0.3018980395374128,0.3952217027779416,0.3267946705542271,GLRX3,1
PUJANA_BREAST_CANCER_LIT_INT_NETWORK,PUJANA_BREAST_CANCER_LIT_INT_NETWORK,1/77,101/21728,0.3018980395374128,0.3952217027779416,0.3267946705542271,MYC,1
WANG_ESOPHAGUS_CANCER_VS_NORMAL_DN,WANG_ESOPHAGUS_CANCER_VS_NORMAL_DN,1/77,101/21728,0.3018980395374128,0.3952217027779416,0.3267946705542271,RPP30,1
BROWNE_HCMV_INFECTION_20HR_DN,BROWNE_HCMV_INFECTION_20HR_DN,1/77,102/21728,0.30438353687664677,0.3977708819661219,0.32890249552216194,OGA,1
REACTOME_COPI_MEDIATED_ANTEROGRADE_TRANSPORT,REACTOME_COPI_MEDIATED_ANTEROGRADE_TRANSPORT,1/77,102/21728,0.30438353687664677,0.3977708819661219,0.32890249552216194,ARF1,1
PASINI_SUZ12_TARGETS_DN,PASINI_SUZ12_TARGETS_DN,2/77,316/21728,0.30861500352886184,0.4029443243954574,0.3331802297721858,DYRK2/MYC,2
REACTOME_POSITIVE_EPIGENETIC_REGULATION_OF_RRNA_EXPRESSION,REACTOME_POSITIVE_EPIGENETIC_REGULATION_OF_RRNA_EXPRESSION,1/77,104/21728,0.3093283575859823,0.4035192519965418,0.3336556168136066,DDX21,1
ZWANG_DOWN_BY_2ND_EGF_PULSE,ZWANG_DOWN_BY_2ND_EGF_PULSE,2/77,317/21728,0.30992250481217,0.40393779727723744,0.3340016969153712,DCLRE1C/DCLRE1A,2
PID_ERBB1_DOWNSTREAM_PATHWAY,PID_ERBB1_DOWNSTREAM_PATHWAY,1/77,105/21728,0.31178774144030486,0.4052966419074499,0.33512527687098453,RPS6,1
STEIN_ESRRA_TARGETS_DN,STEIN_ESRRA_TARGETS_DN,1/77,105/21728,0.31178774144030486,0.4052966419074499,0.33512527687098453,NAP1L1,1
WOO_LIVER_CANCER_RECURRENCE_UP,WOO_LIVER_CANCER_RECURRENCE_UP,1/77,105/21728,0.31178774144030486,0.4052966419074499,0.33512527687098453,EXT1,1
BROWNE_HCMV_INFECTION_8HR_UP,BROWNE_HCMV_INFECTION_8HR_UP,1/77,106/21728,0.3142384811114468,0.40776512298746126,0.3371663754636013,DNAJA1,1
REACTOME_PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS,REACTOME_PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS,1/77,106/21728,0.3142384811114468,0.40776512298746126,0.3371663754636013,ALDH1B1,1
HELLER_SILENCED_BY_METHYLATION_DN,HELLER_SILENCED_BY_METHYLATION_DN,1/77,107/21728,0.3166806065833929,0.410213791875771,0.3391910920645041,MYC,1
KIM_MYCN_AMPLIFICATION_TARGETS_DN,KIM_MYCN_AMPLIFICATION_TARGETS_DN,1/77,107/21728,0.3166806065833929,0.410213791875771,0.3391910920645041,PPP2R3A,1
LEI_MYB_TARGETS,LEI_MYB_TARGETS,2/77,323/21728,0.3177574651807894,0.4112037579390008,0.34000965954503237,MYC/DNAJA1,2
SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN,SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN,2/77,324/21728,0.3190614977078269,0.4112037579390008,0.34000965954503237,CLIP4/GDI2,2
AMBROSINI_FLAVOPIRIDOL_TREATMENT_TP53,AMBROSINI_FLAVOPIRIDOL_TREATMENT_TP53,1/77,108/21728,0.319114147737506,0.4112037579390008,0.34000965954503237,DIAPH1,1
REACTOME_AMYLOID_FIBER_FORMATION,REACTOME_AMYLOID_FIBER_FORMATION,1/77,108/21728,0.319114147737506,0.4112037579390008,0.34000965954503237,GGA2,1
RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_UP,RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_UP,1/77,108/21728,0.319114147737506,0.4112037579390008,0.34000965954503237,GGA2,1
WP_THERMOGENESIS,WP_THERMOGENESIS,1/77,108/21728,0.319114147737506,0.4112037579390008,0.34000965954503237,RPS6,1
GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_UP,GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_UP,1/77,109/21728,0.32153913435287185,0.41360734601701005,0.34199710043853626,KIF5B,1
SESTO_RESPONSE_TO_UV_C0,SESTO_RESPONSE_TO_UV_C0,1/77,109/21728,0.32153913435287185,0.41360734601701005,0.34199710043853626,DNAJA1,1
FARMER_BREAST_CANCER_APOCRINE_VS_LUMINAL,FARMER_BREAST_CANCER_APOCRINE_VS_LUMINAL,2/77,327/21728,0.3229702683077359,0.4149102002128442,0.3430743839093456,MPZL1/RMND1,2
BRUECKNER_TARGETS_OF_MIRLET7A3_UP,BRUECKNER_TARGETS_OF_MIRLET7A3_UP,1/77,110/21728,0.3239555961066456,0.4149102002128442,0.3430743839093456,VDAC2,1
CHENG_IMPRINTED_BY_ESTRADIOL,CHENG_IMPRINTED_BY_ESTRADIOL,1/77,110/21728,0.3239555961066456,0.4149102002128442,0.3430743839093456,DDX50,1
REACTOME_SENESCENCE_ASSOCIATED_SECRETORY_PHENOTYPE_SASP,REACTOME_SENESCENCE_ASSOCIATED_SECRETORY_PHENOTYPE_SASP,1/77,110/21728,0.3239555961066456,0.4149102002128442,0.3430743839093456,UBE2D1,1
WOOD_EBV_EBNA1_TARGETS_UP,WOOD_EBV_EBNA1_TARGETS_UP,1/77,110/21728,0.3239555961066456,0.4149102002128442,0.3430743839093456,MYC,1
FARMER_BREAST_CANCER_APOCRINE_VS_BASAL,FARMER_BREAST_CANCER_APOCRINE_VS_BASAL,2/77,329/21728,0.32557322007110034,0.41619097971091834,0.3441334146032165,NT5C2/MYC,2
MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_UP,MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_UP,1/77,111/21728,0.32636356257439403,0.41619097971091834,0.3441334146032165,DYRK2,1
REACTOME_INTERLEUKIN_4_AND_INTERLEUKIN_13_SIGNALING,REACTOME_INTERLEUKIN_4_AND_INTERLEUKIN_13_SIGNALING,1/77,111/21728,0.32636356257439403,0.41619097971091834,0.3441334146032165,MYC,1
REACTOME_O_LINKED_GLYCOSYLATION,REACTOME_O_LINKED_GLYCOSYLATION,1/77,111/21728,0.32636356257439403,0.41619097971091834,0.3441334146032165,B3GNT2,1
REACTOME_TELOMERE_MAINTENANCE,REACTOME_TELOMERE_MAINTENANCE,1/77,111/21728,0.32636356257439403,0.41619097971091834,0.3441334146032165,PPP6C,1
HOSHIDA_LIVER_CANCER_SURVIVAL_DN,HOSHIDA_LIVER_CANCER_SURVIVAL_DN,1/77,113/21728,0.3311541274482084,0.4219360348003896,0.3488837948887205,CCT8,1
CERVERA_SDHB_TARGETS_2,CERVERA_SDHB_TARGETS_2,1/77,114/21728,0.3335367845005559,0.4242404195282458,0.3507892080851032,CTBP2,1
WP_DNA_DAMAGE_RESPONSE_ONLY_ATM_DEPENDENT,WP_DNA_DAMAGE_RESPONSE_ONLY_ATM_DEPENDENT,1/77,114/21728,0.3335367845005559,0.4242404195282458,0.3507892080851032,MYC,1
MARZEC_IL2_SIGNALING_UP,MARZEC_IL2_SIGNALING_UP,1/77,115/21728,0.33591106356012157,0.4268929939310917,0.35298252685278647,MYC,1
IKEDA_MIR30_TARGETS_UP,IKEDA_MIR30_TARGETS_UP,1/77,116/21728,0.33827699369966113,0.42916171389536406,0.35485845013355016,RAI14,1
LINDGREN_BLADDER_CANCER_WITH_LOH_IN_CHR9Q,LINDGREN_BLADDER_CANCER_WITH_LOH_IN_CHR9Q,1/77,116/21728,0.33827699369966113,0.42916171389536406,0.35485845013355016,PPP6C,1
GLASS_IGF2BP1_CLIP_TARGETS_KNOCKDOWN_DN,GLASS_IGF2BP1_CLIP_TARGETS_KNOCKDOWN_DN,1/77,117/21728,0.3406346038923841,0.43167803930596427,0.3569391094895125,SRPK1,1
PHONG_TNF_RESPONSE_NOT_VIA_P38,PHONG_TNF_RESPONSE_NOT_VIA_P38,2/77,341/21728,0.3411366372864454,0.43167803930596427,0.3569391094895125,RAI14/SRPK1,2
RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP,RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP,2/77,341/21728,0.3411366372864454,0.43167803930596427,0.3569391094895125,MPZL1/BCOR,2
OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_UP,OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_UP,1/77,118/21728,0.3429839230122901,0.43364434406515373,0.3585649764686586,SRPK1,1
WP_SPINAL_CORD_INJURY,WP_SPINAL_CORD_INJURY,1/77,119/21728,0.3453249798345047,0.43623104290204956,0.3607038250902924,MYC,1
YAGI_AML_WITH_11Q23_REARRANGED,YAGI_AML_WITH_11Q23_REARRANGED,2/77,345/21728,0.34630156909436904,0.4370911350311507,0.3614150044663243,GDI2/PRPF18,2
REACTOME_REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,REACTOME_REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,1/77,120/21728,0.34765780303561233,0.4380547594941475,0.3622117910210849,NFYA,1
REACTOME_SYNTHESIS_OF_DNA,REACTOME_SYNTHESIS_OF_DNA,1/77,120/21728,0.34765780303561233,0.4380547594941475,0.3622117910210849,UBE2D1,1
KEGG_LYSOSOME,KEGG_LYSOSOME,1/77,121/21728,0.3499824211939918,0.44060819295120945,0.36432313369158476,GGA2,1
HOLLERN_EMT_BREAST_TUMOR_DN,HOLLERN_EMT_BREAST_TUMOR_DN,1/77,122/21728,0.352298862790144,0.4423939840304442,0.3657997403741512,IDE,1
LEE_NEURAL_CREST_STEM_CELL_DN,LEE_NEURAL_CREST_STEM_CELL_DN,1/77,122/21728,0.352298862790144,0.4423939840304442,0.3657997403741512,NACA,1
MISSIAGLIA_REGULATED_BY_METHYLATION_DN,MISSIAGLIA_REGULATED_BY_METHYLATION_DN,1/77,122/21728,0.352298862790144,0.4423939840304442,0.3657997403741512,DCLRE1A,1
RICKMAN_METASTASIS_UP,RICKMAN_METASTASIS_UP,2/77,351/21728,0.35402512574537726,0.4437844004013416,0.36694942587134644,DYRK2/TFAM,2
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_UP,CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_UP,1/77,123/21728,0.354607156207026,0.4437844004013416,0.36694942587134644,NAP1L1,1
KAN_RESPONSE_TO_ARSENIC_TRIOXIDE,KAN_RESPONSE_TO_ARSENIC_TRIOXIDE,1/77,123/21728,0.354607156207026,0.4437844004013416,0.36694942587134644,NAP1L1,1
WP_HIPPOMERLIN_SIGNALING_DYSREGULATION,WP_HIPPOMERLIN_SIGNALING_DYSREGULATION,1/77,123/21728,0.354607156207026,0.4437844004013416,0.36694942587134644,MYC,1
REACTOME_TCR_SIGNALING,REACTOME_TCR_SIGNALING,1/77,124/21728,0.35690732973037986,0.44628513819077953,0.36901719638166447,UBE2D1,1
MEBARKI_HCC_PROGENITOR_WNT_UP_BLOCKED_BY_FZD8CRD,MEBARKI_HCC_PROGENITOR_WNT_UP_BLOCKED_BY_FZD8CRD,1/77,125/21728,0.35919941154906,0.44839250867357316,0.37075970555517307,EXT1,1
MISSIAGLIA_REGULATED_BY_METHYLATION_UP,MISSIAGLIA_REGULATED_BY_METHYLATION_UP,1/77,125/21728,0.35919941154906,0.44839250867357316,0.37075970555517307,CDC123,1
BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_DN,BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_DN,1/77,126/21728,0.36148342975536096,0.4501032090803905,0.3721742224502054,RPL12,1
CHEBOTAEV_GR_TARGETS_DN,CHEBOTAEV_GR_TARGETS_DN,1/77,126/21728,0.36148342975536096,0.4501032090803905,0.3721742224502054,PPP2R3A,1
REACTOME_RESOLUTION_OF_SISTER_CHROMATID_COHESION,REACTOME_RESOLUTION_OF_SISTER_CHROMATID_COHESION,1/77,126/21728,0.36148342975536096,0.4501032090803905,0.3721742224502054,BUB3,1
KEGG_SPLICEOSOME,KEGG_SPLICEOSOME,1/77,127/21728,0.36375941234534537,0.45141596259145295,0.3732596913102178,PRPF18,1
KIM_WT1_TARGETS_8HR_DN,KIM_WT1_TARGETS_8HR_DN,1/77,127/21728,0.36375941234534537,0.45141596259145295,0.3732596913102178,NFYA,1
MATTIOLI_MGUS_VS_PCL,MATTIOLI_MGUS_VS_PCL,1/77,127/21728,0.36375941234534537,0.45141596259145295,0.3732596913102178,RPS6,1
SCHLOSSER_SERUM_RESPONSE_UP,SCHLOSSER_SERUM_RESPONSE_UP,1/77,127/21728,0.36375941234534537,0.45141596259145295,0.3732596913102178,BTF3,1
PEREZ_TP63_TARGETS,PEREZ_TP63_TARGETS,2/77,359/21728,0.364275246872649,0.451676858118939,0.37347541647752164,OGA/BCOR,2
IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_UP,IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_UP,1/77,128/21728,0.36602738721916617,0.4534689675690927,0.3749572475946989,NAP1L1,1
PID_PDGFRB_PATHWAY,PID_PDGFRB_PATHWAY,1/77,129/21728,0.36828738218139423,0.4558867260168348,0.3769564054594012,MYC,1
DANG_MYC_TARGETS_UP,DANG_MYC_TARGETS_UP,1/77,130/21728,0.3705394249413383,0.4575248705624879,0.3783109285115366,NAP1L1,1
KEGG_PARKINSONS_DISEASE,KEGG_PARKINSONS_DISEASE,1/77,130/21728,0.3705394249413383,0.4575248705624879,0.3783109285115366,VDAC2,1
MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_UP,MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_UP,1/77,130/21728,0.3705394249413383,0.4575248705624879,0.3783109285115366,CTBP2,1
GERY_CEBP_TARGETS,GERY_CEBP_TARGETS,1/77,131/21728,0.37278354311336914,0.459145063934633,0.3796506083812471,NUS1,1
REACTOME_HOST_INTERACTIONS_OF_HIV_FACTORS,REACTOME_HOST_INTERACTIONS_OF_HIV_FACTORS,1/77,131/21728,0.37278354311336914,0.459145063934633,0.3796506083812471,ARF1,1
XU_GH1_AUTOCRINE_TARGETS_DN,XU_GH1_AUTOCRINE_TARGETS_DN,1/77,131/21728,0.37278354311336914,0.459145063934633,0.3796506083812471,RPL37,1
DELACROIX_RARG_BOUND_MEF,DELACROIX_RARG_BOUND_MEF,2/77,367/21728,0.37446598578920676,0.4603647936155137,0.3806591591678737,CTBP2/KIF5B,2
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_UP,CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_UP,1/77,132/21728,0.3750197642172385,0.4603647936155137,0.3806591591678737,NAP1L1,1
NIKOLSKY_BREAST_CANCER_8Q12_Q22_AMPLICON,NIKOLSKY_BREAST_CANCER_8Q12_Q22_AMPLICON,1/77,132/21728,0.3750197642172385,0.4603647936155137,0.3806591591678737,RPL30,1
RASHI_RESPONSE_TO_IONIZING_RADIATION_5,RASHI_RESPONSE_TO_IONIZING_RADIATION_5,1/77,132/21728,0.3750197642172385,0.4603647936155137,0.3806591591678737,UCHL5,1
BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_CIS,BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_CIS,1/77,133/21728,0.37724811567840133,0.4619492253294757,0.38196926900329137,NFYA,1
ELVIDGE_HYPOXIA_BY_DMOG_UP,ELVIDGE_HYPOXIA_BY_DMOG_UP,1/77,133/21728,0.37724811567840133,0.4619492253294757,0.38196926900329137,NAP1L1,1
KEGG_CELL_ADHESION_MOLECULES_CAMS,KEGG_CELL_ADHESION_MOLECULES_CAMS,1/77,133/21728,0.37724811567840133,0.4619492253294757,0.38196926900329137,MPZL1,1
PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_UP,PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_UP,1/77,134/21728,0.37946862482833255,0.4638996091780608,0.3835819715516905,ALDH1B1,1
REACTOME_SIGNALING_BY_NTRKS,REACTOME_SIGNALING_BY_NTRKS,1/77,134/21728,0.37946862482833255,0.4638996091780608,0.3835819715516905,RALB,1
IVANOVA_HEMATOPOIESIS_INTERMEDIATE_PROGENITOR,IVANOVA_HEMATOPOIESIS_INTERMEDIATE_PROGENITOR,1/77,135/21728,0.38168131890484525,0.46544966117274034,0.3848636540285959,ERLIN1,1
KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS,KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS,1/77,135/21728,0.38168131890484525,0.46544966117274034,0.3848636540285959,UBE2D1,1
TSENG_IRS1_TARGETS_DN,TSENG_IRS1_TARGETS_DN,1/77,135/21728,0.38168131890484525,0.46544966117274034,0.3848636540285959,DIAPH1,1
REACTOME_FCERI_MEDIATED_NF_KB_ACTIVATION,REACTOME_FCERI_MEDIATED_NF_KB_ACTIVATION,1/77,136/21728,0.3838862250524083,0.46736724928126816,0.3864492389541716,UBE2D1,1
UDAYAKUMAR_MED1_TARGETS_UP,UDAYAKUMAR_MED1_TARGETS_UP,1/77,136/21728,0.3838862250524083,0.46736724928126816,0.3864492389541716,EIF3A,1
KEGG_INSULIN_SIGNALING_PATHWAY,KEGG_INSULIN_SIGNALING_PATHWAY,1/77,137/21728,0.3860833703224603,0.4692690964939114,0.3880218082967248,RPS6,1
PID_P53_DOWNSTREAM_PATHWAY,PID_P53_DOWNSTREAM_PATHWAY,1/77,137/21728,0.3860833703224603,0.4692690964939114,0.3880218082967248,NFYA,1
REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,2/77,377/21728,0.38711377526603197,0.46973393789914336,0.3884061690057015,SEC24C/UBE2D1,2
CHUNG_BLISTER_CYTOTOXICITY_UP,CHUNG_BLISTER_CYTOTOXICITY_UP,1/77,138/21728,0.3882727816737257,0.46973393789914336,0.3884061690057015,GGA2,1
PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN,PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN,1/77,138/21728,0.3882727816737257,0.46973393789914336,0.3884061690057015,B3GNT2,1
REACTOME_CHROMOSOME_MAINTENANCE,REACTOME_CHROMOSOME_MAINTENANCE,1/77,138/21728,0.3882727816737257,0.46973393789914336,0.3884061690057015,PPP6C,1
WP_MEASLES_VIRUS_INFECTION,WP_MEASLES_VIRUS_INFECTION,1/77,138/21728,0.3882727816737257,0.46973393789914336,0.3884061690057015,EIF3H,1
LINDGREN_BLADDER_CANCER_CLUSTER_1_DN,LINDGREN_BLADDER_CANCER_CLUSTER_1_DN,2/77,378/21728,0.3883727145553134,0.46973393789914336,0.3884061690057015,DYRK2/RAI14,2
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_UP,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_UP,1/77,139/21728,0.3904544859725273,0.4714801717870877,0.3898500672635915,DNAJA1,1
PECE_MAMMARY_STEM_CELL_UP,PECE_MAMMARY_STEM_CELL_UP,1/77,139/21728,0.3904544859725273,0.4714801717870877,0.3898500672635915,NACA,1
FIGUEROA_AML_METHYLATION_CLUSTER_6_UP,FIGUEROA_AML_METHYLATION_CLUSTER_6_UP,1/77,140/21728,0.3926285099930985,0.4721765156792511,0.39042584908739447,BTAF1,1
HOELZEL_NF1_TARGETS_UP,HOELZEL_NF1_TARGETS_UP,1/77,140/21728,0.3926285099930985,0.4721765156792511,0.39042584908739447,NAP1L1,1
REACTOME_C_TYPE_LECTIN_RECEPTORS_CLRS,REACTOME_C_TYPE_LECTIN_RECEPTORS_CLRS,1/77,140/21728,0.3926285099930985,0.4721765156792511,0.39042584908739447,UBE2D1,1
SABATES_COLORECTAL_ADENOMA_UP,SABATES_COLORECTAL_ADENOMA_UP,1/77,140/21728,0.3926285099930985,0.4721765156792511,0.39042584908739447,NAP1L1,1
WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_UP,WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_UP,1/77,140/21728,0.3926285099930985,0.4721765156792511,0.39042584908739447,CTBP2,1
LINDGREN_BLADDER_CANCER_CLUSTER_2A_DN,LINDGREN_BLADDER_CANCER_CLUSTER_2A_DN,1/77,141/21728,0.394794880417896,0.47439579939646365,0.3922608953060996,PPP6C,1
DARWICHE_SKIN_TUMOR_PROMOTER_UP,DARWICHE_SKIN_TUMOR_PROMOTER_UP,1/77,143/21728,0.3991047667529688,0.47918508957017697,0.396220987814953,IDE,1
ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_UP,ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_UP,1/77,144/21728,0.4012483355720574,0.4805875526543767,0.39738063430790643,DCLRE1A,1
WP_BRAINDERIVED_NEUROTROPHIC_FACTOR_BDNF_SIGNALING_PATHWAY,WP_BRAINDERIVED_NEUROTROPHIC_FACTOR_BDNF_SIGNALING_PATHWAY,1/77,144/21728,0.4012483355720574,0.4805875526543767,0.39738063430790643,RPS6,1
WP_NEUROINFLAMMATION_AND_GLUTAMATERGIC_SIGNALING,WP_NEUROINFLAMMATION_AND_GLUTAMATERGIC_SIGNALING,1/77,144/21728,0.4012483355720574,0.4805875526543767,0.39738063430790643,SMAD2,1
LINDGREN_BLADDER_CANCER_CLUSTER_2B,LINDGREN_BLADDER_CANCER_CLUSTER_2B,2/77,389/21728,0.4021470478696826,0.48080812828622665,0.39756302039762775,B3GNT2/RALB,2
BROWNE_HCMV_INFECTION_24HR_DN,BROWNE_HCMV_INFECTION_24HR_DN,1/77,145/21728,0.4033843566136137,0.48080812828622665,0.39756302039762775,EXT1,1
BROWNE_HCMV_INFECTION_30MIN_DN,BROWNE_HCMV_INFECTION_30MIN_DN,1/77,145/21728,0.4033843566136137,0.48080812828622665,0.39756302039762775,NFYA,1
DAZARD_UV_RESPONSE_CLUSTER_G6,DAZARD_UV_RESPONSE_CLUSTER_G6,1/77,145/21728,0.4033843566136137,0.48080812828622665,0.39756302039762775,CTBP2,1
IGLESIAS_E2F_TARGETS_UP,IGLESIAS_E2F_TARGETS_UP,1/77,145/21728,0.4033843566136137,0.48080812828622665,0.39756302039762775,DNAJA1,1
SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_DN,SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_DN,1/77,145/21728,0.4033843566136137,0.48080812828622665,0.39756302039762775,RPL37,1
REACTOME_BETA_CATENIN_INDEPENDENT_WNT_SIGNALING,REACTOME_BETA_CATENIN_INDEPENDENT_WNT_SIGNALING,1/77,146/21728,0.4055128561058412,0.4825668287636339,0.3990172268318346,MYC,1
REACTOME_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,REACTOME_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,1/77,146/21728,0.4055128561058412,0.4825668287636339,0.3990172268318346,DDX21,1
KAAB_FAILED_HEART_ATRIUM_DN,KAAB_FAILED_HEART_ATRIUM_DN,1/77,147/21728,0.4076338601870133,0.48353358375313454,0.3998166019068366,DDX21,1
KATSANOU_ELAVL1_TARGETS_DN,KATSANOU_ELAVL1_TARGETS_DN,1/77,147/21728,0.4076338601870133,0.48353358375313454,0.3998166019068366,CLIP4,1
LEE_NEURAL_CREST_STEM_CELL_UP,LEE_NEURAL_CREST_STEM_CELL_UP,1/77,147/21728,0.4076338601870133,0.48353358375313454,0.3998166019068366,NAP1L1,1
PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_DN,PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_DN,1/77,147/21728,0.4076338601870133,0.48353358375313454,0.3998166019068366,EXT1,1
BASAKI_YBX1_TARGETS_DN,BASAKI_YBX1_TARGETS_DN,2/77,395/21728,0.40960080579034175,0.48371138152614673,0.3999636165172398,RPL37/NAP1L1,2
PODAR_RESPONSE_TO_ADAPHOSTIN_UP,PODAR_RESPONSE_TO_ADAPHOSTIN_UP,1/77,148/21728,0.40974739490577516,0.48371138152614673,0.3999636165172398,NAP1L1,1
REACTOME_ESTROGEN_DEPENDENT_GENE_EXPRESSION,REACTOME_ESTROGEN_DEPENDENT_GENE_EXPRESSION,1/77,148/21728,0.40974739490577516,0.48371138152614673,0.3999636165172398,MYC,1
RODWELL_AGING_KIDNEY_DN,RODWELL_AGING_KIDNEY_DN,1/77,148/21728,0.40974739490577516,0.48371138152614673,0.3999636165172398,UCHL5,1
RODWELL_AGING_KIDNEY_NO_BLOOD_DN,RODWELL_AGING_KIDNEY_NO_BLOOD_DN,1/77,148/21728,0.40974739490577516,0.48371138152614673,0.3999636165172398,UCHL5,1
RYAN_MANTLE_CELL_LYMPHOMA_NOTCH_DIRECT_UP,RYAN_MANTLE_CELL_LYMPHOMA_NOTCH_DIRECT_UP,1/77,148/21728,0.40974739490577516,0.48371138152614673,0.3999636165172398,MYC,1
REACTOME_MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,REACTOME_MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,1/77,149/21728,0.41185348622144957,0.48503542042653586,0.40105841686148286,MYC,1
REACTOME_RHOA_GTPASE_CYCLE,REACTOME_RHOA_GTPASE_CYCLE,1/77,149/21728,0.41185348622144957,0.48503542042653586,0.40105841686148286,DIAPH1,1
VANTVEER_BREAST_CANCER_ESR1_UP,VANTVEER_BREAST_CANCER_ESR1_UP,1/77,149/21728,0.41185348622144957,0.48503542042653586,0.40105841686148286,BTF3,1
DARWICHE_PAPILLOMA_RISK_HIGH_UP,DARWICHE_PAPILLOMA_RISK_HIGH_UP,1/77,150/21728,0.4139521600043379,0.48557245435429475,0.40150247098165104,IDE,1
DARWICHE_SQUAMOUS_CELL_CARCINOMA_UP,DARWICHE_SQUAMOUS_CELL_CARCINOMA_UP,1/77,150/21728,0.4139521600043379,0.48557245435429475,0.40150247098165104,IDE,1
TSAI_RESPONSE_TO_IONIZING_RADIATION,TSAI_RESPONSE_TO_IONIZING_RADIATION,1/77,150/21728,0.4139521600043379,0.48557245435429475,0.40150247098165104,MYC,1
WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_36HR,WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_36HR,1/77,150/21728,0.4139521600043379,0.48557245435429475,0.40150247098165104,SEC24C,1
WP_REGULATION_OF_ACTIN_CYTOSKELETON,WP_REGULATION_OF_ACTIN_CYTOSKELETON,1/77,150/21728,0.4139521600043379,0.48557245435429475,0.40150247098165104,DIAPH1,1
BERENJENO_TRANSFORMED_BY_RHOA_DN,BERENJENO_TRANSFORMED_BY_RHOA_DN,2/77,400/21728,0.41577871771949837,0.48686635576345166,0.40257235171381484,OGA/GGA2,2
LU_EZH2_TARGETS_DN,LU_EZH2_TARGETS_DN,2/77,400/21728,0.41577871771949837,0.48686635576345166,0.40257235171381484,DYRK2/BTAF1,2
LANDIS_ERBB2_BREAST_TUMORS_324_UP,LANDIS_ERBB2_BREAST_TUMORS_324_UP,1/77,151/21728,0.4160434420360213,0.48686635576345166,0.40257235171381484,CTBP2,1
HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP,HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP,1/77,152/21728,0.4181273580096615,0.488145525385687,0.4036300512590148,IDE,1
HUANG_GATA2_TARGETS_UP,HUANG_GATA2_TARGETS_UP,1/77,152/21728,0.4181273580096615,0.488145525385687,0.4036300512590148,RPS6,1
LANDIS_ERBB2_BREAST_TUMORS_324_DN,LANDIS_ERBB2_BREAST_TUMORS_324_DN,1/77,152/21728,0.4181273580096615,0.488145525385687,0.4036300512590148,DERL1,1
PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_DN,PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_DN,2/77,403/21728,0.41947044008472656,0.4893270011406676,0.4046069712444378,PRPF18/MRPS16,2
LU_AGING_BRAIN_DN,LU_AGING_BRAIN_DN,1/77,153/21728,0.42020393353029806,0.4897960676323191,0.4049948255260469,UBE2D1,1
SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP,SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP,2/77,405/21728,0.4219252180090376,0.491414871723686,0.4063333566492412,DYRK2/TFAM,2
SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP,SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP,1/77,154/21728,0.4222731941151492,0.49143289834818155,0.40634826221938525,GTPBP4,1
BIDUS_METASTASIS_DN,BIDUS_METASTASIS_DN,1/77,155/21728,0.4243351651939077,0.49266879352442694,0.40737017967513695,CTBP2,1
KEGG_JAK_STAT_SIGNALING_PATHWAY,KEGG_JAK_STAT_SIGNALING_PATHWAY,1/77,155/21728,0.4243351651939077,0.49266879352442694,0.40737017967513695,MYC,1
REACTOME_TOLL_LIKE_RECEPTOR_CASCADES,REACTOME_TOLL_LIKE_RECEPTOR_CASCADES,1/77,155/21728,0.4243351651939077,0.49266879352442694,0.40737017967513695,UBE2D1,1
MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP,MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP,2/77,408/21728,0.4255977013837845,0.4935037047589315,0.4080605378713194,MARCHF5/BTAF1,2
REACTOME_SARS_COV_INFECTIONS,REACTOME_SARS_COV_INFECTIONS,1/77,156/21728,0.4263898721090362,0.4935037047589315,0.4080605378713194,SRPK1,1
RUIZ_TNC_TARGETS_UP,RUIZ_TNC_TARGETS_UP,1/77,156/21728,0.4263898721090362,0.4935037047589315,0.4080605378713194,NAP1L1,1
WP_BREAST_CANCER_PATHWAY,WP_BREAST_CANCER_PATHWAY,1/77,156/21728,0.4263898721090362,0.4935037047589315,0.4080605378713194,MYC,1
SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_DN,SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_DN,2/77,409/21728,0.4268192551712703,0.4936141307849276,0.40815184519713765,ONECUT2/BCOR,2
MOHANKUMAR_HOXA1_TARGETS_UP,MOHANKUMAR_HOXA1_TARGETS_UP,2/77,410/21728,0.42803949501790617,0.4946382905679948,0.4089986862398989,YME1L1/CCT8,2
GROSS_HYPOXIA_VIA_ELK3_DN,GROSS_HYPOXIA_VIA_ELK3_DN,1/77,157/21728,0.4284373401160638,0.4947112411652675,0.40905900647594584,MYC,1
KEGG_PURINE_METABOLISM,KEGG_PURINE_METABOLISM,1/77,159/21728,0.43251065999502714,0.49863553469005467,0.41230386423698706,NT5C2,1
SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_UP,SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_UP,1/77,159/21728,0.43251065999502714,0.49863553469005467,0.41230386423698706,MARCHF5,1
REACTOME_M_PHASE,REACTOME_M_PHASE,2/77,415/21728,0.4341207745356025,0.4998015864250411,0.4132680306527119,BUB3/UBE2D1,2
ASTON_MAJOR_DEPRESSIVE_DISORDER_DN,ASTON_MAJOR_DEPRESSIVE_DISORDER_DN,1/77,160/21728,0.4345365619459931,0.4998015864250411,0.4132680306527119,PPP2R3A,1
REACTOME_REGULATION_OF_TP53_ACTIVITY,REACTOME_REGULATION_OF_TP53_ACTIVITY,1/77,160/21728,0.4345365619459931,0.4998015864250411,0.4132680306527119,DYRK2,1
PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_DN,PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_DN,1/77,162/21728,0.43856697442480785,0.5036534484847444,0.41645299742951947,EXT1,1
WP_SUDDEN_INFANT_DEATH_SYNDROME_SIDS_SUSCEPTIBILITY_PATHWAYS,WP_SUDDEN_INFANT_DEATH_SYNDROME_SIDS_SUSCEPTIBILITY_PATHWAYS,1/77,162/21728,0.43856697442480785,0.5036534484847444,0.41645299742951947,NFYA,1
WP_EGFEGFR_SIGNALING_PATHWAY,WP_EGFEGFR_SIGNALING_PATHWAY,1/77,163/21728,0.44057153451797715,0.5055626770322751,0.41803167013351716,RALB,1
LIU_CMYB_TARGETS_UP,LIU_CMYB_TARGETS_UP,1/77,164/21728,0.44256903008218373,0.5066746912947077,0.4189511548986223,MARCHF5,1
PHONG_TNF_RESPONSE_VIA_P38_PARTIAL,PHONG_TNF_RESPONSE_VIA_P38_PARTIAL,1/77,164/21728,0.44256903008218373,0.5066746912947077,0.4189511548986223,NAP1L1,1
WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER,WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER,1/77,164/21728,0.44256903008218373,0.5066746912947077,0.4189511548986223,SMAD2,1
GAVIN_FOXP3_TARGETS_CLUSTER_P3,GAVIN_FOXP3_TARGETS_CLUSTER_P3,1/77,165/21728,0.4445594856879933,0.5085595354851813,0.4205096650511327,OGA,1
CAIRO_LIVER_DEVELOPMENT_UP,CAIRO_LIVER_DEVELOPMENT_UP,1/77,166/21728,0.44654292582164923,0.5096451307833185,0.42140730492089806,CTBP2,1
IBRAHIM_NRF1_DOWN,IBRAHIM_NRF1_DOWN,1/77,166/21728,0.44654292582164923,0.5096451307833185,0.42140730492089806,BCOR,1
KEGG_ALZHEIMERS_DISEASE,KEGG_ALZHEIMERS_DISEASE,1/77,166/21728,0.44654292582164923,0.5096451307833185,0.42140730492089806,IDE,1
FOSTER_TOLERANT_MACROPHAGE_UP,FOSTER_TOLERANT_MACROPHAGE_UP,1/77,167/21728,0.4485193748853601,0.5111115158678198,0.4226198062264359,MARCHF5,1
GARCIA_TARGETS_OF_FLI1_AND_DAX1_DN,GARCIA_TARGETS_OF_FLI1_AND_DAX1_DN,1/77,167/21728,0.4485193748853601,0.5111115158678198,0.4226198062264359,RPP30,1
MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP,MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP,1/77,168/21728,0.45048885719758247,0.5125654587667644,0.42382201953437326,UBE2D1,1
SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM2,SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM2,1/77,168/21728,0.45048885719758247,0.5125654587667644,0.42382201953437326,NAP1L1,1
FIGUEROA_AML_METHYLATION_CLUSTER_3_UP,FIGUEROA_AML_METHYLATION_CLUSTER_3_UP,1/77,170/21728,0.4544070184243325,0.5154363570461731,0.42619586249598096,BTAF1,1
NABA_ECM_AFFILIATED,NABA_ECM_AFFILIATED,1/77,170/21728,0.4544070184243325,0.5154363570461731,0.42619586249598096,ANXA7,1
REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION,REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION,1/77,170/21728,0.4544070184243325,0.5154363570461731,0.42619586249598096,KIF5B,1
TIEN_INTESTINE_PROBIOTICS_6HR_DN,TIEN_INTESTINE_PROBIOTICS_6HR_DN,1/77,170/21728,0.4544070184243325,0.5154363570461731,0.42619586249598096,UBE2D1,1
IWANAGA_CARCINOGENESIS_BY_KRAS_UP,IWANAGA_CARCINOGENESIS_BY_KRAS_UP,1/77,171/21728,0.45635574555956426,0.5172498404425122,0.4276953669637183,RAI14,1
CONCANNON_APOPTOSIS_BY_EPOXOMICIN_DN,CONCANNON_APOPTOSIS_BY_EPOXOMICIN_DN,1/77,176/21728,0.4659968034423516,0.5273685110932586,0.43606213330907573,MYC,1
JINESH_BLEBBISHIELD_TRANSFORMED_STEM_CELL_SPHERES_UP,JINESH_BLEBBISHIELD_TRANSFORMED_STEM_CELL_SPHERES_UP,1/77,176/21728,0.4659968034423516,0.5273685110932586,0.43606213330907573,CHMP1B,1
VERHAAK_GLIOBLASTOMA_PRONEURAL,VERHAAK_GLIOBLASTOMA_PRONEURAL,1/77,177/21728,0.46790466564237665,0.5291224910630701,0.4375124365246239,BCOR,1
KEGG_CALCIUM_SIGNALING_PATHWAY,KEGG_CALCIUM_SIGNALING_PATHWAY,1/77,178/21728,0.46980579973107495,0.5308661865462758,0.4389542358665524,VDAC2,1
CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP,CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP,1/77,179/21728,0.4717002291241472,0.5317871385549119,0.43971573809718173,CTBP2,1
DAVICIONI_MOLECULAR_ARMS_VS_ERMS_DN,DAVICIONI_MOLECULAR_ARMS_VS_ERMS_DN,1/77,179/21728,0.4717002291241472,0.5317871385549119,0.43971573809718173,EXT1,1
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_13,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_13,1/77,179/21728,0.4717002291241472,0.5317871385549119,0.43971573809718173,RPP30,1
KEGG_ENDOCYTOSIS,KEGG_ENDOCYTOSIS,1/77,181/21728,0.47546906708443704,0.5356275008771325,0.4428911961529456,CHMP1B,1
DARWICHE_PAPILLOMA_RISK_HIGH_DN,DARWICHE_PAPILLOMA_RISK_HIGH_DN,1/77,182/21728,0.4773435220820933,0.5365123388877063,0.44362283701205546,SAR1A,1
DARWICHE_SQUAMOUS_CELL_CARCINOMA_DN,DARWICHE_SQUAMOUS_CELL_CARCINOMA_DN,1/77,182/21728,0.4773435220820933,0.5365123388877063,0.44362283701205546,SAR1A,1
OKUMURA_INFLAMMATORY_RESPONSE_LPS,OKUMURA_INFLAMMATORY_RESPONSE_LPS,1/77,182/21728,0.4773435220820933,0.5365123388877063,0.44362283701205546,NAP1L1,1
GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP,GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP,1/77,183/21728,0.47921136524554286,0.5377937720826973,0.44468240822449373,CLIP4,1
REACTOME_ION_CHANNEL_TRANSPORT,REACTOME_ION_CHANNEL_TRANSPORT,1/77,183/21728,0.47921136524554286,0.5377937720826973,0.44468240822449373,CUTC,1
GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN,GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN,1/77,184/21728,0.481072619591149,0.5386555543603926,0.4453949851238629,BTAF1,1
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP,1/77,184/21728,0.481072619591149,0.5386555543603926,0.4453949851238629,NAP1L1,1
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_17,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_17,1/77,184/21728,0.481072619591149,0.5386555543603926,0.4453949851238629,NAP1L1,1
GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP,GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP,1/77,185/21728,0.48292730805621975,0.5395060932026401,0.4460982652291612,MINPP1,1
WANG_CISPLATIN_RESPONSE_AND_XPC_UP,WANG_CISPLATIN_RESPONSE_AND_XPC_UP,1/77,185/21728,0.48292730805621975,0.5395060932026401,0.4460982652291612,MYC,1
WP_RAS_SIGNALING,WP_RAS_SIGNALING,1/77,185/21728,0.48292730805621975,0.5395060932026401,0.4460982652291612,RALB,1
REACTOME_FC_EPSILON_RECEPTOR_FCERI_SIGNALING,REACTOME_FC_EPSILON_RECEPTOR_FCERI_SIGNALING,1/77,186/21728,0.484775453499272,0.5403454904011493,0.44679233270830737,UBE2D1,1
WP_VITAMIN_D_RECEPTOR_PATHWAY,WP_VITAMIN_D_RECEPTOR_PATHWAY,1/77,186/21728,0.484775453499272,0.5403454904011493,0.44679233270830737,MYC,1
ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_UP,ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_UP,1/77,186/21728,0.484775453499272,0.5403454904011493,0.44679233270830737,MPZL1,1
VERHAAK_AML_WITH_NPM1_MUTATED_UP,VERHAAK_AML_WITH_NPM1_MUTATED_UP,1/77,187/21728,0.48661707870030035,0.5419894817777272,0.4481516902955212,NAP1L1,1
DARWICHE_SKIN_TUMOR_PROMOTER_DN,DARWICHE_SKIN_TUMOR_PROMOTER_DN,1/77,189/21728,0.49028085910525,0.5452483895843186,0.4508463644379987,SAR1A,1
REACTOME_DNA_REPLICATION,REACTOME_DNA_REPLICATION,1/77,189/21728,0.49028085910525,0.5452483895843186,0.4508463644379987,UBE2D1,1
REACTOME_SIGNALING_BY_INTERLEUKINS,REACTOME_SIGNALING_BY_INTERLEUKINS,2/77,463/21728,0.49069133875153026,0.5452945854697457,0.45088456216108164,ARF1/MYC,2
SHEPARD_CRASH_AND_BURN_MUTANT_DN,SHEPARD_CRASH_AND_BURN_MUTANT_DN,1/77,191/21728,0.4939188299506696,0.548468843476401,0.4535092424158547,BUB3,1
CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_DN,CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_DN,1/77,194/21728,0.49932778548323475,0.5536432610234217,0.457787782955767,DNAJA1,1
RIGGI_EWING_SARCOMA_PROGENITOR_DN,RIGGI_EWING_SARCOMA_PROGENITOR_DN,1/77,194/21728,0.49932778548323475,0.5536432610234217,0.457787782955767,NAP1L1,1
KIM_WT1_TARGETS_DN,KIM_WT1_TARGETS_DN,2/77,472/21728,0.5009097363422446,0.5547958741049221,0.45874083743025057,TIAL1/BUB3,2
KARLSSON_TGFB1_TARGETS_DN,KARLSSON_TGFB1_TARGETS_DN,1/77,195/21728,0.5011180594926057,0.5547958741049221,0.45874083743025057,DNAJA1,1
REACTOME_CELLULAR_SENESCENCE,REACTOME_CELLULAR_SENESCENCE,1/77,196/21728,0.5029020147900127,0.5563541750446398,0.4600293406643593,UBE2D1,1
AFFAR_YY1_TARGETS_UP,AFFAR_YY1_TARGETS_UP,1/77,199/21728,0.5082161881250956,0.5608208184033335,0.4637226480779647,KIF5B,1
KEGG_FOCAL_ADHESION,KEGG_FOCAL_ADHESION,1/77,199/21728,0.5082161881250956,0.5608208184033335,0.4637226480779647,DIAPH1,1
WAMUNYOKOLI_OVARIAN_CANCER_LMP_DN,WAMUNYOKOLI_OVARIAN_CANCER_LMP_DN,1/77,199/21728,0.5082161881250956,0.5608208184033335,0.4637226480779647,CLIP4,1
FISCHER_G1_S_CELL_CYCLE,FISCHER_G1_S_CELL_CYCLE,1/77,200/21728,0.5099750879120977,0.5608208184033335,0.4637226480779647,DCLRE1A,1
JIANG_HYPOXIA_NORMAL,JIANG_HYPOXIA_NORMAL,1/77,200/21728,0.5099750879120977,0.5608208184033335,0.4637226480779647,XPNPEP1,1
KRIEG_KDM3A_TARGETS_NOT_HYPOXIA,KRIEG_KDM3A_TARGETS_NOT_HYPOXIA,1/77,200/21728,0.5099750879120977,0.5608208184033335,0.4637226480779647,NHEJ1,1
LEE_DIFFERENTIATING_T_LYMPHOCYTE,LEE_DIFFERENTIATING_T_LYMPHOCYTE,1/77,200/21728,0.5099750879120977,0.5608208184033335,0.4637226480779647,DCLRE1C,1
MEBARKI_HCC_PROGENITOR_WNT_UP,MEBARKI_HCC_PROGENITOR_WNT_UP,1/77,200/21728,0.5099750879120977,0.5608208184033335,0.4637226480779647,EXT1,1
FOSTER_KDM1A_TARGETS_DN,FOSTER_KDM1A_TARGETS_DN,1/77,202/21728,0.5134742808610865,0.5629933138818144,0.46551900677785524,CTBP2,1
REACTOME_CILIUM_ASSEMBLY,REACTOME_CILIUM_ASSEMBLY,1/77,202/21728,0.5134742808610865,0.5629933138818144,0.46551900677785524,CCT8,1
STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP,STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP,1/77,202/21728,0.5134742808610865,0.5629933138818144,0.46551900677785524,TIAL1,1
WP_FOCAL_ADHESION,WP_FOCAL_ADHESION,1/77,202/21728,0.5134742808610865,0.5629933138818144,0.46551900677785524,DIAPH1,1
REACTOME_MITOTIC_PROMETAPHASE,REACTOME_MITOTIC_PROMETAPHASE,1/77,203/21728,0.515214617215899,0.5644827310934757,0.4667505525244109,BUB3,1
RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_UP,RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_UP,1/77,204/21728,0.5169488088291104,0.5659632144069817,0.46797471115056316,EXOSC7,1
SHEPARD_CRASH_AND_BURN_MUTANT_UP,SHEPARD_CRASH_AND_BURN_MUTANT_UP,1/77,205/21728,0.5186768771119648,0.5674348070847401,0.46919151842844764,B3GNT2,1
LINSLEY_MIR16_TARGETS,LINSLEY_MIR16_TARGETS,1/77,206/21728,0.5203988434020904,0.5684770809669546,0.4700533373710095,CLIP4,1
TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN,TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN,1/77,206/21728,0.5203988434020904,0.5684770809669546,0.4700533373710095,BCOR,1
LIU_PROSTATE_CANCER_DN,LIU_PROSTATE_CANCER_DN,2/77,491/21728,0.5220551930840869,0.5698652698510195,0.4712011810391238,CLIP4/NAP1L1,2
CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_5,CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_5,2/77,493/21728,0.5242467747088333,0.5718352273207791,0.4728300683138128,B3GNT2/DYRK2,2
RIZKI_TUMOR_INVASIVENESS_3D_UP,RIZKI_TUMOR_INVASIVENESS_3D_UP,1/77,209/21728,0.5255283425933823,0.5728103911157958,0.4736363963289217,TFAM,1
CHANDRAN_METASTASIS_UP,CHANDRAN_METASTASIS_UP,1/77,210/21728,0.5272261128252849,0.573814576403366,0.4744667211767738,RPL37,1
PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP,PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP,1/77,210/21728,0.5272261128252849,0.573814576403366,0.4744667211767738,RAI14,1
MANNE_COVID19_NONICU_VS_HEALTHY_DONOR_PLATELETS_DN,MANNE_COVID19_NONICU_VS_HEALTHY_DONOR_PLATELETS_DN,1/77,211/21728,0.5289178866570747,0.5743869481845382,0.47493999490224975,RANBP17,1
REACTOME_PHOSPHOLIPID_METABOLISM,REACTOME_PHOSPHOLIPID_METABOLISM,1/77,211/21728,0.5289178866570747,0.5743869481845382,0.47493999490224975,ARF1,1
SANSOM_APC_TARGETS,SANSOM_APC_TARGETS,1/77,211/21728,0.5289178866570747,0.5743869481845382,0.47493999490224975,MYC,1
SHEPARD_BMYB_MORPHOLINO_UP,SHEPARD_BMYB_MORPHOLINO_UP,1/77,212/21728,0.5306036849899001,0.5757946008921235,0.4761039325089064,METAP1,1
RODWELL_AGING_KIDNEY_UP,RODWELL_AGING_KIDNEY_UP,2/77,500/21728,0.5318652345305149,0.576740144267132,0.4768857684596114,RPL12/NUS1,2
KEGG_REGULATION_OF_ACTIN_CYTOSKELETON,KEGG_REGULATION_OF_ACTIN_CYTOSKELETON,1/77,213/21728,0.5322835286530243,0.5767705684378078,0.4769109251166548,DIAPH1,1
CAIRO_HEPATOBLASTOMA_CLASSES_DN,CAIRO_HEPATOBLASTOMA_CLASSES_DN,1/77,214/21728,0.5339574384040686,0.5781605083964934,0.47806021668565546,NAP1L1,1
IVANOVA_HEMATOPOIESIS_STEM_CELL_LONG_TERM,IVANOVA_HEMATOPOIESIS_STEM_CELL_LONG_TERM,1/77,215/21728,0.5356254349292562,0.5795420152455641,0.47920253521836054,CLIP4,1
LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER,LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER,1/77,216/21728,0.5372875388436544,0.5809151297812153,0.4803379144476824,MYC,1
BOQUEST_STEM_CELL_DN,BOQUEST_STEM_CELL_DN,1/77,218/21728,0.5405941509460184,0.5836363441184917,0.48258798911870165,NAP1L1,1
BROWNE_HCMV_INFECTION_1HR_DN,BROWNE_HCMV_INFECTION_1HR_DN,1/77,218/21728,0.5405941509460184,0.5836363441184917,0.48258798911870165,DYRK2,1
REACTOME_ESR_MEDIATED_SIGNALING,REACTOME_ESR_MEDIATED_SIGNALING,1/77,219/21728,0.5422387000105073,0.5849845245368831,0.4837027512195152,MYC,1
RIGGINS_TAMOXIFEN_RESISTANCE_DN,RIGGINS_TAMOXIFEN_RESISTANCE_DN,1/77,221/21728,0.5455103858305843,0.5876562319661833,0.4859118904014949,RAI14,1
WP_NETWORK_MAP_OF_SARSCOV2_SIGNALING_PATHWAY,WP_NETWORK_MAP_OF_SARSCOV2_SIGNALING_PATHWAY,1/77,221/21728,0.5455103858305843,0.5876562319661833,0.4859118904014949,RPS6,1
OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP,OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP,1/77,222/21728,0.5471375630422384,0.5885511777121022,0.4866518889849374,NAP1L1,1
REACTOME_BIOLOGICAL_OXIDATIONS,REACTOME_BIOLOGICAL_OXIDATIONS,1/77,222/21728,0.5471375630422384,0.5885511777121022,0.4866518889849374,ALDH1B1,1
CHEN_HOXA5_TARGETS_9HR_UP,CHEN_HOXA5_TARGETS_9HR_UP,1/77,223/21728,0.5487589899763845,0.5885818484652369,0.4866772495321843,DCLRE1C,1
PEDRIOLI_MIR31_TARGETS_UP,PEDRIOLI_MIR31_TARGETS_UP,1/77,223/21728,0.5487589899763845,0.5885818484652369,0.4866772495321843,XPNPEP1,1
RODWELL_AGING_KIDNEY_NO_BLOOD_UP,RODWELL_AGING_KIDNEY_NO_BLOOD_UP,1/77,223/21728,0.5487589899763845,0.5885818484652369,0.4866772495321843,RPL12,1
ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP,ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP,1/77,223/21728,0.5487589899763845,0.5885818484652369,0.4866772495321843,CLIP4,1
BROWNE_HCMV_INFECTION_16HR_UP,BROWNE_HCMV_INFECTION_16HR_UP,1/77,224/21728,0.5503746866874666,0.5894592658870113,0.4874027545721959,DDX21,1
VANTVEER_BREAST_CANCER_ESR1_DN,VANTVEER_BREAST_CANCER_ESR1_DN,1/77,224/21728,0.5503746866874666,0.5894592658870113,0.4874027545721959,MPZL1,1
RAO_BOUND_BY_SALL4,RAO_BOUND_BY_SALL4,1/77,229/21728,0.5583679139847207,0.5975870940401283,0.49412336456134826,EXOSC7,1
MARKEY_RB1_ACUTE_LOF_DN,MARKEY_RB1_ACUTE_LOF_DN,1/77,230/21728,0.5599496466524343,0.5988462935979,0.49516455157550177,B3GNT2,1
REACTOME_TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT,REACTOME_TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT,1/77,232/21728,0.5630963562130622,0.6017761493007273,0.4975871443188836,MYC,1
REACTOME_HIV_INFECTION,REACTOME_HIV_INFECTION,1/77,234/21728,0.5662208544641625,0.6042414605761965,0.4996256219136558,ARF1,1
REACTOME_NEDDYLATION,REACTOME_NEDDYLATION,1/77,234/21728,0.5662208544641625,0.6042414605761965,0.4996256219136558,UBE2D1,1
BONOME_OVARIAN_CANCER_SURVIVAL_OPTIMAL_DEBULKING,BONOME_OVARIAN_CANCER_SURVIVAL_OPTIMAL_DEBULKING,1/77,236/21728,0.5693232961375766,0.6066761583931782,0.501638786336073,GGA2,1
BROWNE_HCMV_INFECTION_20HR_UP,BROWNE_HCMV_INFECTION_20HR_UP,1/77,236/21728,0.5693232961375766,0.6066761583931782,0.501638786336073,DNAJA1,1
MARKEY_RB1_ACUTE_LOF_UP,MARKEY_RB1_ACUTE_LOF_UP,1/77,237/21728,0.5708662938203147,0.6078821197884907,0.5026359526204955,NAP1L1,1
MULLIGHAN_MLL_SIGNATURE_1_DN,MULLIGHAN_MLL_SIGNATURE_1_DN,1/77,238/21728,0.5724038349015037,0.6090805385057038,0.5036268821345502,METAP1,1
MARTORIATI_MDM4_TARGETS_FETAL_LIVER_UP,MARTORIATI_MDM4_TARGETS_FETAL_LIVER_UP,1/77,239/21728,0.5739359384246581,0.6102714510731255,0.5046116050821872,GLRX3,1
RUTELLA_RESPONSE_TO_HGF_DN,RUTELLA_RESPONSE_TO_HGF_DN,1/77,240/21728,0.5754626233677128,0.6114548938443419,0.5055901515228837,BCOR,1
SANSOM_APC_MYC_TARGETS,SANSOM_APC_MYC_TARGETS,1/77,241/21728,0.5769839086432471,0.6126309029990799,0.5065625513723607,MYC,1
HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_UP,HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_UP,1/77,242/21728,0.5784998130987075,0.6133591992538663,0.5071647534603937,ANXA7,1
KAYO_AGING_MUSCLE_UP,KAYO_AGING_MUSCLE_UP,1/77,242/21728,0.5784998130987075,0.6133591992538663,0.5071647534603937,RALB,1
CHYLA_CBFA2T3_TARGETS_DN,CHYLA_CBFA2T3_TARGETS_DN,1/77,243/21728,0.580010355516626,0.6140797317002674,0.5077605359333456,RANBP17,1
DOANE_RESPONSE_TO_ANDROGEN_DN,DOANE_RESPONSE_TO_ANDROGEN_DN,1/77,243/21728,0.580010355516626,0.6140797317002674,0.5077605359333456,RAI14,1
UDAYAKUMAR_MED1_TARGETS_DN,UDAYAKUMAR_MED1_TARGETS_DN,1/77,244/21728,0.5815155546148443,0.6152326340162777,0.5087138295654856,OGA,1
REACTOME_SIGNALING_BY_NOTCH,REACTOME_SIGNALING_BY_NOTCH,1/77,245/21728,0.5830154290467311,0.616378257604484,0.5096611046783035,MYC,1
GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP,GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP,1/77,247/21728,0.5859992782039389,0.6190900165728533,0.5119033610434319,RAI14,1
ZHENG_GLIOBLASTOMA_PLASTICITY_UP,ZHENG_GLIOBLASTOMA_PLASTICITY_UP,1/77,248/21728,0.5874832899156048,0.6202145017823313,0.5128331575879829,UCHL5,1
WP_MAPK_SIGNALING_PATHWAY,WP_MAPK_SIGNALING_PATHWAY,1/77,249/21728,0.588962050934064,0.6213318424557791,0.5137570465715829,MYC,1
BILD_HRAS_ONCOGENIC_SIGNATURE,BILD_HRAS_ONCOGENIC_SIGNATURE,1/77,250/21728,0.5904355795935954,0.6219984224086486,0.514308217660025,NAP1L1,1
RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN,RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN,1/77,250/21728,0.5904355795935954,0.6219984224086486,0.514308217660025,BCOR,1
KOBAYASHI_EGFR_SIGNALING_24HR_DN,KOBAYASHI_EGFR_SIGNALING_24HR_DN,1/77,253/21728,0.5948249538151781,0.6261761265946105,0.5177626116204992,NAP1L1,1
PLASARI_TGFB1_TARGETS_10HR_DN,PLASARI_TGFB1_TARGETS_10HR_DN,1/77,254/21728,0.5962777351216383,0.6268125835773694,0.5182888751038572,CLIP4,1
QI_PLASMACYTOMA_UP,QI_PLASMACYTOMA_UP,1/77,254/21728,0.5962777351216383,0.6268125835773694,0.5182888751038572,UBE2D1,1
RICKMAN_METASTASIS_DN,RICKMAN_METASTASIS_DN,1/77,262/21728,0.6077163876053395,0.6383829572712806,0.5278560027006316,ARF1,1
LU_AGING_BRAIN_UP,LU_AGING_BRAIN_UP,1/77,263/21728,0.6091235355674374,0.6394066658868413,0.5287024706891409,NT5C2,1
MCLACHLAN_DENTAL_CARIES_UP,MCLACHLAN_DENTAL_CARIES_UP,1/77,265/21728,0.6119229022555821,0.6414340776835109,0.5303788648889368,NAP1L1,1
MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_UP,MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_UP,1/77,265/21728,0.6119229022555821,0.6414340776835109,0.5303788648889368,CHMP1B,1
HOSHIDA_LIVER_CANCER_SUBCLASS_S3,HOSHIDA_LIVER_CANCER_SUBCLASS_S3,1/77,266/21728,0.6133151557395462,0.64198286131944,0.530832634421957,ALDH1B1,1
KOYAMA_SEMA3B_TARGETS_UP,KOYAMA_SEMA3B_TARGETS_UP,1/77,266/21728,0.6133151557395462,0.64198286131944,0.530832634421957,MINPP1,1
CAIRO_HEPATOBLASTOMA_DN,CAIRO_HEPATOBLASTOMA_DN,1/77,267/21728,0.6147024790555493,0.6420708579816974,0.530905395710242,EXT1,1
KEGG_MAPK_SIGNALING_PATHWAY,KEGG_MAPK_SIGNALING_PATHWAY,1/77,267/21728,0.6147024790555493,0.6420708579816974,0.530905395710242,MYC,1
ROZANOV_MMP14_TARGETS_UP,ROZANOV_MMP14_TARGETS_UP,1/77,267/21728,0.6147024790555493,0.6420708579816974,0.530905395710242,ANXA7,1
HOLLMANN_APOPTOSIS_VIA_CD40_DN,HOLLMANN_APOPTOSIS_VIA_CD40_DN,1/77,268/21728,0.6160848894331049,0.6430603577557409,0.531723577632943,MPZL1,1
ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN,ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN,1/77,274/21728,0.6242771373833056,0.6506922489792141,0.5380341151377165,ERLIN1,1
OISHI_CHOLANGIOMA_STEM_CELL_LIKE_DN,OISHI_CHOLANGIOMA_STEM_CELL_LIKE_DN,1/77,274/21728,0.6242771373833056,0.6506922489792141,0.5380341151377165,XPNPEP1,1
WP_IL18_SIGNALING_PATHWAY,WP_IL18_SIGNALING_PATHWAY,1/77,279/21728,0.6309720182207323,0.6572069365258931,0.543420876936516,NACA,1
MULLIGHAN_MLL_SIGNATURE_2_DN,MULLIGHAN_MLL_SIGNATURE_2_DN,1/77,280/21728,0.6322967958139536,0.6581230029669178,0.5441783394662715,METAP1,1
HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN,HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN,1/77,282/21728,0.6349322845511605,0.6604010672530719,0.5460619892321178,MYC,1
PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_UP,PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_UP,1/77,285/21728,0.6388505969237599,0.6640092702203355,0.549045483032412,DERL1,1
HUTTMANN_B_CLL_POOR_SURVIVAL_UP,HUTTMANN_B_CLL_POOR_SURVIVAL_UP,1/77,286/21728,0.6401474538951197,0.6648896253387119,0.5497734171485255,DIAPH1,1
SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM4,SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM4,1/77,287/21728,0.6414397142276482,0.6657639730536967,0.5504963839579389,CUTC,1
GENTILE_UV_HIGH_DOSE_DN,GENTILE_UV_HIGH_DOSE_DN,1/77,289/21728,0.6440105092363553,0.667963180807953,0.5523148300819269,NFYA,1
IVANOVA_HEMATOPOIESIS_MATURE_CELL,IVANOVA_HEMATOPOIESIS_MATURE_CELL,1/77,292/21728,0.6478326271312698,0.6714562572931394,0.5552031299176233,PRPF18,1
WANG_MLL_TARGETS,WANG_MLL_TARGETS,1/77,293/21728,0.6490976433521549,0.672295947354229,0.555897439554348,CLIP4,1
REACTOME_SIGNALING_BY_NUCLEAR_RECEPTORS,REACTOME_SIGNALING_BY_NUCLEAR_RECEPTORS,1/77,295/21728,0.6516142357524382,0.6739579009391907,0.5572716494483303,MYC,1
WANG_SMARCE1_TARGETS_UP,WANG_SMARCE1_TARGETS_UP,1/77,295/21728,0.6516142357524382,0.6739579009391907,0.5572716494483303,RPL37,1
BLANCO_MELO_MERS_COV_INFECTION_MCR5_CELLS_UP,BLANCO_MELO_MERS_COV_INFECTION_MCR5_CELLS_UP,1/77,296/21728,0.6528658432664147,0.6743086766930545,0.5575616933556273,DYRK2,1
ENK_UV_RESPONSE_EPIDERMIS_UP,ENK_UV_RESPONSE_EPIDERMIS_UP,1/77,296/21728,0.6528658432664147,0.6743086766930545,0.5575616933556273,RALB,1
DURAND_STROMA_S_UP,DURAND_STROMA_S_UP,1/77,300/21728,0.6578280451329079,0.6789593929514232,0.5614072040571201,ONECUT2,1
JINESH_BLEBBISHIELD_VS_LIVE_CONTROL_DN,JINESH_BLEBBISHIELD_VS_LIVE_CONTROL_DN,1/77,308/21728,0.667543348266296,0.6880258498867402,0.5689039325678409,NUS1,1
REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION,REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION,1/77,308/21728,0.667543348266296,0.6880258498867402,0.5689039325678409,UBE2D1,1
CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_4,CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_4,1/77,309/21728,0.6687384538771037,0.6882976565671026,0.5691286797766585,MYC,1
HORIUCHI_WTAP_TARGETS_UP,HORIUCHI_WTAP_TARGETS_UP,1/77,309/21728,0.6687384538771037,0.6882976565671026,0.5691286797766585,SAR1A,1
LIU_SOX4_TARGETS_DN,LIU_SOX4_TARGETS_DN,1/77,310/21728,0.6699293189525724,0.6890435166401544,0.56974540475694,EIF3A,1
CHANDRAN_METASTASIS_DN,CHANDRAN_METASTASIS_DN,1/77,313/21728,0.6734766192025786,0.6922103221011204,0.5723639227686068,EIF3A,1
DOUGLAS_BMI1_TARGETS_DN,DOUGLAS_BMI1_TARGETS_DN,1/77,314/21728,0.6746506701164896,0.6929351566589101,0.5729632625033793,CLIP4,1
SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12,SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12,1/77,319/21728,0.6804587138086651,0.6984152632008381,0.5774945663244592,DERL1,1
WP_NUCLEAR_RECEPTORS_METAPATHWAY,WP_NUCLEAR_RECEPTORS_METAPATHWAY,1/77,321/21728,0.6827531698609779,0.7002839590940495,0.5790397240283396,MYC,1
SHEN_SMARCA2_TARGETS_DN,SHEN_SMARCA2_TARGETS_DN,1/77,322/21728,0.6838942922004324,0.7009679361111228,0.5796052801260692,DIAPH1,1
REACTOME_MAPK_FAMILY_SIGNALING_CASCADES,REACTOME_MAPK_FAMILY_SIGNALING_CASCADES,1/77,327/21728,0.6895394153548613,0.7062642105990887,0.5839845798059554,MYC,1
KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN,KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN,1/77,336/21728,0.6994509954468953,0.7159200632067253,0.5919686584880052,NAP1L1,1
GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN,GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN,1/77,337/21728,0.7005328145077867,0.7165311417595216,0.5924739374565947,DCLRE1C,1
DAVICIONI_MOLECULAR_ARMS_VS_ERMS_UP,DAVICIONI_MOLECULAR_ARMS_VS_ERMS_UP,1/77,339/21728,0.7026849353343003,0.7182353626722654,0.5938830966900507,CTBP2,1
IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_DN,IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_DN,1/77,357/21728,0.7213796900096242,0.7368342652620764,0.6092618630932775,DDX50,1
KOYAMA_SEMA3B_TARGETS_DN,KOYAMA_SEMA3B_TARGETS_DN,1/77,364/21728,0.7283322627207174,0.7434220195450417,0.6147090411593145,RPL37,1
REACTOME_TRANSCRIPTIONAL_REGULATION_BY_TP53,REACTOME_TRANSCRIPTIONAL_REGULATION_BY_TP53,1/77,366/21728,0.7302870658087566,0.7449028870016164,0.6159335174196117,DYRK2,1
DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_UP,DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_UP,1/77,367/21728,0.7312592545519794,0.7453801229157417,0.6163281267040641,MPZL1,1
JINESH_BLEBBISHIELD_TRANSFORMED_STEM_CELL_SPHERES_DN,JINESH_BLEBBISHIELD_TRANSFORMED_STEM_CELL_SPHERES_DN,1/77,375/21728,0.73891325768879,0.7526628496650805,0.6223499526110379,DCLRE1C,1
HATADA_METHYLATED_IN_LUNG_CANCER_UP,HATADA_METHYLATED_IN_LUNG_CANCER_UP,1/77,377/21728,0.7407928906008436,0.753452597227759,0.6230029665845939,BCOR,1
ZHOU_INFLAMMATORY_RESPONSE_LIVE_DN,ZHOU_INFLAMMATORY_RESPONSE_LIVE_DN,1/77,377/21728,0.7407928906008436,0.753452597227759,0.6230029665845939,RMND1,1
BLANCO_MELO_BETA_INTERFERON_TREATED_BRONCHIAL_EPITHELIAL_CELLS_UP,BLANCO_MELO_BETA_INTERFERON_TREATED_BRONCHIAL_EPITHELIAL_CELLS_UP,1/77,378/21728,0.7417276921288156,0.753452597227759,0.6230029665845939,DCLRE1C,1
MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP,MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP,1/77,378/21728,0.7417276921288156,0.753452597227759,0.6230029665845939,NAP1L1,1
RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN,RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN,1/77,383/21728,0.7463520185030331,0.7576293154859086,0.6264565453166726,SAR1A,1
VECCHI_GASTRIC_CANCER_EARLY_DN,VECCHI_GASTRIC_CANCER_EARLY_DN,1/77,384/21728,0.7472670287899982,0.758037521312023,0.6267940760937672,PPP2R3A,1
STEIN_ESRRA_TARGETS_UP,STEIN_ESRRA_TARGETS_UP,1/77,385/21728,0.7481787809818633,0.7584418643972524,0.6271284129087743,VDAC2,1
CHYLA_CBFA2T3_TARGETS_UP,CHYLA_CBFA2T3_TARGETS_UP,1/77,387/21728,0.7499925568368075,0.759759423581084,0.6282178554074771,RALB,1
BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP,BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP,1/77,390/21728,0.7526890698449648,0.7619687981033273,0.6300447080677752,NAP1L1,1
JINESH_BLEBBISHIELD_TO_IMMUNE_CELL_FUSION_PBSHMS_UP,JINESH_BLEBBISHIELD_TO_IMMUNE_CELL_FUSION_PBSHMS_UP,1/77,395/21728,0.7571196069183561,0.7659293490933131,0.6333195458281721,DIAPH1,1
JINESH_BLEBBISHIELD_TO_IMMUNE_CELL_FUSION_PBSHMS_DN,JINESH_BLEBBISHIELD_TO_IMMUNE_CELL_FUSION_PBSHMS_DN,1/77,402/21728,0.7631910215234674,0.7715433172446545,0.6379615350196167,ONECUT2,1
CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_DN,CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_DN,1/77,408/21728,0.7682756849258853,0.7761527425293633,0.6417729036938898,NUS1,1
RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP,RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP,1/77,412/21728,0.7716054381020652,0.7789841786303636,0.6441141167935704,MPZL1,1
MOOTHA_PGC,MOOTHA_PGC,1/77,421/21728,0.7789256893840985,0.7858376579588379,0.6497810133823879,GTPBP4,1
RUTELLA_RESPONSE_TO_HGF_UP,RUTELLA_RESPONSE_TO_HGF_UP,1/77,422/21728,0.7797246156485855,0.7861070818066913,0.6500037903123486,MPZL1,1
SWEET_LUNG_CANCER_KRAS_DN,SWEET_LUNG_CANCER_KRAS_DN,1/77,423/21728,0.7805206920869157,0.7863732671468721,0.6502238894363069,METAP1,1
BOCHKIS_FOXA2_TARGETS,BOCHKIS_FOXA2_TARGETS,1/77,433/21728,0.7883269059701037,0.7931566827936102,0.6558328528761351,TIAL1,1
CUI_TCF21_TARGETS_2_UP,CUI_TCF21_TARGETS_2_UP,1/77,433/21728,0.7883269059701037,0.7931566827936102,0.6558328528761351,RPL12,1
ODONNELL_TFRC_TARGETS_UP,ODONNELL_TFRC_TARGETS_UP,1/77,434/21728,0.7890922888412144,0.7933866686444319,0.6560230199388829,NACA,1
IVANOVA_HEMATOPOIESIS_EARLY_PROGENITOR,IVANOVA_HEMATOPOIESIS_EARLY_PROGENITOR,1/77,449/21728,0.8002505542219707,0.8040586805846857,0.6648473243777652,BCOR,1
REACTOME_RHO_GTPASE_CYCLE,REACTOME_RHO_GTPASE_CYCLE,1/77,450/21728,0.8009733657885343,0.8042382028773463,0.6649957649316993,DIAPH1,1
MARTENS_BOUND_BY_PML_RARA_FUSION,MARTENS_BOUND_BY_PML_RARA_FUSION,1/77,456/21728,0.8052563366321295,0.8079897254190681,0.6680977645549022,RPS6,1
MCCABE_BOUND_BY_HOXC6,MCCABE_BOUND_BY_HOXC6,1/77,458/21728,0.8066636771262866,0.8088527237399264,0.66881134695680855,CHMP1B,1
HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP,HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP,1/77,461/21728,0.8087558864922172,0.810400813718981,0.6700914071132661,NFYA,1
DELACROIX_RAR_BOUND_ES,DELACROIX_RAR_BOUND_ES,1/77,467/21728,0.8128734903697264,0.8139749449637234,0.6730467282265387,GTPBP4,1
ONDER_CDH1_TARGETS_2_DN,ONDER_CDH1_TARGETS_2_DN,1/77,473/21728,0.8169035665329267,0.8174566495163613,0.675925625018514,CLIP4,1
MEISSNER_NPC_HCP_WITH_H3K4ME2,MEISSNER_NPC_HCP_WITH_H3K4ME2,1/77,493/21728,0.8297283069361334,0.8297283069361334,0.686072619010648,ONECUT2,1
